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Summary 
Endosomal sorting complex required for transport (ESCRT) proteins are 
conserved between Archaea, yeast and mammalian cells. ESCRT proteins 
mediate membrane scission events in the downregulation of ubiquitin-labelled 
receptors via the multivesicular body (MVB) pathway and HIV budding from host 
cells. In addition, ESCRT proteins have an established role in the final stage of 
cytokinesis, abscission, although the functional mechanisms by which they 
mediate daughter cell separation have yet to be demonstrated biochemically in 
vivo. 
The ESCRT machinery is composed of four subunits: ESCRT-0, -I, -II and -III; and 
the modular composition of the ESCRT machinery is reflected in its various 
functions. ESCRT proteins are recruited sequentially to the endosomal 
membrane for MVB formation: first, ESCRT-0 sequesters ubiquitylated cargo 
destined for degradation; second, ESCRT-I and II deform the peripheral 
membrane to produce a bud; and third, ESCRT-III constricts the bud neck to form 
an intralumenal vesicle. Thereafter, AAA-ATPase Vps4 redistributes ESCRT-III 
subunits back into the cytoplasm to mediate further MVB formation; it is the 
association of ESCRT-III and Vps4 that forms the conserved membrane scission 
machinery in all ESCRT functions. 
At a precise time during late cytokinesis, ESCRT-I protein TSG101 and ESCRT-
associated protein ALIX are recruited to the midbody where they localise to both 
sides of the dense proteinaceous Flemming body through interactions with 
CEP55; TSG101 and ALIX in turn recruit ESCRT-III components. Immediately 
before abscission, ESCRT-III redistributes outwards from the Flemming body to 
the abscission site; microtubules are severed and the daughter cells separate. 
Thereafter, ESCRT-III appears on the opposite side of the Flemming body and the 
process is repeated to produce the midbody remnant. How this selective and 
specific redistribution of ESCRT proteins is regulated in space and time remains 
unsolved. 
To this end, polo kinase and Cdc14 phosphatase were identified as potential 
regulators of ESCRT function, due to their significant functions in regulating 
cytokinesis. Homologues in the fission yeast Schizosaccharomyces pombe, Plo1p 
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and Clp1p, are required for either formation or stabilisation of the contractile 
ring that drives cytoplasmic cleavage. Furthermore, human polo-like kinase, 
Plk1, maintains CEP55 in a phosphorylated state to negatively regulate its 
localisation to the midbody; and although Plk1 proteolysis facilitates abscission 
complex assembly, Plk1 re-emerges at the midbody late during cytokinesis. It 
was hypothesised, therefore, that polo kinase and Cdc14 phosphatase regulate 
members of the ESCRT machinery to mediate cytokinetic abscission. 
To address this, fission yeast was used to study interactions between Plo1p, 
Clp1p and ESCRT proteins. Initially, ESCRT function in fission yeast cytokinesis 
was examined by characterising formation of the specialised medial cell wall, 
the septum, in individual ESCRT deletion strains. ESCRT genes were shown to be 
required for cytokinesis and cell separation in fission yeast, implying a role for 
the ESCRT proteins in this process.  
A yeast genetics approach was then employed to investigate genetic interactions 
between ESCRT genes and plo1+ and clp1+. Double mutants were produced from 
crosses between ESCRT deletion strains and mutants of plo1 and clp1. Synthetic 
defective growth rates were observed in double mutants, indicating genetic 
interactions between plo1+, clp1+ and ESCRT genes. The effect of single ESCRT 
deletions on vacuolar sorting in fission yeast was characterised. Single mutants 
of plo1 and clp1 were also shown to affect vacuolar sorting, indicating novel 
roles for these proteins in fission yeast. Analysis of vacuolar sorting in double 
mutants provided further characterisation of observed genetic interactions: 
plo1+ was regarded to function upstream of ESCRT genes, and clp1+ downstream. 
The yeast two-hybrid assay was used to further analyse interactions. Physical 
interactions were observed between Plo1p and Sst4p (human HRS, ESCRT-0), 
Vps28p (VPS28, ESCRT-I), Vps25p (EAP20, ESCRT-II), Vps20p (CHMP6, ESCRT-III) 
and Vps32p (CHMP4, ESCRT-III). Clp1p was also shown to interact with Vps28p.  
Interactions were then investigated between human homologues of these 
proteins in HEK293 cells. Immunoprecipitation and co-immunoprecipitation 
methods revealed interactions between Plk1 and CHMP6, CHMP4B, CHMP3 and 
CHMP2A (all ESCRT-III). Furthermore, interactions were demonstrated between 
CDC14A and CHMP4B and CHMP2A. 
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These results indicate that polo kinase and Cdc14 phosphatase have conserved 
roles in regulating ESCRT components. Characterising the nature and functional 
significance of this regulation may inform future approaches in disease 
prevention. 
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Chapter 1 Introduction 
1.1 Cell division is a well-regulated network of events 
1.1.1 Cell division consists of nuclear and cytoplasmic divisions 
From self-serving single-celled organisms to the most complex sentient beings to 
walk this planet, every life form is required to multiply – or else make way for 
another to thrive in its place. To this end, cells of all branches of life have 
developed intricate mechanisms to multiply their genetic material and 
effectively divide it among offspring. Cell division consists of two processes: 
nuclear division, mitosis, and cytoplasmic division, cytokinesis (Balasubramanian 
et al. 2004). 
Following the successful replication of DNA in interphase, cells enter mitosis. 
The first stage is prophase, wherein the chromosomes condense and the 
duplicated centrosomes generate the mitotic spindle. In prometaphase, the 
nuclear membrane breaks down and chromosomes attach to the spindle. In 
metaphase, chromosomes are arranged along the equator of the spindle, and 
then separate and move towards opposite poles during anaphase. By telophase, 
the chromosomes have reached opposite poles and the nuclear envelope re-
forms for each of the new daughter nuclei. Cytokinesis begins early in anaphase 
with the assembly of the actomyosin contractile ring. The actomyosin ring then 
constricts to rapidly ingress the plasma membrane and divide the cytoplasm in 
two; membrane fusion events then resolve the membrane to separate the two 
daughter cells. Regulatory mechanisms are required to temporally restrict DNA 
replication, mitosis and cytokinesis in a manner that ensures chromosome 
segregation follows duplication, and that cytokinesis is halted in the event that 
the requirements of a checkpoint are not met (Balasubramanian et al. 2004).  
The events of the cell cycle can be described within the parameters of four 
successive phases: G1, S, G2 and M (Forsburg and Nurse 1991). S phase refers to 
the period in which genetic material is duplicated, and M in which this material 
is separated between progeny. G1 and G2 represent gap phases in which the cell 
grows, and various checks are made prior to DNA synthesis and mitosis, 
respectively. In higher eukaryotes, such as humans, incorrect regulation of the 
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cell cycle is a major cause of disease, most prominently cancer. Therefore, cell 
cycle control is crucial to maintain the fidelity and proper timing of events. 
These checks and balances, therefore, preserve the genetic integrity of offspring 
and ensure that they receive sufficient provisions for life.  
1.1.2 Cell cycle control by cyclin-dependent kinases 
The key inducer of mitosis among several eukaryotes is the well-conserved 
family of cyclin-dependent kinases (Cdks), a class of serine/threonine kinases. 
Human cells possess four Cdk homologues, of which Cdk1 is the master regulator 
of S phase and mitosis. The budding yeast Saccharomyces cerevisiae and the 
fission yeast Schizosaccharomyces pombe possess one unique Cdk each, Cdc28 
and Cdc2p, respectively. Cdks regulate the cell cycle by phosphorylating 
substrates in a cell cycle-dependent manner to mediate functions including 
initiation of DNA replication, chromosome condensation, nuclear envelope 
breakdown and cytoskeletal reorganisation. Due to their diverse and important 
functions, Cdk activity is tightly regulated throughout the cell cycle. Cdk activity 
is mediated by various mechanisms, including modification of its phosphorylation 
state and cell cycle-specific associations with either stimulatory or inhibitory 
subunits (Morgan 1995).  
Cdks are named for their association with cyclin to form an active heterodimer. 
Eukaryotic cells possess distinct cyclin subunits that differentially associate with 
Cdks for their activation at different stages of the cell cycle. Cellular levels of 
cyclins oscillate according to expression levels and targeted proteolysis (Koepp 
et al. 1999). In mammalian cells, Cyclin B associates with Cdk1 to drive mitosis. 
Cdk is inactive as a monomer, thus controlling cyclin levels in cells provides an 
elaborate method of controlling Cdk activity. Four cyclin subunits exist in fission 
yeast, of which only Cdc13p is essential for cell survival, due to its association 
with fission yeast Cdk, Cdc2p, to drive mitosis and inhibit re-initiation of S phase 
(Hayles et al. 1994). Cdc2p activity must be abolished for mitotic exit, and 
among the methods fission yeast employs to decrease Cdc2p activity is by 
directing Cdc13p for ubiquitin-dependent degradation according to its N-
terminal ‘destruction box’ motif (Yamano et al. 2000). Cdk functions in fission 
yeast and human cells will be mentioned further in Sections 1.3 and 1.4. 
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The research topic of this study is the conserved requirement and regulation of a 
multi-protein complex in cytokinesis. This introductory chapter will begin with a 
brief discussion on the effectiveness of using fission yeast as a model organism 
for cytokinesis. Thereafter, with relevance to this thesis, the key regulators of 
cytokinesis, polo kinase and Cdc14 phosphatase, will be described. Focus will 
then turn to the multi-protein complex, the ESCRT proteins. Finally, the 
predominant models of mammalian abscission will be outlined, with particular 
emphasis on the role of ESCRT proteins.  
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1.2 Schizosaccharomyces pombe as a model organism 
for cytokinesis 
1.2.1 Fission yeast facilitates rapid genetic and protein analysis 
Fission yeast are rod-shaped cells that divide by fission following formation of a 
medial cell wall, termed septation. Fission yeast provides an attractive model 
organism in which to study cytokinesis due to the ease by which it may be 
genetically manipulated and phenotypically characterised, including by 
microscopy. It is also, with respect to mammalian cells, simple and inexpensive 
to handle, and crucially, the genes used for cytokinesis have been well 
conserved among eukaryotes. This can be illustrated in fission yeast lacking the 
major cell cycle regulator cdc2+, as function can be rescued in such mutants by 
incorporating its human homologue (Lee & Nurse 1987). Furthermore, studies in 
fission yeast cytokinesis have uncovered a greater catalogue of knowledge 
regarding contractile ring assembly, constriction and disassembly than in any 
other organism (Pollard & Wu 2010). 
1.2.2 Cytokinesis proceeds by the assembly and constriction of 
an actomyosin contractile ring 
As in humans, fission yeast cytokinesis proceeds with the assembly, maturation 
and constriction of an actomyosin contractile ring, although this process begins 
earlier in fission yeast than in animal cells (Burgess & Chang 2005). Many aspects 
of this system are conserved among higher eukaryotes, including the basic 
composition of the actomyosin ring. However, unlike fission yeast, which marks 
the division plane by the position of the nucleus, human cells determine the 
division plane by the position of the mitotic apparatus. The purpose of 
cytokinesis is to produce two daughter cells with identical nuclei, therefore 
correct positioning and timely contraction of the actomyosin ring is absolutely 
crucial. 
Studies in fission yeast revealed the existence of precursors to the contractile 
ring, membrane-associated interphase nodes, which together with the nucleus 
determine the division site (Vavylonis et al. 2008). Polo kinase, Plo1p, releases 
Mid1p from the nucleus, which matures the interphase nodes into cytokinesis 
nodes by the addition of myosin-II and proteins required for actin assembly and 
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ring stability (Pollard & Wu 2010). Mid1p is required for correct ring positioning, 
and mutations in mid1+ lead to aberrant ring positioning and septation 
(Sohrmann et al. 1996). Fluorescence recovery after photobleaching of myosin-II 
light chain revealed rapid recovery, indicative of highly dynamic protein 
exchanges during maturation of nodes (Vavylonis et al. 2008). Nucleated actin 
forms a network between nodes, which initiates myosin-II-mediated movement 
of nodes to bundle in order to establish a contractile ring attached to the plasma 
membrane. Ring contraction then proceeds via interactions between actin and 
myosin-II, possibly in the same sliding mechanism known to occur in striated 
muscle; although unlike in muscle, actin is lost as the ring contracts (Pollard & 
Wu 2010).  
Well-coordinated timing of chromosome segregation and ring constriction is 
crucial, and part of this requirement is the downregulation of Cdc2p, whose 
activity inhibits cytokinesis (Krapp et al. 2004). The septation initiation network 
(SIN) is responsible for downregulating Cdc2p, and this signalling cascade is 
further responsible for plasma membrane ingression with deposition of a 
specialised cell wall, the septum (Jin et al. 2006).  
1.2.3 Fission yeast septation is analogous to cytokinesis in 
higher eukaryotes 
The septation initiation network is a signalling cascade consisting of protein 
kinases and a GTPase, Spg1p. SIN components assemble at the spindle pole 
bodies via interactions with scaffolding proteins Sid4p and Cdc11p and are 
required for actomyosin ring maturation and contraction, as well as septal 
deposition (Krapp et al. 2004). Plo1p kinase associates with Sid4p to promote the 
Spg1p active state, making Plo1p a key regulator of cytokinesis in fission yeast 
(Krapp et al. 2004).  
SIN signalling is not required for formation of the contractile ring, as rings have 
been shown to form in fission yeast with mutations in SIN genes; however, rings 
fail to contract, and are subsequently disassembled (Jin et al. 2006). Although 
the processes by which ring stability is achieved by the SIN pathway are not fully 
understood, it is known that SIN signalling is required for phosphorylation of 
Cdc14-like phosphatase 1, Clp1p, which is then retained in the cytosol and 
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anchored to the actomyosin ring by Mid1p (Hachet & Simanis 2008; Chen et al. 
2008; Clifford et al. 2008). In its free and active state, Clp1p is able to 
dephosphorylate Cdc15p, a component of mature cytokinesis nodes, which in 
turn contributes to ring stability (Pollard & Wu 2010).  
The final step of fission yeast cell division is medial fission by formation of a 
multi-layered septum, composed of one primary septum at the site of 
constriction, and two secondary septa that subsequently form the new ends of 
the daughter cells (Johnson et al. 1973). Centripetal primary septal deposition 
occurs simultaneously with constriction of the actomyosin ring (Liu et al. 1999). 
The processes required for the dissolution of the primary septum still remain 
unclear, although it has been noted that lessons learned from fission yeast 
septation may enhance our understanding of cytokinesis in mammalian cells (Jin 
et al. 2006; Pollard & Wu 2010). 
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1.3 Polo kinase is a key regulator of cytokinesis 
1.3.1 Polo kinase functions are well-conserved between species 
Polo kinase was first identified in Drosophila melanogaster, in which mutants 
resulted in monopolar spindles and condensed chromosomes (Sunkel & Glover 
1988). Homologues have since been identified in humans, budding and fission 
yeasts, and several other organisms. DNA and protein analyses have since 
identified sequences and motifs of interest, principally, a highly conserved N-
terminal kinase domain and two regulatory polo box regions at the C-terminus. 
Structural and functional studies have shown that polo boxes act as a single 
functional domain for phosphopeptide recognition; thus, polo kinase 
preferentially selects substrates that have been previously phosphorylated, 
particularly by Cdk (Elia et al. 2003). Polo box domains also mediate substrate 
interactions and polo kinase subcellular localisation (Reynolds & Ohkura 2003). 
Furthermore, polo box domains function to maintain the inactive form of human 
polo, Plk1, as polo box and kinase domains have been shown to associate with 
each other; stimulatory phosphorylation by Aurora A on Thr210 relieves the 
inhibitory effect of polo box association (Jang et al. 2002; Seki et al. 2008). 
Polo kinases are key regulators of mitotic events and cytokinesis, with well-
conserved functions between eukaryotes, from amplifying Cdk activity to induce 
mitosis, to promoting chromatid separation (Toyoshima-Morimoto et al. 2001; 
Sumara et al. 2002). A number of these functions in fission yeast and human 
cells will be explored. 
1.3.2 Fission yeast Plo1p controls cytokinesis and septation 
Mutants of fission yeast plo1+ provided the first evidence of a role for Plo1p in 
cytokinesis. Ohkura et al. (1995) conducted several experiments using various 
mutant and over-expressing strains to demonstrate the significance of plo1+ in 
mitotic progression and septal formation. By switching off plo1+ expression, they 
characterised three phenotypes: cells with a cluster of over-condensed 
chromosomes, and unseptated cells with either two clusters of over-condensed 
chromosomes or two uncondensed interphase nuclei. By repressing transcription 
of plo1+ using an nmt (not-made-in-thiamine) promoter (Maundrell 1993), they 
characterised a further phenotype whereby the cells failed to form a septum but 
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still underwent one or two nuclear divisions, the result of which being 
unseptated cells with multiple nuclei (Ohkura et al. 1995). This was confirmed 
by fluorescence microscopy of cells stained with Calcofluor and DAPI. The nmt 
repression was also utilised to demonstrate that plo1+ is involved in the 
formation of the contractile ring. Shortly after the daughter cells separate, actin 
is localised at the newly divided end of the cell. It then localises to both poles of 
the cell during interphase and subsequently forms a ring around the 
circumference in a plane determined by the location of the nucleus. However, 
on repressing plo1+ activity, less than 20% of cells formed the actin ring.  
A series of over-expression experiments were also described which revealed cells 
with over-condensed chromosomes, or an interphase nucleus compressed or 
displaced by one or more septa (Ohkura et al. 1995). These experiments further 
demonstrated that Plo1p is a key regulator of septal formation as over-
expression in G1 or G2 cells gave rise to the septum. However, Plo1p regulates 
septal formation via the SIN pathway (Section 1.2.3), so spontaneous septal 
formation is only apparent in cells with a functional SIN pathway (Tanaka et al. 
2001). Although human cells lack septa, it has been noted that the influence 
Plo1p exerts on septation may have consequences for cytokinesis in higher 
eukaryotes (Ohkura et al. 1995). 
Plo1p phosphorylates Mid1p, which is required for correct positioning of the 
actomyosin contractile ring (Section 1.2.2). Mid1p resides predominantly in the 
nucleus during interphase and Plo1p is required for Mid1p nuclear exit during 
early mitosis; plo1+ over-expression leads to premature exit of Mid1p from the 
nucleus (Bähler et al. 1998). Furthermore, Plo1p phosphorylates multiple 
residues in the Mid1p N-terminus; phosphorylation of these residues is indirectly 
required for myosin-II recruitment (Almonacid et al. 2011). Plo1p, therefore, 
couples mitotic onset with contractile ring assembly. 
1.3.3 Human Plk1 controls cytokinesis 
Similar to its yeast counterparts, human Plk1 is required for the rapid 
amplification of Cdk1 activity to induce mitotic entry; Plk1 achieves this by 
multiple means. Firstly, Plk1 phosphorylates CDC25C, the activating phosphatase 
of Cdk1-Cyclin B; Plk1 phosphorylation of CDC25C in a nuclear export signal 
Chapter 1  25 
 
sequence activates CDC25C and causes translocation to the nucleus (Toyoshima-
Morimoto et al. 2002). Secondly, Plk1 phosphorylates Cdk1-Cyclin B inhibitory 
kinases, Wee1 and Myt1; in the case of Wee1, Plk1 phosphorylation leads to 
proteolysis (Watanabe et al. 2004; Nakajima et al. 2003). Additionally, Plk1 
phosphorylates Cyclin B at centrosomes, which may cause nuclear translocation 
of Cdk1-Cyclin B (Toyoshima-Morimoto et al. 2001). It is by these mechanisms 
that Plk1 triggers the activation of Cdk1-Cyclin B, and thus mitosis, in human 
cells. 
The dynamic control of cytokinesis by Plk1 is reflected in dynamic localisation of 
Plk1 at specific structures throughout mitosis and cytokinesis. Plk1 localisation is 
diffuse during interphase and then targeted to centrosomes late in G2 phase. 
Plk1 persists at centrosomes and kinetochores throughout mitosis, although a 
significant sub-population translocates to the midbody during cytokinesis 
(Golsteyn et al. 1995; Taniguchi et al. 2002). Plk1 is recruited to the midbody by 
PRC1, the microtubule-associated protein regulating cytokinesis 1, and Plk1 
itself primes PRC1 for secondary phosphorylation post-anaphase. To prevent 
early recruitment to the midbody during prophase or prometaphase, PRC1 exists 
in a phosphorylated state, thus inhibiting untimely midbody formation (Neef et 
al. 2003; Hu et al. 2012). Plk1 localisation to the midbody is essential for 
cytokinesis, as Plk1 initiates actomyosin ring formation by recruiting guanine 
nucleotide exchange factor ECT2 to activate GTPase RhoA, which in turn drives 
actin polymerisation and myosin activation (Petronczki et al. 2007). 
Furthermore, Plk1 downregulation is required for translocation of CEP55 to the 
midbody for assembly of the abscission machinery (Section 1.5.6); however, Plk1 
levels peak again late in cytokinesis (Hu et al. 2012), which may reveal further 
functions for Plk1 in cytokinesis. 
1.3.4 Polo kinase function is subject to spatiotemporal control 
Temporal activation of polo kinase is essential for the temporal control of 
cytokinesis. Polo kinase activity is subject to various levels of control, including 
transcriptional activation, subcellular localisation, and substrate selectivity by 
phospho-priming. 
Chapter 1  26 
 
In addition to dynamic localisation of Plk1 during mitosis (Section 1.3.3), Plk1 is 
controlled by dynamic gene expression, as expression levels peak during G2 and 
M phase, as a result of directed transcription followed by proteolysis (Laoukili et 
al. 2005; Lindon & Pines 2004). Fission yeast mRNA analysis has revealed that 
plo1+ is one of approximately 40 genes that are transcribed in a wave at the 
M/G1 interval (Ng et al. 2006). Many of these genes, including plo1+, share an 
upstream activating sequence known as the pombe cell cycle box (PCB); this is 
upregulated by a complex of proteins termed the PCB-binding factor (PBF) 
(Anderson et al. 2002). Plo1p itself has been shown to phosphorylate Mbx1p, a 
member of the PBF, thus contributing to its own regulation (Papadopoulou et al. 
2010). Homologues of this system, termed forkhead homologue-dependent 
transcription factor (FKH-TF), have been found in budding yeast and humans. 
Interestingly, the human forkhead transcription factor, FOXM1, has been shown 
to drive G2/M-specific PLK1+ transcription and is itself a substrate for Plk1 
phosphorylation (Laoukili et al. 2005; Fu et al. 2008). Therefore, similar to the 
Mbx1p-directed Plo1p positive feedback loop observed in fission yeast, Plk1 
drives activation of its own gene expression by phospho-activation of FOXM1. 
The two C-terminal polo-box regions conserved among all polo kinases fold to 
form one functional polo box domain, which then binds phosphorylated peptides 
(Section 1.3.1). Therefore, Plk1 function can be restricted and directed to 
particular phospho-primed substrates; Cdk1 or even Plk1 itself may conduct this 
priming phosphorylation (Park et al. 2010). 
Polo kinases are subject to tight regulation for the orderly completion of mitosis 
and cytokinesis. By increasing expression of polo kinase at particular times in the 
cell cycle, and targeting its functions towards specific substrates, cells are able 
to spatially and temporally control polo kinase for maximum effect.  
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1.4 Cdc14 phosphatase is a key regulator of cytokinesis 
1.4.1 Cdc14 functions are well-conserved between species 
Cdc14 was first identified in budding yeast as a phosphatase responsible for 
downregulation of Cdk activity and mitotic exit. Homologues have since been 
identified in fission yeast, mammalian cells and other organisms. This highly 
conserved protein-tyrosine phosphatase family have important functions in 
conducting dephosphorylation events required for mitotic exit and have roles in 
cytokinesis (Mocciaro & Schiebel 2010).  
Budding yeast Cdc14 is localised in the nucleolus during interphase, but is 
released via the mitotic exit network (MEN) and causes the downregulation of 
Cdc28 via the proteolysis of Clb, homologous to human Cdk1-Cyclin B 
(Trautmann et al. 2001). MEN signalling facilitates the full release of Cdc14 from 
the nucleolus via a positive feedback look driven by Cdc14 itself. Furthermore, a 
negative feedback loop incorporating Cdc28 drives Cdc14 release from the 
nucleolus during anaphase via the disruption of the interaction between Cdc14 
and its competitive inhibitor, Net1/Cfi1 (Visintin et al. 1999). This interaction 
has proven to be temporally significant as disruption during any stage of the cell 
cycle leads to downregulation of Cdc28.  
Cdc14 is retained in the cytoplasm by the MEN and conducts dephosphorylation 
events at the kinetochores, spindle body and contractile ring that antagonise 
Cdc28 activity to drive mitotic exit, as Cdc14 phosphatases have been revealed 
to elicit preferential binding to substrates of proline-directed kinases, such as 
Cdk (Wolfe et al. 2006; Clifford et al. 2008; Lanzetti et al. 2007). Cdc28 is 
needed for mitotic entry, but its activity must be downregulated for mitotic exit 
and cytokinesis (Trautmann et al. 2001; Section 1.1.2). Cdc14 drives Clb cyclin 
proteolysis by dephosphorylating Cdh1, which activates APC/C-mediated 
proteolysis of Clb (Schwab et al. 1997). Furthermore, Cdc14 activates by 
dephosphorylation the Cdc28 inhibitor Sic1, as well as its transcription factor, 
Swi5; this contributes to stable expression of Sic1 and thus deactivation of Cdc28 
(Visintin et al. 1998). Similar transcription factor activation has been noted in 
Caenorhabditis elegans but appears absent in fission yeast (Saito et al. 2004; 
Lanzetti et al. 2007). 
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1.4.2 Clp1p maintains orderly M/G1 progression 
Unlike its budding yeast homologue, fission yeast Clp1p is not required for 
mitotic exit, but is required for synchronising cytokinesis with the next cell 
cycle. Deletion mutants of clp1 result in defects in chromosome segregation and 
cytokinesis (Trautmann et al. 2004). Clp1p is released early in mitosis from the 
nucleolus; however, the fission yeast homologue of the MEN, the SIN, is not 
required for this process, but is required to retain Clp1p in the cytoplasm 
(Trautmann et al. 2001). Clp1p then antagonises Cdk Cdc2p, which leads to SIN 
activation. This coordinates cytokinesis and septation with the next cell cycle, in 
which Cdc2p plays a major role. Fission yeast Clp1p-mediated downregulation of 
Cdc2p activity is more direct than that of Cdc14 upon Cdc28 in budding yeast 
(Figure 1.1). 
 
 
 
 
 
 
Figure 1.1: Feedback loops within fission yeast signalling contribute to Cdc2p 
downregulation. 
Clp1p downregulates Cdc2p by dephosphorylating an inhibitory kinase, Wee1p, and 
an activating phosphatase, Cdc25p. Cdc2p exerts kinase downregulation on Clp1p, 
which is capable of auto-dephosphorylation. Both Clp1p and Cdc2p control common 
substrates via their phosphorylation status. Blue, activation; red, inhibition. 
Cdc2p self-regulates by the phosphorylation of its activator and inhibitor 
(Trautmann et al. 2001). Wee1p is a protein kinase that phosphorylates Cdc2p to 
inhibit its function and Cdc25p is a phosphatase that acts in opposition to 
Wee1p, thus activating Cdc2p. Clp1p, therefore, downregulates Cdc2p activity in 
a direct manner by dephosphorylating both its activator and inhibitor. Clp1p 
further antagonises Cdc2p activity by reversing inhibitory Cdc2p-dependent 
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phosphorylation events. For instance, Sid1p is a component of the SIN whose 
localisation is inhibited by Cdc2p; it is possible that this inhibition is relieved not 
only by the downregulation of Cdc2p, as mediated by Clp1p, but that Clp1p 
reverses the phosphorylation of Sid1p, thus activating the SIN in a direct 
manner. 
1.4.3 Temporal control of Clp1p activation is required for M/G1 
progression 
Regulation of Clp1p differs from the regulation of Cdc14 in budding yeast, which 
is primarily at the level of control of localisation (Wolfe et al. 2006). Clp1p is 
released from the nucleolus at the start of mitosis and concentrates at the 
kinetochores and contractile ring; however, despite being capable of binding 
substrates, it does not conduct dephosphorylation events until mitotic exit. It 
must therefore follow that Clp1p is otherwise regulated. It has been suggested 
that following release from the nucleolus, Clp1p is phosphorylated by Cdc2p, but 
then auto-dephosphorylates during anaphase to activate SIN signalling (Wolfe et 
al. 2006). This auto-dephosphorylation in the presence of substrates may elicit a 
temporal activation of Clp1p substrates, as they would therefore bind in order of 
affinity. 
1.4.4 Clp1p regulates ring stability and contraction 
Mutants of clp1 reveal negative genetic interactions with several cytokinetic 
genes, including those required for assembly of the actomyosin ring and septal 
formation. Mid1p is required for proper assembly and orientation of the 
contractile ring (Section 1.2.2). Mid1p plays a scaffolding role at the contractile 
ring and Clp1p is included in its list of substrates (Clifford et al. 2008). Clp1p 
may play several important roles at the contractile ring, including regulating the 
mobility of Cdc15p, which is required for ring stability, and myosin-II, which is 
required for contraction with actin. Disruption of the Mid1p-Clp1p interaction 
has particularly deleterious effects on cytokinesis in fission yeast strains already 
compensating for otherwise silent mutations in actomyosin ring components, 
thus confirming an important role for Mid1p recruitment to the cytokinetic 
machinery. Clp1p remains at the ring until the end of cytokinesis and then 
returns to the nucleolus.  
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1.4.5 Clp1p controls M/G1 gene expression 
Clp1p has also emerged as a mediator of cell cycle-specific gene expression via 
the PBF-PCB complex (Papadopoulou et al. 2010; Section 1.3.4). Mbx1p, a 
member of the PBF, is phosphorylated and activated by both Plo1p and Cdc2p; 
Cdc2p phosphorylation is reversed by Clp1p to attenuate gene expression. In 
fission yeast with clp1Δ null mutation, gene expression occurs throughout the 
cell cycle, therefore, Clp1p serves to temporally restrict gene expression to the 
M/G1 interval. This direct involvement of Clp1p in gene expression is not 
conserved in budding yeast Cdc14 function, although Cdc14 does 
dephosphorylate transcription factors to allow them to enter the nucleus 
(Section 1.4.1), thus upregulating transcription, as opposed to Clp1p which 
downregulates.  
1.4.6 The role of human CDC14 in mitosis and cytokinesis is less 
well characterised 
Human cells possess two Cdc14 homologues, CDC14A and CDC14B, sharing 
between them approximately 50% sequence homology, predominantly in the N-
terminal region encompassing the protein-tyrosine phosphatase catalytic domain 
(Lanzetti et al. 2007). Although human CDC14 is less well characterised than its 
yeast counterparts, mutants of CDC14A result in cytokinetic defects (Kaiser et 
al. 2002).  
Human CDC14 isoforms exhibit differential subcellular localisation and functions. 
CDC14A localises to the centrosomes during interphase and at the spindle 
midzone and midbody during mitosis and cytokinesis. On the other hand, CDC14B 
is found predominantly in the nucleolus of interphase cells, and then at the 
spindle apparatus of mitotic cells (Kaiser et al. 2002). CDC14A depletion results 
in delayed centrosome separation and chromosome segregation, and defects in 
cytokinesis (Mailand et al. 2002; Lanzetti et al. 2007). Furthermore, and related 
to its budding yeast homologue (Section 1.4.1), CDC14A has been shown to 
phosphorylate CDH1 in vitro, which lead to reconstitution of the APC/C-CDH1 
proteolytic module. This suggests a mechanism similar to budding yeast by which 
CDC14A may degrade cyclin subunits in human cells (Bembenek & Yu 2001). 
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Less is known about CDC14B function, although stabilising activities related to 
microtubules may suggest a role in regulating spindle dynamics in mitosis 
(Asakawa & Toh-e 2002).  
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1.5 Abscission is mediated by the ESCRT proteins 
1.5.1 Abscission occurs at the midbody in mammalian cells 
Actomyosin ring constriction and furrow ingression in mammalian cells results in 
the formation of the midbody bridge connecting two daughter cells. At the 
centre of the midbody resides the Flemming body, a dense proteinaceous ring 
surrounding the interlocking ends of anti-parallel microtubule arrays. Abscission 
occurs at the midbody bridge and is mediated by signals from the Flemming body 
(Neto & Gould 2011; Schiel & Prekeris 2010). Abscission can be divided into two 
broad mechanisms: first, the formation of the abscission zone, and second, 
microtubule severing and membrane scission mediated by the endosomal sorting 
complex required for transport (ESCRT) proteins. 
1.5.2 Vesicular trafficking is required for secondary ingression 
At the completion of furrowing, an intercellular bridge connects daughter cells. 
Present models suggest that a further ingression, so-called secondary ingression, 
is required to thin the bridge diameter prior to the membrane scission event, as 
the diameter of the bridge at the Flemming body is too great for membrane 
remodelling machinery such as the ESCRT proteins (Elia et al. 2011). Hence, 
membrane scission is conducted at secondary ingression sites located 
approximately 1 µm from the centre of the Flemming body. The fusion of 
membrane vesicles with each other and the plasma membrane in the 
intercellular bridge mediates the formation of secondary ingression sites, a 
process that involves the trafficking of Rab GTPase-positive secretory and 
endosomal vesicles (Schiel et al. 2011; Wilson et al. 2005; Goss & Toomre 2008). 
Such extensive vesicular recruitment to the midbody requires machinery for 
spatial targeting and tethering to the plasma membrane, and as such, the 
exocyst has been implicated in mammalian cytokinesis. The exocyst is a 
multimeric protein complex with roles in membrane tethering to the plasma 
membrane; fission yeast with mutated exocyst components are unable to cleave 
following septum formation, and defects have also been noted in plant 
cytokinesis (Sztul & Lupashin 2006; Martín-Cuadrado et al. 2005; Fendrych et al. 
2010). Furthermore, exocyst components have been shown to interact with 
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known regulators of abscission, such as endosomal GTPases Rab11 and Arf6 
(Fielding et al. 2005; Cascone et al. 2008).  
Rab11 and its effector FIP3 are implicated in cytokinetic membrane trafficking 
(Neto et al. 2011). Rab11 recruits FIP3 to vesicles of the recycling endosomes, 
and interaction with a motor protein facilitates the delivery of these vesicles to 
the cleavage furrow, where the interaction of Rab11/FIP3 with Arf6 and the 
exocyst complex facilitates the tethering of vesicles to the plasma membrane 
(Wilson et al. 2005). Accumulation of intracellular vesicles by the exocyst, 
therefore, is a necessary step in membrane thinning and formation of secondary 
ingression zones (Gromley et al. 2005). However, vesicular trafficking to the 
midbody may serve a second important role – that of assembling the abscission 
machinery (Gould & Lippincott-Schwartz 2009). 
McDonald and Martin-Serrano (2009) have presented a model for abscission that 
includes Rab-GTPase-mediated trafficking of endosome-derived vesicles to the 
midbody. This model describes abscission in three stages. First, Rab GTPases 
mediate the transport of post-Golgi and endosome-derived vesicles to the 
midbody, where they are targeted to specific sites on the plasma membrane by 
the exocyst. Assemblies of septin filaments are proposed to outline 
compartments in the plasma membrane to restrict movement of the exocyst, 
thereby promoting targeted vesicle delivery to the abscission site (Estey et al. 
2010). In the second stage, vesicle fusion with the plasma membrane is 
mediated by the interaction of SNARE proteins endobrevin and syntaxin-2. 
Finally, CEP55 recruits late-acting fission complex proteins for ESCRT-mediated 
membrane scission (McDonald & Martin-Serrano 2009; Section 1.5.6). 
1.5.3 ESCRT proteins form a conserved membrane scission 
machinery 
ESCRT proteins were identified in budding yeast as Class E vps gene products  
and are known to have important roles in several processes, such as sorting 
during downregulation of ubiquitin-labelled receptors via the formation of 
multivesicular bodies (MVB) and in HIV budding from host cells (Raymond et al. 
1992; McDonald & Martin-Serrano 2009).  
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Ubiquitin-labelled receptors are trafficked to the endosome where MVBs are 
formed by invagination of the endosomal membrane; MVBs then fuse with the 
lysosome to mediate protein degradation. The ESCRT proteins are essential to 
the formation of MVBs (Wollert & Hurley 2010). The ESCRT machinery consists of 
four main subunits assembled sequentially on the endosomal membrane: ESCRT-
0, -I, -II and –III, and AAA-ATPase Vps4 disassembles the machinery (Teis et al. 
2009).  
ESCRT proteins are required for multivesicular body biogenesis and HIV virion 
egress. Both events require the internal resolution of a cytoplasm-filled 
membrane tubule; such an event is topologically opposed to that mediated by 
dynamin, but is similar to the final scission step of cytokinesis (Hinshaw 2000; 
Hurley & Hanson 2010). ESCRT-III has been identified as the primary driving force 
in ESCRT-mediated membrane scission events, with Vps4 required to redistribute 
ESCRT-III subunits back into the cytoplasm (Wollert et al. 2009; Lin et al. 2005; 
Babst et al. 1998). Vps4 is necessary for all ESCRT-mediated processes (Morita et 
al. 2010; Neto & Gould 2011). 
1.5.4 ESCRT function has diverged between species 
Despite first being characterised in S. cerevisiae, neither ESCRT localisation at 
bud necks nor a direct requirement for ESCRT proteins in abscission has been 
identified (McMurray et al. 2011). In contrast, filaments of GTP-binding septin 
proteins are required for deposition of new cell wall material, which is in turn 
required to drive plasma membrane ingression (Bi 2001). However, budding 
yeast mutants of ESCRT-III gene SNF7+ (fission yeast vps32+, human CHMP4+), 
resulted in cytokinetic failure and increased DNA content (McMurray et al. 2011). 
Furthermore, genetic studies in budding yeast mutants with cytokinesis-
sensitised backgrounds due to impaired septin function have suggested a role for 
ESCRT proteins in recycling key enzymes required for cytokinesis (McMurray et 
al. 2011).  
Fission yeast requires ESCRT proteins for MVB formation and cytokinesis, while 
human cells utilise ESCRT machinery for MVB formation, cytokinesis and HIV 
budding from host cells (McDonald & Martin-Serrano 2009). These observations 
imply divergent functions for ESCRT proteins between organisms. Interestingly, 
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studies in Archaea have revealed roles for ESCRT-III and VPS4 in cell division and 
potentially viral budding (Samson & Bell 2009). This observation is particularly 
significant because Archaea lack endomembrane structures, thus strengthening 
the view that ESCRT proteins have a well-conserved function in the scission 
aspect of cytokinesis, rather than endosomal sorting for vesicular fusion 
(McDonald & Martin-Serrano 2009). 
1.5.5 A division of labour exists among the ESCRT machinery 
The modular nature of ESCRT components suggests divergent functions, both 
within particular cells, but further, between organisms and even branches of 
evolution. Emphasis has been placed on understanding the mechanisms of 
ESCRT-III as the principal engine of membrane deformation. ESCRT classes 0-II, 
therefore, are regarded as being auxiliary to ESCRT-III. In fact, studies in 
Archaea indicate a lack of ESCRT-0-II homologues, but underpin the conservation 
of the ESCRT-III interaction with VPS4 (Samson & Bell 2009). 
ESCRT proteins function sequentially in the formation of MVBs (Teis et al. 2009). 
Wollert & Hurley (2010) described an in vitro model of ESCRT assembly and 
function whereby ESCRT-0 self-assembles and, together with clathrin, forms 
large domains on the endosomal membrane. One significant finding with regard 
to membrane budding was the discovery that it is performed by a super-complex 
of ESCRT-I and -II (Wollert & Hurley 2010), as opposed to the previously-held 
position that membrane budding was mediated by ESCRT-III (Teis et al. 2008). 
Although the mechanisms by which ESCRT-I/II forms membrane invaginations are 
unclear, it is possible that they hold the membrane open via rigid 
superstructures, allowing ESCRT-III to perform the scission step (Figure 1.2; 
Wollert & Hurley 2010).  
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Figure 1.2: Multivesicular body biogenesis is mediated by sequential function of 
ESCRT subunits. 
(A) ESCRT-0 sequesters ubiquitylated cargo to endosomal membranes destined for 
degradation in the lysosome. (B) ESCRT-I and -II form rigid stalks that deform the 
peripheral membrane, resulting in inward budding. (C) ESCRT-III polymerises and 
constricts the bud neck. (D) Critical proximity results in membrane fusion and 
formation of an intralumenal vesicle (ILV) within a multivesicular body (MVB). Vps4 
recycles ESCRT-III back into the cytoplasm. Adapted from (Wollert & Hurley 2010). 
ESCRT proteins are not lost in the process of membrane remodelling; rather, 
ESCRT-III remains on the periphery of the MVB membrane until Vps4 recycles it 
back into the cytoplasm to mediate the formation of further MVBs (Wollert & 
Hurley 2010). 
1.5.6 ESCRT-III is recruited to the midbody by TSG101/ESCRT-I 
and ALIX 
Centrosomal protein of 55 kDa (CEP55) is recruited to the midbody by 
centralspindlin component MKLP1 following mitotic degradation of Plk1, the 
negative phospho-regulator of CEP55 midbody recruitment (Bastos & Barr 2010). 
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CEP55 has several important roles in cytokinesis, including organising the 
Flemming body by recruiting late-acting proteins for abscission (Skop et al. 2004; 
Zhao et al. 2006). Tumour susceptibility gene 101 protein (TSG101), an ESCRT-I 
component, and apoptosis-linked gene 2-interacting protein (ALIX) are recruited 
to the midbody from centrosomes by CEP55 (Morita et al. 2007). Both TSG101 
and ALIX have established early roles in MVB biogenesis (Hurley & Emr 2006; 
Martin-Serrano et al. 2003), HIV egress (Morita & Sundquist 2004) and abscission 
(Morita et al. 2007). TSG101 and ALIX have sometimes interchangeable roles 
(Fisher et al. 2007), and both function with downstream ESCRT pathways 
members in protein sorting and membrane fission (Morita et al. 2007). CEP55 
localises to the Flemming body itself, whereas TSG101 and ALIX localise to either 
side (Elia et al. 2011). TSG101 localises as membrane-associated rings either side 
of the Flemming body; it is at these sites that ESCRT-III assembles in a 
TSG101/ALIX-dependent manner (Elia et al. 2011). Indeed, ALIX mutations 
unable to bind CEP55 or ESCRT-III, as well as depletion of either TSG101 or ALIX, 
inhibit abscission (Morita et al. 2007). 
1.5.7 ESCRT-III performs the final scission step of cytokinesis 
ESCRT-III has been proposed to assemble sequentially during intralumenal vesicle 
scission: first by recruitment of CHMP6, then CHMP4, which polymerises into a 
spiral, then CHMP3 and CHMP2 which terminate the spiral and recruit VPS4 for 
ESCRT redistribution (Wollert et al. 2009; Hurley & Hanson 2010). During 
cytokinesis, ESCRT proteins are recruited to the midbody and have a direct role 
in abscission, as demonstrated by resultant multinucleate cells on ESCRT 
depletion (Morita et al. 2007). CHMP4B localises to the Flemming body 
peripheries in a series of cortical rings exhibiting significant overlap with 
TSG101/ESCRT-I; along with CHMP2A, both have been shown to localise to 
secondary ingression zones immediately prior to abscission (Elia et al. 2011; 
Guizetti et al. 2011). A model for ESCRT-mediated abscission is demonstrated in 
Figure 1.3. 
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Figure 1.3: A model for ESCRT-mediated cytokinetic abscission. 
CEP55 localises to the Flemming body and recruits TSG101/ESCRT-I and ALIX to the 
Flemming body peripheries in ring formations, which in turn recruit ESCRT-III 
component CHMP4B, also in membrane-associated ring formations. Nucleation sets 
CHMP4B in motion away from the Flemming body, and breakage by VPS4 facilitates 
localisation towards the secondary ingression zone. Finally, microtubule severing, 
perhaps by spastin, allows CHMP4B to constrict the membrane bridge to within critical 
proximity for fusion. Adapted from (Elia et al. 2012). 
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Abscission occurs sequentially at the secondary ingression zones either side of 
the midbody. CHMP4B localises in low levels during early cytokinesis as two 
cortical rings; however, a second pool of CHMP4B localises approximately 1 µm 
from the centre of the Flemming body, representing the abscission site (Elia et 
al. 2011). Guizetti et al (2011) reported membrane ripples corresponding to the 
abscission site; these ripples were absent in CHMP2A-depleted cells, indicating 
that ESCRT-III is necessary for cortical constriction (Guizetti et al. 2011).  
Timing studies indicate that abscission takes place in the last 20 minutes of 
cytokinesis, during which time, one side of the Flemming body acutely narrows 
and microtubules break before membrane scission. Consistent with this 
observation, CHMP4B localises to the abscission site 20 minutes before 
abscission, which triggers an acute decrease in microtubule diameter, 
coincidental with a much greater abundance of membrane-severing spastin on 
the midbody arm where abscission occurs (Elia et al. 2011). Spastin depletion 
was shown to delay abscission, but rippled constriction zones were still present 
(Yang et al. 2008; Guizetti et al. 2011). VPS4 co-localises with CHMP4B at the 
constriction site and abscission occurs 10 minutes later (Elia et al. 2011). 
Following the first abscission event, CHMP4B localises to the second abscission 
site, microtubules bundle and sever, and abscission occurs to produce the 
midbody remnant.  
Live cell imaging revealed that the second CHMP4B pool emanates from the first 
(Elia et al. 2011), which is evidence for a model for CHMP4B redistribution from 
the Flemming body to the abscission site. This model suggests that CHMP4B is 
nucleated by an as-yet-unknown factor, but then a second pool arises from 
polymer breakage, presumably by VPS4, and proceeds to the site of constriction. 
Consistent with this is the observation that ATP depletion inhibits CHMP4B 
breakage, resulting in a continuous polymer extending a significant distance 
from the Flemming body. Computational modelling suggests that equilibrium of 
elastic forces may drive the ESCRT-III fission complex to the constriction site. 
This model is consistent with the observation that ESCRT-III mediates membrane 
scission of much smaller diameters than that present at the midbody, as the 
constriction site is a more manageable 50 nm. Scission then occurs due to 
constrictive force of fission complex attachment to the plasma membrane, 
consistent with the observation that ESCRT-III proteins assemble into spiral 
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filaments in vitro with exposed membrane interactions sites (Elia et al. 2011; 
Lata et al. 2008). 
1.5.8 How is the ESCRT machinery regulated in cytokinesis? 
Although the model presented (Elia et al. 2012; Section 1.5.7) aptly describes a 
mechanism for ESCRT-mediated abscission, there are still several issues that 
require elucidation, perhaps most notably, the mechanism of CHMP4B 
nucleation. Elia et al (2012) suggest the involvement of lipid interactions, due to 
the proposed role of membrane trafficking in secondary ingression formation 
(Neto et al. 2011) and the in vitro preference of ESCRT-III for acidic membranes 
(Muzioł et al. 2006). They therefore propose that attractive forces mediated by 
the lipid bilayer composition may drive ESCRT-III to the constriction site (Elia et 
al. 2012). Guizetti et al (2011) reported an absence of endocytic vesicles at the 
constriction site; however, their analysis did not preclude the presence of 
vesicles of other origins. It is worth noting, however, that ESCRT components 
may bind lipid bilayers in MVB formation and HIV budding due to interactions 
with phosphatidylinositol 3-phosphate or cholesterol-rich lipid raft domains, 
respectively (Guizetti & Gerlich 2010; Whitley et al. 2003; Lin et al. 2005; 
Yorikawa et al. 2005); such enriched domains have been reported to accumulate 
in the midbody (Neto et al. 2011). Although an interesting proposition, it seems 
unlikely that lipid composition alone could mediate ESCRT-III nucleation, though 
it may aid ESCRT-III translocation coincidentally with nucleation by another 
factor.  
Furthermore, biochemical analysis has yet to confirm that the cortical rings 
reported at constriction sites (Guizetti et al. 2011) are actually ESCRT proteins; 
it is possible that the rings are in fact septin-based, as septin-7 and -9 are also 
essential components of cytokinesis (Estey et al. 2010; Hu et al. 2012; Neto & 
Gould 2011; Sections 1.5.2 and 1.5.4). 
The precise role and regulation of the ESCRT machinery in abscission has yet to 
be solved. ESCRT components are phosphoproteins, so kinases and phosphatases 
are likely candidates for ESCRT regulation. For instance, CEP55 depletion results 
in failed accumulation of late-acting abscission factors at the midbody, including 
ESCRT proteins, Aurora B kinase and Plk1 (Morita et al. 2007). Aurora B has been 
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shown to phosphorylate CHMP4C to delay abscission and prevent the 
accumulation of DNA damage (Carlton et al. 2012); indeed budding yeast Aurora 
B localises to the anaphase spindle due to the phosphatase activity of Cdc14 
(Pereira & Schiebel 2003). In addition, human CDC14A is required for Rab5-
mediated endocytic trafficking (Lanzetti et al. 2007); it is possible that such an 
association may provide a role for CDC14A in trafficking to the midbody during 
cytokinesis. Furthermore, although Plk1 downregulation is required for CEP55 
midbody localisation, and thus ESCRT localisation, Plk1 reappears on late 
midbodies (Hu et al. 2012). These observations make phospho-regulation of 
ESCRT proteins an attractive direction of investigation.  
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1.6 The present study 
1.6.1 Hypotheses 
In this study, the role of ESCRT proteins in cytokinesis was investigated. It was 
hypothesised that polo kinase and Cdc14 phosphatase regulate ESCRT 
components in fission yeast and that these interactions are conserved in human 
cells. Furthermore, it was hypothesised that interactions with the ESCRT 
proteins are required for controlling phosphorylation status, and that this in turn 
mediates ESCRT function in cytokinesis. 
1.6.2 Approach and principal findings 
Fission yeast was used as a model organism to test interactions between Plo1p, 
Clp1p and the ESCRT proteins. Initially, septation phenotypes among wild-type 
and fission yeast strains with individual deletions in ESCRT genes were 
characterised. ESCRT genes were shown to be required for cell division in fission 
yeast, implying a role for the ESCRT proteins in this process. 
A yeast genetics approach was employed to investigate genetic interactions 
between ESCRT genes and plo1+ and clp1+. Double mutants were produced from 
crosses between ESCRT deletion strains and mutants of plo1 and clp1. Defective 
growth rates were observed in double mutants, indicating genetic interactions 
between plo1+, clp1+ and ESCRT genes. 
The effect of single ESCRT deletions on vacuolar sorting in fission yeast was 
characterised. Single mutants of plo1 and clp1 were also shown to affect 
vacuolar sorting, although phenotypes were dissimilar to those observed in 
ESCRT deletion strains. Analysis of the vacuolar sorting in double mutants 
provided further characterisation of observed genetic interactions; and plo1+ 
was regarded to function upstream of ESCRT genes, and clp1+ downstream. 
The yeast two-hybrid assay was used to analyse protein-protein interactions. 
Physical interactions were observed between Plo1p and Sst4p (human HRS, 
ESCRT-0), Vps28p (VPS28, ESCRT-I), Vps25p (EAP20, ESCRT-II), Vps20p (CHMP6, 
ESCRT-III) and Vps32p (CHMP4, ESCRT-III). Clp1p was also shown to interact with 
Vps28p.  
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Interactions were then investigated between human homologues of these 
proteins. Immunoprecipitation and co-immunoprecipitation methods in mitotic 
HeLa cells demonstrated interactions between Plk1 and known binding partner 
FOXM1 (Fu et al. 2008). Interactions were not detected between Plk1 and ESCRT 
proteins, so HEK293 cells were used to over-express ESCRT proteins.  
Plk1 co-immunoprecipitated over-expressed CHMP6 (fission yeast Vps20p), 
CHMP4B (Vps32p), CHMP3 (Vps24p) and CHMP2A (Vps2p, all ESCRT-III). 
Furthermore, immunoprecipitation and co-immunoprecipitation methods 
demonstrated interactions between CDC14A and CHMP4B and CHMP2A in HEK293 
cells. 
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Chapter 2 Materials and methods 
2.1 Materials 
2.1.1 Media 
All measurements for the production of media given below refer to dissolving in 
one litre of distilled water. All media was autoclaved prior to use. To produce 
solid media, 20 g/l bacto agar (BD Biosciences) was added prior to autoclaving. 
2.1.1.1 E. coli media 
Bacteria were cultured and maintained as described (Sambrook et al. 2001).  
Luria broth (LB): 20 g/l Lennox L broth (Sigma). 
To select for ampicillin or kanamycin resistance in bacterial growth, antibiotics 
were added to cooled media at a working concentration of 50 µg/ml. 
2.1.1.2 S. cerevisiae media 
S. cerevisiae were cultured and maintained as described (Sambrook et al. 2001). 
Synthetic dropout (SD): 20 g D-glucose, 6.7 g Difco yeast nitrogen bases w/o 
amino acids (BD Biosciences) and 0.64 g CSM-Leu-Trp (Bio101 Systems). 
Yeast extract/peptone/dextrose (YPD): 50 g/l YPD (BD Biosciences). 
2.1.1.3 S. pombe media 
S. pombe were cultured and maintained as described (Moreno et al. 1991). 
Edinburgh minimal media (EMM): 20 g D-glucose, 5 g ammonium chloride, 0.1 g 
sodium sulphate, 0.1 g magnesium chloride, 15 mg calcium chloride, 3 g 
potassium hydrogen phthalate, 1.8 g disodium hydrogen orthophosphate, 1 ml 
vitamins (per litre: 10 g inositol, 10 g nicotinic acid, 1 g calcium pantothenate 
and 10 mg biotin) and 0.1 ml trace (per litre: 5 g boric acid, 5.2 g manganese 
sulphate, 4 g zinc sulphate, 2 g ferric chloride, 1.44 g molybdic acid, 0.4 g 
copper sulphate, 10 g citric acid and 0.1 g potassium iodide). 
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EMM was supplemented appropriately with (per litre EMM) 375 mg adenine or 
uracil, or 187.5 mg leucine or histidine. 
Malt extract (ME): 30 g bacto malt extract. 
Yeast extract (YE): 30 g D-glucose, 5 g bacto yeast extract, 225 mg adenine and 
225 mg uracil. 
2.1.2 Oligonucleotide primers 
Lab No. 
(GO) 
Primer 
annotation 
Species Description Sequence 
744 sst4+R S. pombe Reverse primer to amplify 
sst4+ from S. pombe 
genomic DNA  
GCG CGC GTC GAC CTA AAG 
CTC GAT TAA AGA TGC TTC 
TTG AAC TTC 
746 sst6.aa20-
487R 
S. pombe Reverse primer to amplify 
sst6+ from S. pombe 
genomic DNA  
GCG CGC GTC GAC TTA AGA 
GTA TTG AAG CAT TTC GTC 
CCG TAT TAA 
748 vps20+R S. pombe Reverse primer to amplify 
vps20+ from S. pombe 
genomic DNA  
GCG CGC GTC GAC TTA TCC 
CAG GAC TGG ATC TTT TCG 
AAG TTC T 
750 vps36+R S. pombe Reverse primer to amplify 
vps36+ from S. pombe 
genomic DNA  
GCG CGC CTC GAG CTA TGA 
TTC ATC AAA CCA TTT AGT 
CAA TTC TTC T 
751 sst4+F S. pombe Forward primer to amplify 
sst4+ from S. pombe 
genomic DNA 
CGC GCG TGG ATC CGA ATG 
TCT CGG TGG TGG AAT TCC 
AAT TCT CAG 
752 sst6.aa20-
487F 
S. pombe Forward primer to amplify 
sst6 intron-free from S. 
pombe genomic DNA 
CGC GCG TGG ATC CGA ATT 
AGA TTT TGG AAG AAT GGA 
CTT GCT GAA 
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753 vps20+F S. pombe Forward primer to amplify 
vps20+ from S. pombe 
genomic DNA 
CGC  GCG  TGG  ATC  CGA 
ATG GGG GTT AAC AGT AGT 
AAA ATT AAT GAT 
754 vps36+F S. pombe Forward primer to amplify 
vps36+ from S. pombe 
genomic DNA 
GCG CGC CCC CCG GGG ATG 
GCC TTT TAT TTA GAA ACA 
ACC CCT TCT 
757 vps28+F S. pombe Forward primer to amplify 
vps28+ from S. pombe 
genomic DNA 
CGC GCG TGG ATC CGA ATG 
ACT GAA TAC TAC GAT CTG 
AAC CTT TTA 
758 vps28+R S. pombe Reverse primer to amplify 
vps28+ from S. pombe 
genomic DNA  
CGC GCG TGG ATC CGA ATG 
ACT GAA TAC TAC GAT CTG 
AAC CTT TTA 
759 sst4+F 
(internal) 
S. pombe Forward primer to amplify 
a central region of sst4+ 
from S. pombe genomic 
DNA 
TTG GTA TCT ATT CTA CGA 
TCT CCT GC 
760 sst4+R 
(internal) 
S. pombe Reverse primer to amplify 
a central region of sst4+ 
from S. pombe genomic 
DNA  
GAG TTC CTG TAG CTG ATA 
TTC CGT 
761 vps2+F S. pombe Forward primer to amplify 
vps2+ from S. pombe 
genomic DNA 
CGC GCG TGG ATC CGA ATG 
GGC TTA ACT TCT TGG CTA 
TTT GGA GGG 
762 vps2+R S. pombe Reverse primer to amplify 
vps2+ from S. pombe 
genomic DNA  
CGC GCG TGG ATC CGA ATG 
GGC TTA ACT TCT TGG CTA 
TTT GGA GGG 
763 vps4+F S. pombe Forward primer to amplify 
vps4+ from S. pombe 
genomic DNA 
CGC GCG TGG ATC CGA ATG 
TCC AAT CCA GAT TGT TTA 
AGT AAA GCA 
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764 vps4+R S. pombe Reverse primer to amplify 
vps4+ from S. pombe 
genomic DNA  
CGC GCG TGG ATC CGA ATG 
TCC AAT CCA GAT TGT TTA 
AGT AAA GCA 
765 vps25+F S. pombe Forward primer to amplify 
vps25+ from S. pombe 
genomic DNA 
CGC GCG TGG ATC CGA ATG 
CGT GTT CCA TCC ATT TAT 
AAC TTT CCT 
766 vps25+R S. pombe Reverse primer to amplify 
vps25+ from S. pombe 
genomic DNA  
GCG CGC CTC GAG TTA AGC 
TTT CAG TAC CTT GAA CCC 
GCT 
768 vps32+F S. pombe Forward primer to amplify 
vps32+ from S. pombe 
genomic DNA 
CGC GCG TGG ATC CGA ATG 
TCT GGA TTT TTA AGA TGG 
TTT GGG GGC 
769 vps32+R S. pombe Reverse primer to amplify 
vps32+ from S. pombe 
genomic DNA  
GCG CGC CTC GAG TTA AAG 
AGA GAA TTC AGC CTG TAG 
TTT TCG 
770 plk1+F 
(pGBKT7) 
Human Forward primer to amplify 
PLK1+ from vector 
template to clone into 
pGBKT7 
CGC GCG CAT ATG ATG AGT 
GCT GCA GTG ACT GCA GGG 
AAG CTG 
771 plk1+R 
(pGBKT7) 
Human Reverse primer to amplify 
PLK1+ from vector 
template to clone into 
pGBKT7 
GCG CGC GAA TTC TTA GGA 
GGC CTT GAG ACG GTT GCT 
GGC CGA 
772 plk1+F 
(pHB18) 
Human Forward primer to amplify 
PLK1+ from vector 
template to clone into 
pHB18 
CGC GCG GAA TTC ATG AGT 
GCT GCA GTG ACT GCA GGG 
AAG CTG 
773 plk1+R 
(pHB18) 
Human Reverse primer to amplify 
PLK1+ from vector 
template to clone into 
pHB18 
GCG CGC CTC GAG TTA GGA 
GGC CTT GAG ACG GTT GCT 
GGC CGA 
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774 cdc14a2+F 
(pGBKT7 
and pHB18) 
Human Forward primer to amplify 
CDC14A+ from vector 
template to clone into 
pGBKT7 and pHB18 
GCG CGC GAA TTC ATG GCA 
GCG GAG TCA GGG GAA CTA 
ATC GGG 
775 cdc14a2+R 
(pGBKT7 
and pHB18) 
Human Reverse primer to amplify 
CDC14A+ from vector 
template to clone into 
pGBKT7 and pHB18 
GCG CGC GGA TCC TCA GAA 
GGC TTC CTT GGC ACT ATT 
AAA TTT 
776 vps4F 
(exons 3&4) 
S. pombe Forward primer to amplify 
exons 3 and 4 of vps4+ 
from S. pombe genomic 
DNA 
CGC GCG TGG ATC CGA ATG 
TCC AAT CCA GAT TGT TTA 
AGT AAA GCA 
 
2.1.3 Plasmid sources 
Lab No. 
(GB) 
Gene 
product 
Species Description Plasmid Source 
331 Gal4 
activation 
domain 
S. Cerevisiae Yeast two-hybrid 
activation domain 
pACT2 (Reynolds & 
Ohkura 2003) 
332 Gal4 DNA-
binding 
domain 
S. Cerevisiae Yeast two-hybrid 
DNA-binding 
domain 
pBTM116 (Reynolds & 
Ohkura 2003) 
586 Gal4 DNA-
binding 
domain 
S. Cerevisiae Yeast two-hybrid 
DNA-binding 
domain 
pGBT9 (Clifford et al. 
2008) 
620 Ub-GFP-
SpCPS 
S. pombe Ubiquitin-GFP-
labelled CPS to 
characterise 
vacuolar sorting 
in S. pombe 
pREP41 (Iwaki et al. 2007) 
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664 Plk1-YFP Human YFP-labelled Plk1 pCMX (Lindon & Pines 
2004) 
676 Gal4 
activation 
domain 
Human Yeast two-hybrid 
activation domain 
pHB18 (Agromayor & 
Martin-Serrano 
2006) 
677 Gal4 DNA-
binding 
domain 
Human Yeast two-hybrid 
DNA-binding 
domain 
pGBKT7 (Agromayor & 
Martin-Serrano 
2006) 
678 CHMP3-
myc 
Human Myc-tagged 
CHMP3 
pcDNA3 Katherine Bowers, 
University College 
London 
680 CHMP4B-
myc 
Human Myc-tagged 
CHMP4B 
pcDNA3 Katherine Bowers, 
University College 
London 
682 CHMP6-HA Human HA-tagged CHMP6 pIRESneo2 Katherine Bowers, 
University College 
London 
684 CDC14A-
myc 
Human Myc-tagged 
CDC14A  
pcDNA3 (Lanzetti et al. 
2007) 
685 CDC14A.C
278S-myc 
Human Myc-tagged 
CDC14A.C278S 
pcDNA3 (Lanzetti et al. 
2007) 
686 Plk1.K82R
-YFP 
Human YFP-labelled 
Plk1.K82R 
pEYFP-C3 (Lindon & Pines 
2004) 
715 CHMP4B-
YFP 
Human YFP-labelled 
CHMP4B 
pCR3.1 (Carlton et al. 
2012) 
716 CHMP2A-
GFP 
Human GFP-labelled 
CHMP2A 
pmEGFP Addgene plasmid 
31805 (Guizetti et 
al. 2011) 
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717 CHMP6-
GFP 
Human GFP-labelled 
CHMP6 
pmEGFP Addgene plasmid 
31806 (Guizetti et 
al. 2011) 
754 VPS28-V5 Human V5-tagged VPS28 pcDNA5-
V5 
Philip Woodman, 
The University of 
Manchester 
 
2.1.4 Antibodies 
2.1.4.1 Primary antibodies 
For immunoblotting, all antibodies were incubated overnight at 4°C, unless 
otherwise stated. 
Epitope Clonality Host 
species 
Dilution Diluent Source  
(catalogue no.) 
CHMP2 Polyclonal Goat 1:1000 5% BSA-PBST Santa Cruz 
Biotechnology (C-17) 
CHMP3 Monoclonal Mouse 1:750 5% BSA-PBST Santa Cruz 
Biotechnology (F-1) 
CHMP4A Polyclonal Goat 1:1000 5% BSA-PBST Santa Cruz 
Biotechnology (P-16) 
CHMP6 Polyclonal Rabbit 1:1000 3% BSA-PBST Abcam (ab76929) 
Cyclin B1 Polyclonal Rabbit 1:1000 3% BSA-PBST Abcam (ab2096-100) 
FOXM1 Monoclonal Mouse 1:200 5% BSA-TBST Santa Cruz 
Biotechnology (263C2a) 
GFP Polyclonal Rabbit 1:1000 5% BSA-PBST Abcam (ab290) 
HA.11 Monoclonal Mouse 1:1000 5% milk-PBST Covance/Cambridge 
Biosciences (MMS-101P) 
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Myc Polyclonal Rabbit 1:1000 5% BSA-PBST Abcam (ab9106) 
Plk1  
(two nights) 
Monoclonal Rabbit 1:750 5% BSA-TBST Cell Signaling (208G4) 
TSG101 Monoclonal Mouse 1:1000 3% BSA-PBST Abcam (ab4A10) 
VPS28 Monoclonal Mouse 1:250 5% BSA-PBST Santa Cruz 
Biotechnology (E-7) 
 
2.1.4.2 Secondary antibodies 
For immunoblotting, all horseradish peroxidase-linked secondary antibodies were 
diluted in 1% milk-PBST/TBST and incubated at room temperature for two hours. 
Epitope Host 
species 
Dilution Source (catalogue no.) 
Goat IgG Swine 1:2000 Caltag (G50007) 
Mouse IgG Sheep 1:1000 GE Healthcare (NA931) 
Rabbit IgG Goat 1:80,000 Sigma (A9169) 
 
2.1.5 Standard solutions 
Unless stated otherwise, all buffers and reagents were prepared in distilled 
water. 
Enhanced chemiluminescence (ECL) detection reagents 
Solution 1: 0.1 M Tris-HCl, pH 8.5, 450 mg/l luminol (Sigma) in 2% (v/v) DMSO 
and 130 mg/l Coumaric acid (Sigma) in 1% (v/v) DMSO 
Solution 2: 0.1 M Tris-HCl, pH 8.5 and 0.02% (v/v) H2O2 
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Immunoprecipitation wash buffer 1 (pH 7.5) 
20 mM Hepes, 100 mM KCl and 1mM DTT 
Immunoprecipitation wash buffer 2 (pH 7.5) 
20 mM Hepes, 250 mM NaCl, 1% (v/v) Triton X-100 and 1mM DTT 
Laemmli sample buffer (4X LSB) 
200mM Tris-HCl, pH 6.8, 8% (w/v) SDS, 40% (v/v) glycerol, 0.4% (w/v) 
bromophenol blue and 400 mM DTT 
Lysis buffer 
50 mM Tris-HCl, 50 mM NaF, 1 mM Na4PPi, 1 mM EGTA and 1 mM EDTA. The 
following were added on day of use: 10% (v/v) glycerol, 0.01% (v/v) Triton X-100, 
0.5% Igepal (Nonidet P-40 substitute), 1 mM DTT, 1 mM activated vanadate, 1 µM 
microcystin and one Complete mini EDTA-free protease inhibitor tablet 
Phosphate-buffered saline (PBS) (pH 7.2) 
85 mM NaCl, 1.7 mM KCl, 5 mM Na2HPO4 and 0.9 mM KH2PO4 
Phosphate-buffered saline + Triton X-100 (PBST)  
PBS and 0.01% (v/v) Triton X-100. 250 mM NaCl was added to produce high-salt 
PBST 
Ponceau S stain 
0.2% (w/v) Ponceau S and 1% (v/v) acetic acid 
SDS-PAGE running buffer 
25 mM Tris-HCl, 250 mM glycine and 0.1% (w/v) SDS 
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Transfer buffer 
25 mM Tris-HCl, 192 mM glycine and 20% (v/v) ethanol 
Tris-buffered saline (TBS) (pH 7.5) 
20 mM Tris-HCl, pH 7.5, 137 mM NaCl 
Tris-buffered saline + Tween-20 (TBST)  
TBS and 0.1% (v/v) Tween-20. 250 mM NaCl was added to produce high-salt TBST 
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2.2 Yeast methods 
2.2.1 General yeast methods 
The general molecular methods of Sambrook et al. (2001) were employed. Yeast 
strains were obtained from glycerol stocks frozen at -70°C, or by mating strains 
from frozen stocks. S. cerevisiae strains were grown on solid rich medium (YPD) 
or minimal synthetic dropout medium (Section 2.1.1.2). S. pombe strains were 
grown on solid yeast extract (YE), mated on solid malt extract (ME) and 
genotypically screened on solid Edinburgh minimal medium (EMM) (Section 
2.1.1.3). All strains were assigned a laboratory number, ‘GGBY’ for S. cerevisiae 
and ‘GG’ for S. pombe, in accordance with the laboratory collection (Appendix 
6.1).  
2.2.2 Septal defect analysis in S. pombe 
S. pombe septa were visualised using Calcofluor stain and fluorescent 
microscopy as described (Mitchison & Nurse 1985). Cells were cultured overnight 
in liquid YE and 1 ml was transferred to a microcentrifuge tube (if the cells were 
too confluent, they were diluted as appropriate in YE). 50 µl Calcofluor stain 
(Sigma) was added; cells were inverted and then incubated at room temperature 
for five minutes. Cells were then centrifuged at 4,000 rpm for one minute and 
washed three times with distilled H2O. The pellet was resuspended in 20-50 µl 
distilled H2O and visualised using the brightfield and DAPI filters of a Zeiss 
Axiovert 135 fluorescent microscope equipped with a Zeiss 63X Plan-
APOCHROMAT oil-immersion objective lens. The images were collected and 
processed using Microsoft PowerPoint. 
2.2.3 S. pombe mating and tetrad dissection 
Parent yeast strains were freshly grown at 30°C, having been recovered from -
70°C stocks three days earlier, or re-plated from 20°C (room temperature) one 
day earlier. Temperature-sensitive strains were incubated at 25°C, and so were 
afforded an additional day incubation. Mating of strains was performed by 
mixing approximately equal amounts of two parent strains on solid ME medium 
with an arbitrary volume of distilled water (approximately 10 µl). The mating 
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mixture was incubated at 25°C for two days and a sample was observed under a 
standard light microscope to confirm ascus formation.  
A small number of cells were spread onto solid YE medium and tetrads were 
selected using a Singer MSM Ascus Dissector. Tetrads were incubated at 37°C for 
4-6 hours to allow the ascus membranes to degrade. The four spores were 
separated and then incubated at 30°C for three days, or 25°C for five days, to 
permit growth. 
2.2.4 Selection of double mutants 
2.2.4.1 Genotypic screening 
Once spores had developed into colonies, they were genetically screened by 
replica plating onto selective media: supplemented EMM, supplemented YE 
(G418, Sigma), or YE at different temperatures. After two days of incubation at 
30°C, double mutants were identified and streaked onto fresh solid YE. These 
were incubated at 30°C for two days and then stored in 30% sterile glycerol 
frozen at -70°C.  
Once dissected, the crosses with a temperature-sensitive parent were incubated 
at 25°C for five days. Genotypes were confirmed by replica plating; usually 
analysed after three days of growth at 25°C, except for those grown on solid YE 
medium incubated at 36°C, which were observed microscopically after only one 
day. Double mutants were identified and incubated at 25°C on fresh solid 
medium for three days before storage in 30% sterile glycerol frozen at -70°C.  
2.2.4.2 Mating type determination 
To determine mating types of new strains, double mutants were re-plated onto 
solid ME and mated with standard h+ and h- strains. Tetrad formation was then 
scored microscopically after two days. 
2.2.5 Growth rate comparison 
Growth rates of double mutants were compared to their parents by streaking to 
single colonies two or three isolates of a double mutant and each of its parent 
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strains on YE and supplemented EMM solid medium. These were then grown at 
25°C, 30°C or 36°C for 2-4 days. 
2.2.6 FM 4-64 staining of S. pombe vacuoles for confocal 
microscopy 
S. pombe cells were cultured in 100 ml liquid EMM, supplemented appropriately, 
including 10 µM thiamine to repress gene expression under nmt1+ control 
(Maundrell 1993), and incubated overnight at the appropriate temperature. 16-
20 hours before microscopy, the culture was centrifuged at 3,000 rpm for five 
minutes; the pellet was washed twice in EMM and resuspended in 25 ml EMM. Up 
to 10 ml of this resuspension was cultured in a final volume of 100 ml 
supplemented EMM lacking thiamine to induce gene expression under nmt1+ 
control. After incubating for 16-20 hours at the appropriate temperature, the 
culture was centrifuged at 3,000 rpm for five minutes and resuspended in 500 µl 
in a microcentrifuge tube. 10 µM FM 4-64 (Invitrogen) was added and the cells 
were incubated shaking for 30 minutes (Iwaki et al. 2007). The culture was then 
centrifuged at 4,000 rpm for one minute and washed twice in EMM. The pellet 
was resuspended in 500 µl EMM and incubated shaking for 90 minutes. 5 µl was 
placed on a chamber designed for liquid cultures (Lab-Tek II Chamber 155379) 
and confocal microscopy was performed (Section 2.2.7). 
2.2.7 Cell imaging via confocal microscopy 
Confocal microscopy was performed using a Carl Zeiss LSM 5 Exciter microscope 
fitted with a He/Ne and Ag laser system, and using a 63X high NA objective lens. 
The images were collected using Zeiss Pascal software and processed using 
Microsoft PowerPoint. 
2.2.8 Cloning events for yeast two-hybrid analysis 
plo1+ and clp1+ were previously cloned into the bait vector used for yeast two-
hybrid (Papadopoulou et al 2008); therefore, ESCRT genes were cloned into the 
equivalent prey vector, pACT2 (Clontech). Oligonucleotides were designed 
containing restriction sites (York Bioscience), and S. pombe genomic DNA was 
used as the template for PCR. PCR was performed using the Stratagene 
RoboCycler Gradient 96 machine to allow easy identification of the most 
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appropriate annealing temperature. The presence of DNA product was confirmed 
by ethidium bromide staining and agarose gel electrophoresis; the product was 
then cloned using the StrataClone Blunt PCR Cloning Kit. Correct ligation was 
confirmed by an EcoRI digestion and agarose gel electrophoresis, and positive 
vector DNA was sequenced (University of Dundee). On sequence confirmation 
(using software Vector NTI, Invitrogen), the gene was excised from the 
StrataClone vector and ligated into pACT2; this was confirmed by restriction 
digestion. 
2.2.9 Transformation of S. pombe and S. cerevisiae  
Lithium acetate transformation of S. pombe and S. cerevisiae were performed as 
described (Okazaki et al. 1990). Appropriate yeast strains lacking reporter 
plasmid genes were grown overnight in 10 ml rich liquid medium. Cells were 
harvested by centrifugation for five minutes at 3,000 rpm and washed in 30 ml 
sterile H2O. The cells were resuspended in 1 ml sterile H2O and transferred to a 
microcentrifuge tube. The cells were next centrifuged for one minute at 4,000 
rpm, washed once with 1 ml TE/LiAc (10 mM Tris-Cl, 1 mM EDTA, 1 mM lithium 
acetate, pH 7.5) and then resuspended in 500 µl TE/LiAc. 100 µl of cells were 
then transferred to individual microcentrifuge tubes for transformation, and 2 µl 
salmon sperm DNA (10 mg/ml) and 10 µl transforming DNA were added. After ten 
minutes at room temperature, 260 µl PEG/TE/LiAc (40% (w/v) polyethylene 
glycol in TE/LiAc) was added and the cells were incubated for 30-60 minutes at 
30°C; cells were inverted several times during the incubation period. After the 
incubation, 43 µl dimethyl sulfoxide was added and the cells were incubated at 
42°C for five minutes. The cells were then centrifuged at 4,000 rpm for minute, 
with the pellet washed once with distilled H2O before being resuspended in 500 
µl distilled H2O and transferred to the appropriate selective solid medium. 
Transformed cells were then incubated at 30°C for 3-5 days. Single colonies 
were selected and streaked onto fresh solid medium and grown for three days; 
from these, single colonies were selected and master plates were prepared. 
After three days, the colonies from master plates were frozen in 30% glycerol at 
-70°C. 
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2.2.10 X-Gal overlay assay 
Yeast two-hybrid analysis was performed as described (Reynolds & Ohkura 2003). 
S. cerevisiae strains carrying bait and prey plasmids were cultured on solid 
synthetic dropout media lacking leucine and tryptophan and grown for three 
days at 30°C. The plates were scanned prior to the assay. A solution of 9.3 ml 
0.5 M potassium phosphate buffer (19.5% (v/v) 1 M KH2PO4, 30.5% (v/v) 1 M 
K2HPO4 in distilled H2O), 0.6 ml dimethyl formamide and 0.1 ml 10% SDS was 
mixed with 80 mg low-melting agarose (SeaPlaque GTG Agarose) and melted 
using a microwave oven. The solution was incubated at room temperature for 2-
3 minutes before 30 µl X-Gal (40 mg/ml stock solution in dimethyl formamide) 
and 6 µl β-mercaptoethanol were added with gentle mixing. In a fume hood, the 
mixture was poured over the surface of the S. cerevisiae colonies and to allowed 
to cool before cultures were incubated at 30°C. Cells were reviewed for colour 
development every second hour over the next six to eight hours and then 
incubated overnight. Colour reactions were recorded by scanning typically 12-36 
hours after the assay was performed.  
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2.3 Mammalian methods 
2.3.1 Cell culture 
2.3.1.1 General cell culture maintenance 
Human cell lines were cultured in Corning T75 flasks, 6-well plates or Falcon 10 
cm dishes. Both HeLa and HEK293 cells (cultured from stocks obtained from the 
American Tissue Culture Collection) were incubated at 37°C in a humidified 
atmosphere containing 5% CO2. To passage the cells into fresh medium, the 
medium was aspirated from cultures 70-80% confluent and 5 ml trypsin (0.05% 
(v/v) in EDTA) was added to each culture and incubated for 5 minutes. 10 ml 
fresh medium was added to each suspension and 3 ml was transferred to 9 ml 
medium in each subsequent flask. 
2.3.1.2 Culturing cells from frozen stocks 
Cryogenic vials containing frozen cell stocks were thawed from liquid nitrogen 
storage and diluted into 12 ml fresh, pre-warmed medium in a Corning T75 flask. 
The culture was incubated at 37°C with the medium being aspirated and 
replaced after 24 hours.  
2.3.1.3 HeLa cell culture maintenance 
HeLa cell cultures were maintained in DMEM (Gibco) supplemented with 10% 
(v/v) FCS EU (Gibco), 1% (v/v) glutamine (Gibco) and 1% (v/v) 
penicillin/streptomycin antibiotic (Gibco). HeLa cells were passaged into fresh 
medium three times weekly, and in the absence of antibiotics prior to 
transfection. 
2.3.1.4 HEK293 cell culture maintenance 
HEK293 cell cultures were maintained in MEM (Gibco) supplemented with 10% 
(v/v) FCS EU, 1% (v/v) glutamine, 1% (v/v) penicillin/streptomycin and 1% (v/v) 
sodium pyruvate. HEK293 cells were passaged into fresh medium twice weekly, 
and in the absence of antibiotics prior to transfection.  
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2.3.2 Amplification of the plasmids containing ESCRT genes 
E. coli transformations were performed using the Invitrogen One Shot TOP10 
Chemically Competent E. coli kit. Colonies were selected and transferred to 3 ml 
LB supplemented with ampicillin or kanamycin and incubated for 16 hours at 
37°C with rotation. 100 ml LB supplemented with ampicillin or kanamycin was 
inoculated with 100 µl of the bacterial culture. Plasmids were then purified 
using the QIAfilter Plasmid Purification for Maxi kit (Qiagen). Spectrophotometry 
was performed to quantify the concentration of DNA purified. 
2.3.3 Transfecting HeLa and HEK293 cells 
HeLa or HEK293 cells were split in medium lacking antibiotics and plated in 6-
well plates (or for immunofluorescence, onto ethanol-washed coverslips in 12-
well plates) one day prior to transfection. After 24 hours, master mixes of DNA, 
Lipofectamine 2000 (Invitrogen) and Opti-MEM (Gibco) were prepared to allow 
each well to receive the stipulated amount of DNA and half the volume of 
Lipofectamine 2000 as per the Lipofectamine 2000 protocol. In the no-DNA 
controls, additional Opti-MEM was used in place of DNA. Master mixes were 
incubated for 20 minutes at room temperature. Medium was aspirated and 
replaced with fresh antibiotic-free medium, and then master mixes were added. 
Cells were then incubated at 37°C, 5% CO2 for 48 hours; the medium was 
aspirated and replaced the following day with antibiotic-free medium. 
2.3.4 Cell fixation and DAPI staining for immunofluorescence 
Cells were washed three times with PBS, fixed with 3% paraformaldehyde for 20 
minutes and then washed twice with PBS. Cells were then permeabilised in 0.1% 
(v/v) Triton X-100/PBS for 2 minutes. 1 µg/ml DAPI in 0.1% Triton X-100/PBS was 
added to cells for 10 minutes before a final three washes with PBS. Coverslips 
were fixed to glass slides with mounting medium and left overnight to dry. 
2.3.5 HeLa cell synchronisation and lysate preparation 
2.3.5.1 HeLa cell synchronisation to metaphase and telophase 
HeLa cells were synchronised as described (Harper 2005). 5 mM thymidine was 
added to 24 flasks of HeLa cells (approximately 60% confluency); cells were 
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incubated for 16 hours, after which they were washed twice with cold PBS and 
twice with warm DMEM. Cells were then given 12 ml fresh DMEM and incubated 
for eight hours, at which point 100 ng/ml nocodazole was added to the cultures. 
16 hours later, the medium was gently aspirated and the flasks vigorously 
agitated to dislodge the cells. The cells from all 24 flasks were collected in 20 
ml PBS and centrifuged for five minutes at 1,000 rpm. The cells were washed 
twice with cold sterile PBS and thrice with warm DMEM. The cells were 
resuspended in 30 ml DMEM and transferred to two 10 cm plates. Metaphase-
arrested cells were incubated for 45 minutes and telophase-arrested cells were 
incubated for 90 minutes.  
2.3.5.2 Plk1 inhibition in HeLa cells 
To inhibit Plk1 kinase, cells were cultured and synchronised (Section 2.3.5.1) 
and 60 µl BI 2536 was added along with nocodazole. 
2.3.5.3 Lysate preparation 
100 µl lysis buffer (Section 2.1.5) was added to each well of a 6-well plate and 
cells were incubated on ice for five minutes. Cells were then scraped into 
centrifuge tubes. Mitosis-arrested cells were scraped into a centrifuge tube and 
pelleted for five minutes at 2,000 rpm, 4°C. Cells were resuspended in 2 ml lysis 
buffer.  
Cells were then passed 10 times through a 26-gauge needle, rested on ice for 20 
minutes and then again passed 10 times through the needle. The homogenised 
mix was transferred to microcentrifuge tubes and centrifuged for 15 minutes at 
15,000 x g, 4°C. The supernatants were retained and quantified before storing 
at -80°C. 
2.3.6 Protein quantification 
The Micro BCA Protein Assay Kit (Pierce) and FLUOstar OPTIMA (BMG Labtech) 
were used to quantify protein concentrations from cell lysate preparations. 
Briefly, standard protein concentrations, 0-12 mg/ml, were prepared from 
bovine serum albumin (BSA) and pipetted in duplicate on a Corning 96-well 
plate. The protein samples were pipetted in duplicate in both 1:1 and 1:10 
Chapter 2  62 
 
dilutions. 100 µl of the Micro BCA buffer mix (50% A, 48% B and 2% C) was added 
to each well and the plate was incubated at 37°C for 30 minutes. The dilutions 
were then analysed using FLUOstar OPTIMA; a standard curve was established 
from which the protein concentrations of the samples were extrapolated. 
2.3.7 Immunoprecipitation from HeLa or HEK293 lysates 
2.3.7.1 Immunoprecipitation of Plk1 from non-transfected HeLa or HEK293 
lysates 
Immunoprecipitations were modified from (Fielding et al. 2005) and (Fu et al. 
2008). One mg of cell lysate, brought up to 500 µl in lysis buffer, was incubated 
overnight at 4°C with rotation with 7.5 µl (HeLa cell lysates) or 10 µl (HEK293 
cell lysates) anti-Plk1 antibody. Various negative controls were performed as 
follows: 50 ng IgG from rabbit serum (I5006, Sigma) was incubated with lysate, 
anti-Plk1 was incubated with 500 µl lysis buffer, and to perform a beads-only IP, 
lysate was incubated overnight without any addition. After incubation, 30 µl 
Protein A sepharose beads (GE Healthcare Life Sciences), pre-washed twice and 
resuspended in cold lysis buffer, was added and lysate mixtures were again 
incubated with rotation at 4°C for two hours. After incubation, mixtures were 
centrifuged at 4°C for 25 seconds and the supernatant was retained. Beads were 
washed twice in IP wash buffer 1 and thrice in IP wash buffer 2. Beads were then 
resuspended in 75 µl 1X LSB, mixed vigorously using a vortex and heated to 65°C 
for ten minutes. Beads were centrifuged for five minutes and the supernatant 
was retained. Samples were either analysed immediately using SDS-PAGE or 
stored at -80°C. 
2.3.7.2 Immunoprecipitation of FOXM1, ESCRT proteins and various 
epitopes 
To immunoprecipitate FOXM1, ESCRT proteins or other proteins via epitopes, the 
method described (Section 2.3.7.1) was followed with different antibody and 
beads combinations. The following antibodies were captured using Protein A 
sepharose beads: anti-CHMP6, anti-GFP and anti-myc antibodies. The following 
antibodies were captured using Protein G sepharose beads: anti-FOXM1, anti-HA, 
anti-TSG101 and anti-VPS28 antibodies. 
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2.3.8 SDS-PAGE  
Protein samples were mixed 3:1 with 4X LSB, heated to 65°C for ten minutes and 
loaded on a 10-15% 1.5 mm Tris-HCl SDS gel. The gels were cast using Bio-Rad 
mini-Protean III gel casting units and comprised 30% (w/v) acrylamide (Severn 
Biotech), 10% SDS, 10% ammonium persulphate and tetramethylethylenediamine 
(TEMED). To determine molecular weight, Bio-Rad Precision Plus Protein 
Standards All Blue (161-0373) was run in at least one lane of the gel. Gels were 
run in SDS-PAGE running buffer (Section 2.1.5) at 80 V constant voltage during 
the stacking portion of the gel and then 120 V, using the Bio-Rad Protean III 
system.  
2.3.9 Immunoblotting 
2.3.9.1 Transfer to nitrocellulose membrane 
Following SDS-PAGE, proteins were transferred to nitrocellulose membrane using 
the Bio-Rad mini Protean III trans-blot system. Transfer cassettes were 
assembled with sponges, filter paper (Whatman 3MM blotting paper), SDS gel and 
nitrocellulose membrane (Pall Corporation), all pre-soaked in transfer buffer 
(Section 2.1.5). Transfer was performed using a constant current of 200 mA for 
two hours or 50 mA overnight. 
2.3.9.2 Membrane blocking and protein probing  
Following transfer, membranes were washed in PBS or TBS and briefly stained 
with Ponceau S to confirm that proteins had successfully transferred. Membranes 
were washed again and non-specific sites were blocked in 1% (w/v) milk (Marvel) 
in PBS/TBS, incubating with rotation for one hour at room temperature. 
Membranes were then washed in PBS/TBS and incubated rotating in a solution of 
primary antibody in the appropriate concentration of BSA (Sigma) in PBST/TBST 
at 4°C for one or two nights (Section 2.1.4.1). Membranes were then washed 
several times in PBST/TBST and incubated with rotation in a solution of 
appropriate horseradish peroxidase (HRP)-conjugated secondary antibody diluted 
in 1% (w/v) milk-PBST/TBST for two hours at room temperature (Section 
2.1.4.2). Membranes were then washed several times in PBST/TBST or high salt 
solutions as necessary. 
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2.3.9.3 Immunodetection of proteins via enhanced chemiluminescence 
(ECL) 
Membranes were rotated at room temperature for one minute in a 1:1 solution 
of ECL 1 and 2 (Section 2.1.5). Membranes were then fixed between plastic film 
in a developing box. In a dark room, Kodak Medical X-ray films were exposed to 
the membranes and then developed in a Kodak X-OMAT 2000 Processor. 
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Chapter 3 Plo1p kinase and Clp1p (Cdc14) 
phosphatase interact with ESCRT proteins to 
control cell division in S. pombe 
3.1 Introduction 
The ESCRT proteins have a role in cytokinesis in humans (Morita et al. 2007). 
However, the regulation of these proteins remains largely unresolved. One of the 
most widespread methods of protein regulation is activation/deactivation via 
phosphorylation status. The fission yeast Schizosaccharomyces pombe ESCRT 
proteins all have amino acid residues that are potentially regulated by 
phosphorylation (www.pombase.org). Thus, two candidate regulators were 
identified in fission yeast on the basis of their significant roles in cytokinesis: 
Plo1p kinase and Clp1p (Cdc14p) phosphatase (Barr et al. 2004; Trautmann et al. 
2001).  
3.1.1 Fission yeast is an appropriate model organism for studying 
cell division  
Fission yeast cell division progresses in a manner similar to animals, primarily by 
cytoplasmic cleavage furrowing driven by constriction of an actomyosin ring. In 
excess of 100 cytokinesis genes have been identified in fission yeast, and it has 
been noted that significant overlap exists between human cytokinesis genes and 
their yeast homologues (Wu et al. 2003). Therefore, understanding cytokinesis in 
fission yeast should generate findings applicable to higher eukaryotes, including 
humans (Pollard & Wu 2010). 
3.1.2 Aims 
Genetic interactions between ESCRT genes and plo1+ and clp1+ were investigated 
using a three-pronged approach. Initially, the effect of deleting chromosomal 
copies of individual ESCRT genes upon fission yeast cytokinesis and cell 
separation was characterised through observed effects on septation. Further, 
due to the established role of ESCRT proteins in vacuolar sorting (Hurley & Emr 
2006), the effect of mutations in plo1 and clp1 on vacuolar sorting was analysed 
via the distribution of a GFP-labelled receptor and vacuolar staining in cells. 
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Finally, the genetic interactions between ESCRT genes and plo1 and clp1 
mutants were investigated by growth rate analysis. 
The yeast two-hybrid assay was then employed to extend the genetic 
interactions observed into detectable protein-protein interactions between 
ESCRT proteins and Plo1p and Clp1p.  
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3.2 Results 
3.2.1 The ESCRT proteins have a role in cell division in fission 
yeast 
Central to this investigation is the observation that ESCRT proteins are involved 
in cytokinesis in human cells (Morita et al. 2007). To this end, the effect of 
ESCRT proteins on cell separation in S. pombe was first investigated. Fission 
yeast cell separation proceeds by mitosis, followed by the physical division of 
the cells, so-called septation (Sohrmann et al. 1996). Thus, septation in fission 
yeast was analysed as it serves as an analogous system to mammalian 
cytokinesis. 
To study septation in fission yeast, cells were cultured in rich liquid medium and 
then exposed to Calcofluor stain (Materials and Methods 2.2.2), which 
specifically stains newly deposited cell wall. The septa of dividing cells were 
then visualised using fluorescence microscopy. Initially, the unperturbed 
septation phenotypes in wild-type cells were characterised. Phenotypes were 
then characterised in cells containing individual ESCRT chromosomal deletions 
(Iwaki et al. 2007) (Figure 3.1A). The relative frequencies of these phenotypes 
were then quantified in mutants and compared to wild-type (Figure 3.1B). A list 
of the strains used and produced in this study is shown in Appendix 6.1. 
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Figure 3.1: ESCRT proteins are required for septation in fission yeast. 
Wild-type fission yeast, and strains containing individual chromosomal deletions of 
ESCRT genes were grown in rich liquid medium to mid-exponential phase and 
harvested. Cells were stained with Calcofluor white and visualised by fluorescence 
microscopy. Images were captured of both fluorescence via a DAPI filter and bright 
field. (A) Panels A-F indicate the observed septation phenotypes across various yeast 
strains. Diagrams above panels represent each phenotype: (A) a normal septum, (B) a 
misaligned septum, (C) a non-perpendicular septum, (D) multiple septa, (E) no septal 
formation, and (F) failed separation of daughter cells following septation. Scale bars – 
10 microns. (B) Statistical analysis of the frequency of septation phenotypes A-F 
among ESCRT-deleted yeast strains, in comparison to the wild-type frequencies (400 
cells, n=3; *p < 0.05). Each of the ESCRT genes labels is accompanied by its 
respective ESCRT subunit (E-0-III).  
Characterising septation in wild-type cells revealed two prevalent phenotypes: 
cells dividing normally and cells with delayed separation following septation. 
Characterising ESCRT-deleted strains revealed an increased proportion of cells 
with various septal defects, such as misaligned and non-perpendicular septa. 
There was also an increase in the proportion of cells with multiple septa, or 
even the complete absence of a septum. The latter was identified due to the 
length of the cell in comparison to the rest of the population: cells with failed 
septal formation would reach approximately double, or even three times the 
length of other cells. 
However, the largest proportion of septal defects was in the identified F 
phenotype. This phenotype presented as two small joined cells with their 
contact edges stained (Figure 3.1A, panel F) and was thus described as two 
daughter cells that had failed to separate efficiently following septation. 
Although fission yeast do not immediately separate following division (Mitchison 
& Nurse 1985), an increased prevalence was observed of this phenotype relative 
to wild-type. To quantify the frequency of these phenotypes, 400 cells were 
counted in triplicate for wild-type and each ESCRT-deleted strain. Each 
phenotype was represented as a percentage of the total dividing population 
before being compared to the wild-type phenotype in the application of a 
Student’s t-Test (with a two-tailed distribution, processed using Microsoft 
Excel). Statistical analysis by this means revealed a significant (p < 0.05) 
increase in the failed separation F phenotype for chromosomal deletions of four 
ESCRT genes: sst4, vps20, vps24 and vps4 (Figure 3.1B).  
These data show that the absence of ESCRT genes leads to defective septation in 
fission yeast; in some cells, this defect manifested as delayed septation, in other 
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cells as defective septation. These data imply that ESCRT proteins, particularly 
ESCRT-0, -III and Vps4p, are required for cell division in fission yeast. 
3.2.2 Cell division defects observed in ESCRT mutants are 
exacerbated when combined with mutants of plo1, clp1, 
mid1 and ark1 
To identify fission yeast proteins that may regulate ESCRT protein function 
during cell division, septation phenotypes were examined in strains that 
contained double mutants of ESCRT deletions combined with mutants in genes 
plo1, clp1, mid1 and ark1. These preliminary data were produced by graduate 
student Brinta Roy, whom I supervised, and are shown in Appendix 6.2. In each 
case, double mutants were produced by tetrad analysis (Materials and Methods 
2.2.3), and the septation phenotypes characterised by Calcofluor staining 
(Section 3.2.1). A list of the strains used and produced in this study is shown in 
Appendix 6.1. 
Cells with a temperature-sensitive mutant of plo1 exhibited an increased 
proportion of phenotypes C-F. An increased proportion of the C and F 
phenotypes was observed in cells containing a clp1 null mutation. Interestingly, 
both plo1 and clp1 mutants when combined with individual mutations in ESCRT 
genes frequently revealed a decreased proportion of the F phenotype; this may 
indicate phenotypic rescue and the interaction of these genes within a shared 
pathway. Both sets of double mutants also exhibited increases in aberrant 
phenotypes B-E, particularly double mutants with clp1Δ. 
The observation of misaligned and non-perpendicular septa is similar to that 
reported in cells containing mutations in mid1 (Sohrmann et al. 1996), which is 
required for actin ring formation in fission yeast (Ng et al. 2006). Thus, cells 
with a mid1 null mutation were characterised, and an increased proportion of all 
aberrant B-E phenotypes was noted (Figure 3.1A). In addition, a further dividing 
phenotype of branched cells, sometimes with multiple septa, was identified. 
Double mutants of mid1Δ and ESCRT genes revealed an increased proportion of, 
in particular, C phenotypes, as well as the branched phenotype, designated G 
phenotype.  
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Ark1p is the fission yeast homologue of Aurora kinase, which has an established 
role in late stages of the cell cycle (Petersen & Hagan 2003). Thus, in light of the 
data collected in this study, it was investigated whether two temperature-
sensitive mutants of ark1, ark1-T8 and ark1-T11 (Koch et al. 2011), exacerbate 
the septation phenotypes observed in ESCRT mutant strains. Single mutants were 
revealed to have an increased proportion of C, E and F phenotypes, and analysis 
of double mutants with ESCRT genes revealed a higher prevalence of B-E 
phenotypes in particular.  
These observations indicate that ESCRT proteins mediate cell separation in 
fission yeast and that Plo1p, Clp1p, Mid1p and Ark1p potentially regulate ESCRT 
proteins in cell division. 
3.2.3 plo1+ and clp1+ interact genetically with ESCRT genes 
To test the hypothesis that Plo1p and Clp1p regulate ESCRT protein function, a 
yeast genetic approach was employed. This method allowed for the rapid 
analysis of a large number of genetic interactions between plo1+, clp1+ and eight 
ESCRT genes. 
Double mutants were produced by crossing yeast strains containing individual 
deletions of ESCRT genes (Iwaki et al. 2007) with various mutant strains of plo1 
and clp1. Progeny were characterised by tetrad analysis (Materials and Methods 
2.2.3), an example of which is shown in Figure 3.2. A temperature-sensitive 
mutant of plo1, plo1-ts35 (Anderson et al. 2002), and three different mutations 
of clp1 were used: chromosomal deletion clp1Δ (Trautmann et al. 2001), 
phosphatase-dead clp1.D257A and clp1.3A, a gain-of-function mutant with 
reduced phosphorylation by Cdc2p (Wolfe et al. 2006). A list of the strains used 
and produced in this study is shown in Appendix 6.1.  
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Figure 3.2: Fission yeast double mutants were generated by ascus dissection. 
Yeast strains were mated on solid ME medium and then transferred to solid YE 
medium for ascus dissection using a Singer MSM Ascus Dissector. This particular 
cross was incubated at 25°C, then replica plated to four selective solid media: YE 
grown at 36°C, YE with the addition of G418 (kanamycin), EMM lacking leucine and 
EMM lacking adenine. The double mutant is boxed in blue. 
A strong indication of a genetic interaction between two genes is the generation 
of a synthetic lethal offspring, where two viable single mutants produce a non-
viable double mutant. In this scenario, synthetic lethality may indicate a direct 
relationship between gene products, such that the combination of their 
activities is necessary for the survival of the organism (Future work 5.3). 
However, it may equally demonstrate the involvement of the respective gene 
products in distinct pathways, both of which are required for cell survival. None 
of the crosses between ESCRT deletions and plo1 or clp1 mutants produced such 
a synthetic lethal phenotype. However, more subtle genetic interactions may be 
inferred from impaired growth rates. To search for the presence of such 
phenotypes, parent and offspring strains were streaked to single colonies on rich 
and minimal solid media at various temperatures (Materials and Methods 2.2.5). 
As plo1-ts35 is a temperature-sensitive strain with a permissive temperature of 
25°C and a restrictive temperature of 36°C, it was hypothesised that combining 
this with mutations in ESCRT genes may result in the reduction of the restrictive 
temperature. Therefore, yeast strains were also grown at 25°C and 30°C to 
search for growth differences. Figure 3.3 illustrates the identification of just 
such a synthetic growth phenotype in double mutant vps28Δ plo1-ts35 grown at 
30°C.  
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Figure 3.3: plo1-ts35 shows synthetic growth phenotypes with vps28Δ. 
Single and double mutants of plo1-ts35 and vps28Δ were streaked to single colonies 
on solid YE medium. Images were captured after three days of growth at 30°C. 
The results of the growth rate studies of all the ESCRT deletion strains with plo1-
ts35 and the three clp1 mutant strains are shown in Table 3.1 and summarised in 
Table 3.2. Excitingly, it was observed that plo1-ts35 and mutants of clp1 showed 
genetic interactions with several ESCRT deletions, as they exhibited synthetic 
phenotypes at one or more of the temperatures and media investigated. 
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ESCRTΔ Media Temp   plo1-ts35 clp1Δ clp1.D257A clp1.3A 
sst4Δ  
E-0 
 
 
 
YE 
25°C ✗ ✗ ✗ ✗ 
30°C   ✓ ✗ ✗ ✗ 
36°C ✗ ✓ ✓ ✗ 
EMM 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
sst6Δ  
E-I YE 
25°C ✗       
30°C ✗       
36°C ✗       
EMM 
25°C ✗       
30°C ✗       
36°C ✗       
vps28Δ  
E-I YE 
25°C ✗ ✗ ✗ ✗ 
30°C ✓ ✗ ✗ ✗ 
36°C ✗ ✓ ✗ ✓ 
EMM 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
vps36Δ  
E-II YE 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✓ ✗ ✓ 
EMM 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
vps25Δ  
E-II YE 
25°C ✗ ✗ ✗ ✗ 
30°C ✓ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
EMM 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
vps20Δ  
E-III YE 
25°C ✗ ✗ ✗ ✗ 
30°C ✓ ✗ ✗ ✗ 
36°C ✓ ✓ ✓ ✓ 
EMM 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
vps2Δ  
E-III YE 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✓ ✓ ✗ ✗ 
EMM 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
vps4Δ 
YE 
25°C ✓ ✗ ✗ ✗ 
30°C ✓ ✗ ✗ ✗ 
36°C ✓ ✓ ✓ ✓ 
EMM 
25°C ✗ ✗ ✗ ✗ 
30°C ✗ ✗ ✗ ✗ 
36°C ✗ ✗ ✗ ✗ 
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Table 3.1: Synthetic growth phenotypes of mutations in plo1, clp1 and ESCRT 
genes. 
The table summarises growth rate analysis data, such as illustrated in Figure 3.3. 
Double mutants of plo1-ts35 or mutant clp1 with ESCRT mutants that resulted in 
synthetic growth phenotypes are indicated by ticks. Three temperatures were 
investigated on both rich (YE) and supplemented minimal (EMM) media. Double 
mutants could not be readily generated from sst6Δ and clp1 as the genes are tightly 
linked, being less than 4.2 kb apart on the same chromosome (www.pombase.org). 
The genetic interactions observed in crosses between ESCRT deletion strains and 
plo1-ts35 and clp1 mutant strains are summarised in Table 3.2. This shows a 
global perspective of the genetic interactions observed between these strains, as 
the represented genetic interactions may refer to one or more observations of a 
synthetic phenotype in the six conditions analysed for each genetic cross (rich 
and minimal media, and three temperatures). 
ESCRTΔ plo1-ts35 clp1Δ clp1.D257A clp1.3A 
sst4Δ E-0 !  !  !  ✗ 
sst6Δ E-I !  Genes  are  tightly   linked 
vps28Δ E-I !  !  ✗ !  
vps36Δ E-II ✗ !  ✗ !  
vps25Δ E-II !  ✗ ✗ ✗ 
vps20Δ E-III !  !  !  !  
vps2Δ E-III !  !  ✗ ✗ 
vps4Δ !  !  !  !  
Table 3.2: A summary of synthetic growth phenotypes of mutations in plo1, clp1 
and ESCRT genes. 
The table summarises the growth rate analysis data presented in Table 3.1. Double 
mutants of plo1-ts35 or clp1Δ with ESCRT mutants that resulted in synthetic growth 
phenotypes are indicated by ticks. Double mutants could not be readily generated 
from sst6Δ and clp1 as the genes are tightly linked, being less than 4.2 kb apart on the 
same chromosome (www.pombase.org). 
These synthetic phenotypes indicate genetic interactions, which in turn suggest 
that ESCRT proteins interact with Plo1p and Clp1p. 
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3.2.4 Plo1p and Clp1p affect ESCRT-mediated vesicular 
trafficking 
To augment the genetic data indicating interactions between plo1+, clp1+ and 
ESCRT genes, a parallel study was performed analysing the effect of plo1 and 
clp1 mutants upon sorting during downregulation of ubiquitin-labelled receptors. 
The basis of this study is the observation that ESCRT proteins have roles in cell 
sorting (Iwaki et al. 2007). The hypothesis that Plo1p and Clp1p regulate ESCRT 
components leads to the current hypothesis that genetic mutants of plo1 and 
clp1 will affect vesicular trafficking in an ESCRT-dependent manner. Iwaki et al 
(2007) demonstrated the principle of this experiment by generating a ubiquitin-
GFP-labelled receptor (Ub-GFP-SpCPS) that localised to vacuoles in wild-type 
fission yeast cells. They then showed that in ESCRT-null strains, the pattern of 
fluorescence changed from vacuolar to endosomal, indicating defective sorting. 
This finding supports the observation that ESCRT proteins have roles in vacuolar 
sorting. 
To examine receptor localisation in fission yeast, the Ub-GFP-SpCPS construct 
(Iwaki et al. 2007) was transformed into wild-type fission yeast and strains with 
individual deletions in ESCRT genes. FM 4-64, a stain for yeast vacuolar 
membranes, was used to identify the vacuoles, and the cells were visualised by 
confocal fluorescence microscopy (Materials and Methods 2.2.6). Similar to 
reported descriptions (Iwaki et al. 2007), wild-type cells exhibited a largely 
vacuolar pattern of sorting (Figure 3.4). This was identified by the overlap in 
fluorescence between Ub-GFP-SpCPS and the FM 4-64-stained vacuoles. 
However, the ESCRT-deleted yeast strains, with one ESCRT mutant chosen from 
each ESCRT class, exhibited a punctate pattern of fluorescence associated with 
Ub-GFP-SpCPS (Figure 3.4). Iwaki et al (2007) identified this as endosomal, via 
the localisation of RFP-labelled phosphatidylinositol-(3,4,5)-triphosphate, which 
has previously been shown to accumulate on the endosome (Mitra et al. 2004). 
Cells with a vps4Δ deletion exhibited a sorting pattern similar to wild-type cells. 
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Figure 3.4: Defective vacuolar sorting is observed in fission yeast with 
individual chromosomal deletions of ESCRT genes. 
Wild-type and ESCRT-deleted fission yeast strains, transformed with Ub-GFP-SpCPS, 
were cultured in liquid minimal medium, stained with FM 4-64 and visualised using a 
confocal microscope. Strains were cultured at 30°C, although similar profiles were 
noted in strains cultured at 25°C. Scale bar – 10 microns. 
The wild-type phenotype presented here differs from the luminal GFP 
distribution reported (Iwaki et al. 2007); this may be due to the culturing of 
these strains, as nutrient stress may contribute to differences in the observed 
phenotypes. Nevertheless, once a reproducible phenotype for the wild-type and 
ESCRT-deleted strains was achieved, the Ub-GFP-SpCPS and vacuolar distribution 
in plo1-ts35 and clp1 mutant cells was characterised (Figure 3.5). Distinct 
vacuolar profiles were noted in these strains, particularly in plo1-ts35 cells, 
which exhibited a uniform array of vacuoles that precisely co-localised with the 
Ub-GFP-SpCPS construct (Figure 3.5A). In contrast, Ub-GFP-SpCPS tended to 
localise to the lumina of clp1Δ cells (Figure 3.5B). The clp1 mutant, clp1.D257A, 
revealed a phenotype closer to wild-type cells. The clp1.3A mutant revealed a 
phenotype similar to the reported wild-type phenotype (Iwaki et al. 2007), 
which is, according to these data presented, more similar to the phenotype 
observed in plo1-ts35 cells. 
 
A 
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Figure 3.5: Mutants of plo1 and clp1 cause defective vacuolar sorting in fission 
yeast. 
Wild-type and ESCRT-deleted fission yeast strains, transformed with Ub-GFP-SpCPS, 
were cultured in liquid minimal medium, stained with FM 4-64 and visualised using a 
confocal microscope. Strains were cultured at (A) 25°C or (B) 30°C. Scale bar – 10 
microns. 
One way to infer a role for Plo1p and Clp1p in regulating ESCRT protein function 
would be to observe similar patterns of Ub-GFP-SpCPS and vacuolar distribution 
in cells containing mutations in their genes. However, this was not observed. 
One possible explanation for this may be linked to the observation that Plo1p 
and Clp1p are active late in the cell cycle (Ng et al. 2006; Papadopoulou et al. 
2010); thus their regulation of the ESCRT proteins may be restricted to ESCRT 
functions in cytokinesis. This would be consistent with the hypothesis of this 
study that Plo1p and Clp1p regulate ESCRT proteins in cytokinesis.  
Nevertheless, plo1-ts35 and clp1Δ did present striking profiles of vacuolar 
morphology, albeit distinct to that observed in ESCRT deletion strains. These 
observations prompted an epistasis experiment, whereby the Ub-GFP-SpCPS 
construct was transformed into double mutants of ESCRT deletions and plo1-ts35 
and clp1Δ; one representative of each ESCRT class was selected. This allowed 
the qualitative analysis of the Ub-GFP-SpCPS and vacuolar distributions in double 
mutants compared to each parent. Such analysis might allow inferences to be 
made as to the possible dependency of ESCRT genes on plo1+ and clp1+ to control 
the cell sorting function.  
The images produced from such an epistatic analysis revealed that all but one of 
the plo1-ts35 ESCRT double mutants exhibited a phenotype closer to their plo1-
ts35 parent (Figure 3.6). In contrast, all of the clp1Δ ESCRT double mutants 
exhibited a phenotype closer to their ESCRT parent (Figure 3.7). The results of 
these experiments are summarised in Table 3.3. 
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Figure 3.6: Genetic interactions between plo1-ts35 and ESCRT deletions in 
controlling cell sorting. 
Double mutants of plo1-ts35 and ESCRT deletions, transformed with Ub-GFP-SpCPS, 
were cultured in liquid minimal medium at 25°C, stained with FM 4-64 and visualised 
using a confocal microscope. Scale bar – 10 microns. 
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Figure 3.7: Genetic interactions between clp1Δ and ESCRT deletions in 
controlling cell sorting. 
Double mutants of clp1Δ and ESCRT deletions, transformed with Ub-GFP-SpCPS, 
were cultured in liquid minimal medium at 25°C, stained with FM 4-64 and visualised 
using a confocal microscope. Scale bar – 10 microns.  
ESCRTΔ plo1-ts35 clp1Δ 
sst4Δ E-0 plo1-ts35 sst4Δ 
vps28Δ E-I plo1-ts35 vps28Δ 
vps36Δ E-II plo1-ts35 vps36Δ 
vps20Δ E-III plo1-ts35 vps20Δ 
vps4Δ vps4Δ vps4Δ 
Table 3.3: A summary of the vacuolar sorting epistasis data in double mutants 
of ESCRT genes and plo1 or clp1. 
The table summarises the epistasis data collected in double mutants of plo1-ts35 or 
clp1Δ with ESCRT genes. The mutants named in the body of the table indicate which 
parent the double mutants resembled. 
Qualitatively, the plo1-ts35 double mutants with sst4Δ, vps28Δ, vps36Δ and 
vps20Δ more closely resembled the plo1-ts35 single mutant, whereas the plo1-
ts35 vps4Δ double mutant more closely resembled its vps4Δ parent. However, all 
of the clp1Δ double mutants more closely resembled their respective ESCRT 
deletion parent. These epistasis data suggest that plo1+ functions upstream of 
the ESCRT genes, and clp1+ downstream, in controlling cell sorting in fission 
yeast.  
3.2.5 Plo1p and Clp1p interact physically with ESCRT proteins 
The observations presented in Sections 3.2.2 to 3.2.4 suggest genetic 
interactions between plo1+, clp1+ and ESCRT genes. The simplest explanation for 
these genetic interactions is that the encoded proteins physically interact. This 
was tested using the yeast two-hybrid method (Fields & Song 1989). Plo1p or 
Clp1p fused to the DNA-binding domain of the GAL4 transcription factor in the 
so-called bait vector (Reynolds & Ohkura 2003; Papadopoulou et al. 2010) were 
co-transformed into budding yeast cells with individual ESCRT proteins fused to 
the DNA-activation domain in the prey vector. Transcriptional readout from the 
gal4 promoter linked to the reporter gene in these yeast cells, as shown by the 
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production of a blue pigment from substrate X-Gal, indicates that the proteins 
interact in vivo. 
To facilitate cloning the ESCRT genes, the StrataClone Blunt PCR Cloning kit was 
employed (Materials and Methods 2.2.8). Genes were amplified using suitable 
oligonucleotides (Materials and Methods 2.1.2) and proof-reading Pfu 
polymerase for PCR and then cloned into the StrataClone vector. Once the 
integrity of cloned genes was confirmed by sequencing, they were sub-cloned 
into the prey vector, pACT2. Constructs were then transformed into budding 
yeast strains GGBY 138 or 171. A list of the strains used and produced in this 
study is shown in Appendix 6.1.  
Transformed yeast strains were grown on solid minimal medium alongside 
appropriate controls for three days at 30°C. To test for interactions with Plo1p, 
each of the ESCRT proteins was interrogated for interactions with wild-type 
Plo1p, a kinase-dead mutant (Plo1.K69R) and two mutants in the polo-box 
domain, which is required for substrate binding (Plo1.472-684 and 
Plo1.DHK625AAA) (Reynolds & Ohkura 2003). The interaction of Plo1p with 
Mbx1p was used as the positive control for the assay (Papadopoulou et al. 2008). 
The X-Gal overlay assay was performed (Materials and Methods 2.2.10) and 
images were captured both approximately 12 hours later, and after 1-2 days, 
depending on the strength of the interaction. 
A number of the ESCRT proteins exhibited interactions with wild-type Plo1p and 
inactive Plo1p (Plo1.K69R). These are shown in Figure 3.8, which is summarised 
in Table 3.4, and were Vps28p (ESCRT-I), Vps20p (ESCRT-III) and Vps32p (ESCRT-
III). 
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Figure 3.8: Vps28p, Vps20p and Vps32p physically interact with wild-type Plo1p. 
Budding yeast strains were transformed with the yeast two-hybrid bait and prey 
plasmid constructs indicated. The ESCRT proteins were fused to the prey domain of 
the GAL4 transcription factor; however, for ease of identification, the bait and prey 
plasmids have not been labelled consistently. The strains were grown for three days 
on selective medium when the X-Gal overlay assay was performed. 
However, other ESCRT proteins exhibited interactions with inactive Plo1p, yet 
not wild-type; these are shown in Figure 3.9 and summarised in Table 3.4, and 
were Sst4p (ESCRT-0) and Vps25p (ESCRT-II).  
 
Chapter 3  89 
 
 
Figure 3.9: Sst4p and Vps25p physically interact with kinase-dead Plo1p. 
Budding yeast strains were transformed with the yeast two-hybrid bait and prey 
plasmid constructs indicated. The ESCRT proteins were fused to the prey domain of 
the GAL4 transcription factor; however, for ease of identification, the bait and prey 
plasmids have not been labelled consistently. The strains were grown for three days 
on selective medium when the X-Gal overlay assay was performed. 
One possible explanation for interactions with Sst4p and Vps25p only being 
detected with a catalytically inactive version of Plo1p is that wild-type Plo1p 
normally only interacts transiently with these proteins, which is not detected by 
this two-hybrid assay. Possibly, the catalytically inactive version of Plo1p ‘traps’ 
Sst4p and Vps25p, resulting in a more stable interaction, which is, in contract, 
detected. 
Those ESCRT proteins that exhibited no interaction with Plo1p are shown in 
Figure 3.10 and summarised in Table 3.4. These were Sst6aa.20-487, a form of 
Sst6p that omitted a short, early intron (ESCRT-I), Vps36p (ESCRT-II), Vps2p 
(ESCRT-III) and Vps4p.  
Finally, none of the ESCRT proteins exhibited interactions with the Plo1 mutants 
of the polo-box domain, which is consistent with this domain’s role in substrate 
binding (Reynolds & Ohkura 2003).  
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Figure 3.10: Sst6p, Vps36p, Vps2p and Vps4p do not exhibit physical 
interactions with Plo1p. 
Budding yeast strains were transformed with the yeast two-hybrid bait and prey 
plasmid constructs indicated. The ESCRT proteins were fused to the prey domain of 
the GAL4 transcription factor; however, for ease of identification, the bait and prey 
plasmids have not been labelled consistently. The strains were grown for three days 
on selective medium when the X-Gal overlay assay was performed. 
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ESCRT Plo1p Plo1.K69R Plo1.472-684 Plo1.DHK625AAA 
Sst4p 
E-0 
✗ !  ✗ ✗ 
Sst6aa.20-487 
E-I 
✗ ✗ ✗ ✗ 
Vps28p 
E-I 
!  !  ✗ ✗ 
Vps36p 
E-II 
✗ ✗ ✗ ✗ 
Vps25p 
E-II 
✗ !  ✗ ✗ 
Vps20p 
E-III 
!  !  ✗ ✗ 
Vps32p 
E-III 
!  !  ✗ ✗ 
Vps2p 
E-III 
✗ ✗ ✗ ✗ 
Vps4p ✗ ✗ ✗ ✗ 
Table 3.4: A summary of blue yeast observation in yeast two-hybrid analysis of 
Plo1p and the ESCRT proteins. 
The table summarises the presence or absence of yeast cells showing blue colour 
when each of the ESCRT proteins was assayed with various versions of Plo1p by 
yeast two-hybrid analysis. 
Yeast two-hybrid analysis with Clp1p yielded more ambiguous results (Figure 
3.11), and thus some interpretation was required. In this instance, ESCRT 
proteins were tested for interactions with wild-type Clp1p and a truncated form 
of Clp1p (Clp1aa.1-371, a gift from K. Gould, Vanderbilt University). 
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Figure 3.11: ESCRT proteins do not definitively exhibit physical interactions 
with Clp1p. 
Budding yeast strains were transformed with the yeast two-hybrid bait and prey 
plasmid constructs indicated. The ESCRT proteins were fused to the prey domain of 
the GAL4 transcription factor; however, for ease of identification, the bait and prey 
plasmids have not been labelled consistently. The strains were grown for three days 
on selective medium when the X-Gal overlay assay was performed. 
Experiments with Clp1p using yeast two-hybrid are more difficult to interpret 
than Plo1p, as the positive control, Clp1p-Mbx1p (Papadopoulou et al. 2008), did 
not result in yeast cells that were deep blue, which would indicate a strong 
physical interaction. However, one interesting observation was made with 
Vps28p (ESCRT-I). In all Clp1p yeast two-hybrid assays, blue colouration was 
observed for Clp1aa.1-371, except with Vps28p (Figure 3.12).  
 
Figure 3.12: Vps28p and Clp1aa.1-371 results in a negative yeast two-hybrid 
assay. 
Budding yeast strains were transformed with the yeast two-hybrid bait and prey 
plasmid constructs indicated. The ESCRT proteins were fused to the prey domain of 
the GAL4 transcription factor; however, for ease of identification, the bait and prey 
plasmids have not been labelled consistently. The strains were grown for three days 
on selective medium when the X-Gal overlay assay was performed. 
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Clp1aa.1-371 with an empty vector or Mbx1p resulted in deep blue colonies, but 
in the Vps28p assay alone, Clp1aa.1-371 returned white colonies. This is because 
Clp1p is itself able to bind DNA (Papadopoulou et al. 2010). Thus, it is apparent 
that the Clp1aa.1-371 mutant is capable of auto-activating the gal4 promoter 
without a binding partner. Therefore, the absence of blue in this assay indicates 
an interaction between Clp1p and Vps28p, as Vps28p sequesters Clp1p from its 
DNA-binding function.  
Clp1p yeast two-hybrid data are presented in Table 3.5 and a summary of Plo1p 
and Clp1p yeast two-hybrid interactions with the ESCRT proteins is provided in 
Table 3.6. 
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 ESCRT Clp1p Clp1aa.1-371 
Sst4p 
E-0 
✗ !  
Sst6aa.20-487 
E-I 
✗ !  
Vps28p 
E-I 
✗ ✗ 
Vps36p 
E-II 
✗ !  
Vps25p 
E-II 
✗ !  
Vps20p 
E-III 
✗ !  
Vps32p 
E-III 
✗ !  
Vps2p 
E-III 
✗ !  
Vps4p ✗ !  
Table 3.5: A summary of blue yeast observation in yeast two-hybrid analysis of 
Clp1p and the ESCRT proteins. 
The table summarises the presence or absence of yeast cells showing a blue colour 
when each of the ESCRT proteins was assayed with various versions of Clp1p by 
yeast two-hybrid analysis. 
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 ESCRT Plo1p Clp1p 
Sst4p 
E-0 
!  ✗ 
Sst6aa.20-487 
E-I 
✗ ✗ 
Vps28p 
E-I 
!  !  
Vps36p 
E-II 
✗ ✗ 
Vps25p 
E-II 
!  ✗ 
Vps20p 
E-III 
!  ✗ 
Vps32p 
E-III 
!  ✗ 
Vps2p 
E-III 
✗ ✗ 
Vps4p ✗ ✗ 
Table 3.6: A summary of physical interactions between the ESCRT proteins and 
Plo1p and Clp1p. 
The table summarises protein interactions inferred from yeast two-hybrid analysis 
between the ESCRT proteins and Plo1p and Clp1p. 
To summarise all the yeast two-hybrid data, Plo1p was shown to interact with 
Sst4p (ESCRT-0), Vps28p (ESCRT-I), Vps25p (ESCRT-II), Vps20p (ESCRT-III), and 
Vps32p (ESCRT-III), and Clp1p was shown to interact with Vps28p (ESCRT-I). 
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3.3 Concluding remarks 
3.3.1 Principal findings 
In this chapter, it has been shown that ESCRT genes are required for cell 
separation in fission yeast, implying that the ESCRT machinery has a role in this 
process (Figure 3.1).  
Double mutants of ESCRT chromosomal deletions and mutants of plo1 or clp1 
revealed defective growth rates, indicating that the plo1+ and clp1+ genes 
interact with ESCRT genes (Table 3.2).  
Furthermore, plo1 and clp1 mutants were shown to affect vacuolar sorting in 
fission yeast (Figure 3.5). Analysis of the double mutants with ESCRT deletions 
demonstrated phenotypes similar to one or other of the parents, which 
facilitated characterisation of these genetic interactions (Table 3.3). 
Finally, the Plo1p and Clp1p proteins were shown to physically interact with 
several proteins of the ESCRT machinery (Table 3.6). 
3.3.2 Summary 
These results combined suggest that ESCRT proteins along with Plo1p and Clp1p 
regulate cytokinesis and septation in fission yeast. The next chapter of this 
thesis will explore whether similar findings can be observed in human cells. 
102 
 
Chapter 4 Plk1 kinase and CDC14A phosphatase 
interact with ESCRT proteins in humans 
4.1 Introduction 
4.1.1 Fission yeast shares a high degree of conservation with 
higher eukaryotes 
Data presented in Chapter 3 show that Plo1p and Clp1p genetically and 
physically interact with members of the ESCRT machinery in fission yeast. As a 
model organism, fission yeast has allowed the discovery of a large number of 
genetic and protein interactions, facilitating comprehension of numerous 
biological processes. Furthermore, fission yeast and human cells share a high 
degree of similarity, particularly in the events of cell division (Pollard & Wu 
2010). Therefore, it was hypothesised that the interactions observed in yeast 
and presented in Chapter 3 may be conserved in humans. This two-step 
approach was employed as yeast allowed the rapid screening of many potential 
interactions, which then informed which interactions to study in humans, where 
such analyses are more time-consuming and expensive.  
4.1.2 Aims and key findings 
In this study, interactions between human Plk1 (Plo1p) and CDC14A (Clp1p) with 
ESCRT proteins were investigated. Immunoprecipitation and co-
immunoprecipitation methods were employed, whereby a purification of one 
protein from human cell lysate was undertaken using a selective antibody. This 
immunoprecipitate was then screened for the presence of co-purifying 
interacting partners using specific antibodies.  
Initially, interactions between Plk1 and ESCRT proteins were screened in HeLa 
cervical cancer cells that endogenously expressed proteins at wild-type levels. 
Interactions were not detected, so cell lysates containing over-expressed ESCRT 
proteins were then analysed. As HeLa cells exhibited low transfection efficiency, 
ESCRT proteins were instead over-expressed in human embryonic kidney 
(HEK293) cells. Once a set of conditions in HEK293 cells was determined that 
allowed observation of interactions, the same conditions were replicated in 
HeLa cells.  
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In a different set of experiments, a functional assay was performed to determine 
if Plk1 kinase inhibition resulted in an ESCRT protein phospho-mobility shift.  
Finally, using immunoprecipitation and co-immunoprecipitation methods, 
interactions between CDC14A and ESCRT proteins were detected in over-
expressing HEK293 cells.  
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4.2 Results 
4.2.1 Investigating interactions between Plk1 and ESCRT proteins 
in HeLa cells  
4.2.1.1 Interactions between Plk1 and FOXM1 were detected in metaphase-
arrested cells 
Plk1 was immunoprecipitated from HeLa cell lysates. HeLa cells were grown to 
approximately 90% confluency and harvested (Materials and Methods 2.3.5.3). 
Following quantification of lysate protein content (Materials and Methods 2.3.6), 
1 mg of lysate was incubated with 13 µg anti-Plk1 antibody, or 50 ng IgG from 
rabbit serum as a control for random protein binding to antibody. To control for 
false positive cross-reactions with detection antibodies, anti-Plk1 antibody was 
also incubated in lysis buffer. Following incubation with Protein A sepharose 
beads to capture the antibodies, the samples were centrifuged briefly to collect 
the bead-antibody-protein complexes, and the supernatants containing unbound 
proteins were retained. The beads were extensively washed and then heated in 
the presence of Laemmli sample buffer to dissociate immunoprecipitated 
proteins from the bead-antibody complexes. The mixtures were centrifuged, and 
the supernatant, containing immunoprecipitated Plk1 protein, was retained 
(Materials and Methods 2.3.7.1). The samples were then subjected to SDS-PAGE 
(Materials and Methods 2.3.8) and immunoblotting (Materials and Methods 
2.3.9) to detect the immunoprecipitation of Plk1 and co-immunoprecipitation of 
binding partners of Plk1. 
Initially, Plk1 was immunoprecipitated from an asynchronous population of 
untreated HeLa cells. Plk1 was successfully immunoprecipitated, but FOXM1, 
which has been shown to bind Plk1 using this method (Fu et al. 2008), was not 
detected (Figure 4.1). 
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Figure 4.1: FOXM1 did not co-immunoprecipitate with Plk1 from asynchronous 
HeLa cell lysates. 
Plk1 was immunoprecipitated from HeLa cell lysate. Either anti-Plk1 antibody (Plk1 in 
figure) or random rabbit IgG (IgG in figure) was added to cell lysate, and as a further 
control, anti-Plk1 antibody was added to lysis buffer in the absence of cell lysate. The 
lysate following incubation with Protein A sepharose beads was retained (supernatant 
in figure: 20 µg was loaded). Complexes were dissociated from beads (IP: one quarter 
was loaded). Input refers to the cell lysate that was interrogated: 20 µg was loaded. 
*IgG heavy chain. Various exposures are shown of immunoblots derived from a single 
SDS gel. Experiments were repeated with qualitatively similar results and data from a 
typical experiment are shown. Molecular weight standards and antibodies used for 
immunoblotting are indicated. 
Immunoblotting with anti-Plk1 antibody revealed that Plk1 was 
immunoprecipitated (Figure 4.1, bottom panel, right), but that FOXM1 was not 
co-immunoprecipitated (Figure 4.1, top panel, right). The detection of Plk1 in 
the supernatant (Figure 4.1, bottom panel, left) indicates the incomplete 
immunoprecipitation of Plk1 from the input lysate. Immunoprecipitated Plk1 
appears to run more slowly most likely due to uneven SDS-PAGE, as indicated by 
the uneven distribution of IgG heavy chain. 
In each immunoprecipitation, 1 mg of protein from cell lysate was used. 
However, the Plk1 abundance within lysates was not known. Furthermore, Plk1 
has roles predominantly in late stages of the cell cycle, during M-phase and 
cytokinesis, when potential interactions with ESCRT proteins might occur (Lénárt 
et al. 2007). Therefore, HeLa cells were synchronised to metaphase and 
telophase to enrich for Plk1 and associated proteins. Published 
immunoprecipitation of Plk1 and co-immunoprecipitation of FOXM1 has shown a 
greater abundance of both proteins, and of co-immunoprecipitations, in mitotic 
cell lysates (Fu et al. 2008). 
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HeLa cells were arrested in metaphase using thymidine and nocodazole 
(Materials and Methods 2.3.5.1) and interrogated with anti-Plk1 antibody, as 
described. Using this method, Plk1 was immunoprecipitated from both 
metaphase- and telophase-arrested cells; FOXM1 was co-immunoprecipitated 
from metaphase-arrested cells, but none of the assayed ESCRT proteins were 
detected (Figure 4.2).  
 
 
A 
B 
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Figure 4.2: FOXM1 co-immunoprecipitated with Plk1 from metaphase-arrested 
cell lysates. 
HeLa cells were arrested in metaphase and telophase by thymidine-nocodozole block. 
(A) Equal amounts of lysates (20 µg) were immunoblotted with anti-Cyclin B1 antibody 
to confirm synchronisation. Non-specific reactive proteins (** in figure) were used as a 
loading control. Plk1 was immunoprecipitated from (B and C) metaphase- or 
telophase-arrested HeLa cell lysates. Either anti-Plk1 antibody (Plk1 in figure) or 
random rabbit IgG (IgG in figure) were added to cell lysate, and as a further control, 
anti-Plk1 antibody was added to lysis buffer in the absence of cell lysate. The lysate 
following incubation with Protein A sepharose beads was retained (supernatant in 
figure: 20 µg was loaded). Complexes were dissociated from beads (IP: one quarter 
was loaded). Input refers to the cell lysate that was interrogated: 20 µg was loaded. 
*IgG heavy chain. FOXM1 co-immunoprecipitation is highlighted in a box. Membranes 
were cut to immunoblot using different antibodies then brought back together for ECL 
developing. Experiments were repeated with qualitatively similar results and data from 
a typical experiment are shown. Molecular weight standards and antibodies used for 
immunoblotting are indicated.  
Immunoblotting arrested lysates for Cyclin B1 detection confirmed that cells had 
arrested in metaphase and telophase (Figure 4.2A), as Cyclin B1 protein levels 
are downregulated during telophase (Clute & Pines 1999).  
Plk1 was immunoprecipitated from HeLa cells arrested in metaphase and 
telophase. Immunoblotting for FOXM1 detected multiple reactive proteins in 
input lysates and supernatants. One of these FOXM1 proteins was present in the 
immunoprecipitation of Plk1, indicating that FOXM1 co-immunoprecipitated with 
Plk1 from metaphase-arrested cells (Figure 4.2B). Multiple reactive proteins on 
immunoblotting anti-FOXM1 antibody and co-immunoprecipitation of a single 
protein are consistent with that which has been published (Fu et al. 2008). 
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ESCRT proteins TSG101 (fission yeast Sst6p, ESCRT-I) (Figure 4.2B), CHMP6 
(Vps20p, ESCRT-III) and VPS28 (Vps28p, ESCRT-I) (Figure 4.2C), did not appear to 
co-immunoprecipitate with Plk1 from either metaphase- or telophase-arrested 
cell lysates. However, these observations did not preclude the possibility of 
detecting an interaction by immunoprecipitating ESCRT proteins and searching 
for co-immunoprecipitated Plk1. 
4.2.1.2 Immunoprecipitation of VPS28 did not yield detection of Plk1 
To assay if interactions could be detected when immunoprecipitation was 
performed in reverse, FOXM1 and ESCRT proteins were immunoprecipitated and 
then screened to search for co-immunoprecipitated Plk1. Asynchronous and 
metaphase- and telophase-arrested HeLa cell lysates were all interrogated with 
antibodies for FOXM1, CHMP6, TSG101 and VPS28 (Materials and Methods 
2.3.7.2). Of these, VPS28 was successfully immunoprecipitated (Figure 4.3). 
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Figure 4.3: Plk1 did not co-immunoprecipitate with VPS28 from asynchronous 
or arrested HeLa cell lysates. 
VPS28 was immunoprecipitated from (A) asynchronous HeLa cell lysates, or (B) 
metaphase-arrested or (C) telophase-arrested lysates from HeLa cells following a 
thymidine-nocodazole block. Either anti-VPS28 antibody (VPS28 in figure) or random 
rabbit IgG (IgG in figure) was added to cell lysate and, as a further control, anti-VPS28 
antibody was added to lysis buffer in the absence of cell lysate. The lysate following 
incubation with Protein G sepharose beads was retained (supernatant in figure: 20 µg 
was loaded). Complexes were dissociated from beads (IP: one quarter was loaded). 
Input refers to the cell lysate that was interrogated: 20 µg was loaded, although no 
lysate remained for immunoblotting in (A). *IgG heavy chain. Various exposures are 
shown of immunoblots derived from a single SDS gel. Immunoblot splices used to 
rearrange lanes are from a single exposure. Experiments were repeated with 
qualitatively similar results and data from a typical experiment are shown. Molecular 
weight standards and antibodies used for immunoblotting are indicated. 
VPS28 was immunoprecipitated from asynchronous HeLa cell lysates (Figure 
4.3A) and from metaphase- and telophase-arrested HeLa cell lysates (Figures 
C 
B 
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4.3B and C). Plk1 did not co-immunoprecipitate with VPS28 in any of the assayed 
conditions. 
However, endogenous Plk1 has been shown to co-immunoprecipitate over-
expressed FOXM1 from HEK293 cells (Fu et al. 2008), so the investigation was 
directed towards over-expressed cell lysates.  
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4.2.2 Investigating interactions between Plk1 and over-expressed 
ESCRT proteins in HEK293 cells 
The initial investigation in human cells was restricted to asynchronous HeLa 
cells. When a known binding partner, FOXM1 (Fu et al. 2008), was not detected 
on immunoprecipitation of Plk1, interactions were then sought in HeLa cell 
lysates from cells arrested in metaphase and telophase. However, although Plk1 
interaction was confirmed with FOXM1 in metaphase-arrested cell lysates, ESCRT 
interactions remained undetected. Therefore, HeLa cells were transfected with 
plasmids to over-express individual ESCRT proteins to potentially increase the 
chance of detecting interactions. However, on assaying transfection efficiency, 
HeLa cells were found not to transfect effectively: routinely, less than 5% of 
cells expressed the transfected protein. Therefore, human embryonic kidney 
(HEK293) cells were instead employed (Fu et al. 2008), as they accepted DNA 
and over-expressed proteins more efficiently than HeLa cells: expression was 
routinely observed in 20-30% of HEK293 cells. 
4.2.2.1 Plk1 interacts with CHMP6 (fission yeast Vps20p, ESCRT-III) 
HEK293 cells were grown to a confluency of 90% in antibiotic-free medium. Fresh 
medium was supplemented with purified CHMP6-GFP DNA (Materials and 
Methods 2.3.2) in complex with transfection reagent, Lipofectamine 2000 
(Materials and Methods 2.3.3). The medium was replaced the following day and 
cell lysates were prepared on the third day (Materials and Methods 2.3.5.3). 
Following quantification of lysate protein content (Materials and Methods 2.3.6), 
1 mg of lysate was interrogated – first with anti-Plk1 antibody, followed by 
Protein A sepharose beads – or with beads in the absence of anti-Plk1 antibody. 
By this method, Plk1 was immunoprecipitated from HEK293 cell lysates (Figure 
4.4A) and CHMP6-GFP was co-immunoprecipitated with Plk1 (Figure 4.4B). In 
addition, to demonstrate that anti-Plk1 antibody did not non-specifically bind to 
GFP, Plk1 was immunoprecipitated from HEK293 lysates over-expressing either 
CHMP6-GFP or FIP3-GFP (Figure 4.4C).   
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Figure 4.4: Over-expressed CHMP6 co-immunoprecipitates with Plk1 from 
HEK293 cell lysates. 
(A) HEK293 cell lysates were prepared and interrogated with anti-Plk1 antibody; a 
beads-only control was included (10 µg input and one-eighth IP were loaded). (B) 
HEK293 cells were transfected with DNA for CHMP6-GFP. Lysates were prepared 
and Plk1 was immunoprecipitated. A beads-only control was included (10 µg input and 
one-eighth IP were loaded). (C) HEK293 cells were transfected with DNA for either 
CHMP6-GFP or FIP3-GFP (5 µg input and one-fifteenth IP was loaded). 
Immunoprecipitated complexes were dissociated from beads. Input refers to the cell 
lysate that was interrogated. *IgG heavy chain. Various exposures are shown of 
immunoblots derived from a single SDS gel. Immunoblot splices used to rearrange 
lanes are from a single exposure. Experiments were repeated with qualitatively similar 
results and data from a typical experiment are shown. Molecular weight standards and 
antibodies used for immunoblotting are indicated. 
Plk1 was successfully immunoprecipitated from HEK293 cell lysates (Figure 
4.4A), although immunoblotting of Plk1 was not robust, presumably because 
levels of Plk1 in HEK293 cells are low (our unpublished observations). CHMP6 was 
revealed to co-immunoprecipitate with Plk1 (Figure 4.4B). In the beads-only 
control, little or no CHMP6-GFP was co-immunoprecipitated. Furthermore, FIP3-
GFP was not detected on immunoprecipitation of Plk1, indicating that the co-
immunoprecipitation of CHMP6-GFP was not due to an interaction between GFP 
and anti-Plk1 antibody (Figure 4.4C). However, CHMP6-GFP co-
immunoprecipitation with Plk1 would be more robustly demonstrated by 
A B 
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immunoprecipitating, in parallel, Plk1 from lysates over-expressing GFP and 
CHMP6-GFP, respectively. 
4.2.2.2 Plk1 interacts with CHMP6 (Vps20p, ESCRT-III), CHMP4B (Vps32p, 
ESCRT-III), CHMP3 (Vps24p, ESCRT-III) and CHMP2A (Vps2p, ESCRT-
III) 
Following the observation that CHMP6-GFP was co-immunoprecipitated with 
Plk1, further ESCRT proteins were investigated. Purified DNA for CHMP6-GFP, 
CHMP4B-YFP, CHMP3-myc and CHMP2A-GFP were individually transfected into 
HEK293 cells, and lysates were prepared (Section 4.2.2.1). One mg of each cell 
lysate was then interrogated with anti-Plk1 antibody or Protein A sepharose 
beads alone. Interestingly, immunoblot analysis of lysates and subsequent 
immunoprecipitated products revealed that the ESCRT proteins co-
immunoprecipitated with Plk1 (Figure 4.5). 
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Figure 4.5: Over-expressed CHMP6, CHMP4B, CHMP3 and CHMP2A co-
immunoprecipitate with Plk1 from HEK293 cell lysates. 
HEK293 cells were transfected with DNA for CHMP6-GFP, CHMP4B-YFP, CHMP3-
myc, CHMP2A-GFP, or with Lipofectamine 2000 in the absence of transforming DNA. 
Lysates were prepared and anti-Plk1 antibody (Plk1 in figure) was added to each cell 
lysate. Complexes were dissociated from beads (IP: one-fifteenth was loaded). Input 
refers to the cell lysate that was interrogated: 5 µg was loaded. Various exposures are 
shown of immunoblots derived from a single SDS gel. Immunoblot splices used to 
rearrange lanes are from a single exposure. *IgG heavy chain. Experiments were 
repeated with qualitatively similar results and data from a typical experiment are 
shown. Molecular weight standards and antibodies used for immunoblotting are 
indicated. 
Immunoprecipitation of Plk1 from HEK293 cell lysates over-expressing individual 
ESCRT proteins revealed interactions between Plk1 and CHMP6, CHMP4B, CHMP3 
and CHMP2A. CHMP6-GFP, CHMP4B-YFP and CHMP2A-GFP were all detected in 
lysates on immunoblotting with anti-GFP antibody and CHMP3-myc was detected 
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in lysate on immunoblotting with anti-myc antibody. Immunoblotting non-
transfected cell lysate revealed the presence of non-specific reactive proteins, 
including the 50 kDa heavy chain of anti-Plk1 IgG, and facilitated identification 
of all four ESCRT proteins as co-immunoprecipitated species. 
However, Plk1 immunoblotting was irregular, as in Figure 4.5, Plk1 is only clearly 
detected in three of five immunoprecipitations. There was, therefore, a 
question over whether ESCRT proteins were actually co-immunoprecipitated by 
interactions with Plk1. To this end, an experiment was designed to reduce Plk1 
levels in cell lysates and thereby assay the impact upon ESCRT co-
immunoprecipitation. 
4.2.2.3 Sequential immunoprecipitation of Plk1 depletes the co-
immunoprecipitation of CHMP6, CHMP4B, CHMP3 and CHMP2A 
Another immunoprecipitation method was employed to demonstrate that the co-
immunoprecipitated ESCRT proteins were detected as a result of specific 
interactions between Plk1 and the ESCRT proteins. HEK293 cell lysates over-
expressing individual ESCRT proteins were repeatedly interrogated with anti-Plk1 
antibody. Following the addition of anti-Plk1 antibody and incubation with 
Protein A sepharose beads, lysates were centrifuged and the supernatants 
removed. Proteins were then purified from the beads by heating in Laemmli 
sample buffer. However, the supernatants, which represented unbound proteins 
in lysate, were interrogated a second time with anti-Plk1 antibody. The 
immunoprecipitation process was performed, sequentially, three times. 
Immunoblotting each sequential lysate of repeatedly interrogated supernatants 
and immunoprecipitated products revealed depleted ESCRT co-
immunoprecipitation, despite almost no reduction in lysates (Figure 4.6). 
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Figure 4.6: Sequential immunoprecipitation of Plk1 depletes detection of over-
expressed ESCRT proteins from anti-Plk1 immunoprecipitations. 
(A) Plk1 was depleted from HEK293 cell lysates by sequential interrogation using anti-
Plk1 antibody. HEK293 cells were transfected with DNA for (B) CHMP6-GFP, (C) 
CHMP4B-YFP, (D) CHMP3-myc, (E) CHMP2A-GFP, or with Lipofectamine 2000 in 
the absence of transforming DNA. Lysates were prepared and anti-Plk1 antibody (Plk1 
in figure) was added to each cell lysate. The lysate following incubation with Protein A 
sepharose beads was retained (supernatant in figure: 5 µg was loaded). Anti-Plk1 
antibody was re-introduced into the supernatant (S1). Centrifugation following 
incubation with Protein A sepharose beads resulted in supernatant 2. This was 
interrogated a third time, resulting in supernatant 3. The third supernatant (S3) 
resulting from anti-Plk1 interrogation of CHMP2A-transfected supernatant 2 was 
mistakenly discarded. For (B) CHMP6, (C) CHMP4B and (D) CHMP3, a Protein A 
sepharose beads-only immunoprecipitation was performed on supernatant 3, resulting 
in S4. Non-transfected lysates were also interrogated with anti-Plk1 antibody. 
Complexes were dissociated from beads (IP: one-fifteenth was loaded). Input refers to 
the cell lysate that was interrogated: 5 µg was loaded. Various exposures are shown 
of immunoblots derived from a single SDS gel. Immunoblot splices used to rearrange 
lanes are from a single exposure. *IgG heavy chain. Molecular weight standards and 
antibodies used for immunoblotting are indicated. 
Sequential immunoprecipitation using anti-Plk1 antibody depleted Plk1 levels in 
HEK293 cell lysates (Figure 4.6A). Sequential immunoprecipitation of Plk1 
depleted the detection of co-immunoprecipitated ESCRT proteins CHMP6 (Figure 
4.6B), CHMP4B (Figure 4.6C), CHMP3 (Figure 4.6D) and CHMP2A (Figure 4.6E). 
However, ESCRT proteins were still detected in the final supernatant following 
the third anti-Plk1 immunoprecipitation at qualitatively comparable levels to the 
first supernatant; this final supernatant represents lysate containing unbound 
proteins. 
E 
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The subsequent beads-only immunoprecipitation of the third supernatant 
resulted in negligible co-immunoprecipitation of CHMP6 (Figure 4.6B), CHMP4B 
(Figure 4.6C) and CHMP3 (Figure 4.6D), particularly when compared to the 
protein levels detected in the final supernatant, S4. 
Depleted Plk1 levels within cell lysates resulted in depleted ESCRT co-
immunoprecipitation. These data indicate that ESCRT proteins are detected in 
anti-Plk1 immunoprecipitations due to specific interactions with Plk1. It is also 
possible that ESCRT proteins are being co-immunoprecipitated due to 
interactions with an unknown factor binding to either Plk1 or anti-Plk1 antibody; 
therefore, ESCRT proteins are no longer co-immunoprecipitated on depletion of 
either Plk1 or the unknown protein. 
4.2.2.4 Plk1-ESCRT interactions remained after increasing the detergent in 
assay conditions 
Experiments presented in Sections 4.2.2.2 and 4.2.2.3 demonstrate that all of 
the ESCRT proteins assayed co-immunoprecipitated with Plk1, at least when 
over-expressed. As the ESCRT proteins are members of a complex (Teis et al. 
2009), it is possible that they were co-immunoprecipitating with each other. To 
overcome this, an experiment was designed in which ESCRT dissociation was 
attempted using detergent. It was hypothesised that this might allow the co-
immunoprecipitation of only certain ESCRT proteins with Plk1, and not others, 
thus establishing the specific binding partners of Plk1 among the ESCRT proteins. 
Purified DNA for CHMP6-GFP, CHMP4B-YFP, CHMP3-myc and CHMP2A-GFP were 
individually transfected into HEK293 cells and lysates were prepared (Section 
4.2.2.1). However, in order to disrupt potential interactions between the ESCRT 
proteins, the Triton X-100 detergent concentration of the lysis buffer was 
increased tenfold. One mg of each cell lysate was then interrogated with anti-
Plk1 antibody or Protein A sepharose beads alone. Immunoblot analysis of the 
lysates and subsequent immunoprecipitated products revealed no change in the 
interactions previously observed (Figure 4.7). 
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Figure 4.7: CHMP6, CHMP4B, CHMP3 and CHMP2A co-immunoprecipitate with 
Plk1 in the presence of increased detergent conditions. 
HEK293 cells were transfected with DNA for (A) CHMP6-GFP, CHMP4B-YFP, 
CHMP2A-GFP or (B) CHMP3-myc, or with Lipofectamine 2000 in the absence of 
transforming DNA. Lysates were prepared in buffer with a tenfold higher detergent 
content. Anti-Plk1 antibody (Plk1 in figure) was added to each cell lysate. Complexes 
were dissociated from beads (IP: one-fifteenth was loaded). Input refers to the cell 
lysate that was interrogated: 5 µg was loaded. Various exposures are shown of 
immunoblots derived from a single SDS gel. Immunoblot splices used to rearrange 
lanes are from a single exposure. *IgG heavy chain. Experiments were repeated with 
qualitatively similar results and data from a typical experiment are shown. Molecular 
weight standards and antibodies used for immunoblotting are indicated.  
B 
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CHMP6, CHMP4B, CHMP2A (Figure 4.7A) and CHMP3 (Figure 4.7B) were all 
detected on over-expression in HEK293 cells and immunoprecipitation of Plk1. 
Thus, immunoprecipitation of Plk1 from HEK293 lysates prepared with a higher 
concentration of detergent Triton X-100 did not affect the interactions observed 
between Plk1 and ESCRT proteins. This suggests that all of the assayed ESCRT 
proteins interact directly with Plk1. However, this assumes that increasing the 
Triton X-100 concentration dissociated the ESCRT complex, which was not 
otherwise assayed. 
4.2.2.5 Immunoprecipitation of ESCRT proteins did not result in the co-
immunoprecipitation of endogenous or over-expressed Plk1 
Several ESCRT proteins were shown to co-immunoprecipitate with Plk1 (Figure 
4.5). To assay whether the observed interactions could be detected when the 
immunoprecipitation was performed in reverse, ESCRT proteins were 
immunoprecipitated and screened to detect co-immunoprecipitated Plk1. 
However, due to the difficulty of detecting Plk1, HEK293 cells were co-
transfected with purified DNA for Plk1-YFP and CHMP6-HA, CHMP4B-myc or 
CHMP3-myc. Cells were also transfected with purified DNA for the individual 
ESCRT proteins. Lysates were prepared (Section 4.2.2.1) and 1 mg of each cell 
lysate was interrogated with either anti-HA or anti-myc antibody. Immunoblot 
analysis of lysates and subsequent immunoprecipitated products did not reveal 
interactions between ESCRT proteins and Plk1-YFP (Figure 4.8). 
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Figure 4.8: Plk1 was not detected on immunoprecipitation of ESCRT proteins. 
HEK293 cells were transfected with DNA for  (A) CHMP4B-myc, CHMP3-myc or (B) 
CHMP6-HA. Cells were also co-transfected with Plk1-YFP. Lysates were prepared 
and interrogated with either (A) anti-myc antibody and Protein A sepharose beads, or 
(B) anti-HA antibody and Protein G sepharose beads. Complexes were dissociated 
from beads (IP: one-fifteenth was loaded). Input refers to the cell lysate that was 
interrogated: 5 µg was loaded. Various exposures are shown of immunoblots derived 
from a single SDS gel. Immunoblot splices used to rearrange lanes are from a single 
exposure. *IgG heavy chain. Experiments were repeated with qualitatively similar 
results and data from a typical experiment are shown. Molecular weight standards and 
antibodies used for immunoblotting are indicated. 
B 
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Immunoprecipitation using anti-myc antibody produced purified CHMP3 and 
CHMP4B from over-expressing HEK293 cell lysates (Figure 4.8A). Several non-
specific reactive proteins were detected, and the myc-tagged ESCRT proteins 
are indicated. However, although endogenous Plk1 and over-expressed Plk1-YFP 
were detected in lysates, neither was detected on immunoprecipitation of 
CHMP3 or CHMP4B.  
In addition, immunoprecipitation using anti-HA antibody produced purified 
CHMP6 from over-expressing HEK293 cell lysates (Figure 4.8B). Endogenous Plk1 
and Plk1-YFP were detected in lysates, but, again, neither was detected on 
immunoprecipitation of the ESCRT proteins. 
4.2.2.6 Immunoprecipitation of Plk1-YFP did not result in co-
immunoprecipitation of ESCRT proteins 
The effect of Plk1.K82R, a kinase-dead form of Plk1 (Golsteyn et al. 1995), upon 
interactions with ESCRT proteins was investigated. Purified DNA for Plk1-YFP or 
Plk1.K82R-YFP was co-transfected into HEK293 cells with purified DNA for 
CHMP6-HA, CHMP4B-myc or CHMP3-myc. Lysates were prepared and 
immunoprecipitated using anti-GFP antibody (Figure 4.9). 
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Figure 4.9: Anti-GFP immunoprecipitation of Plk1-YFP did not result in co-
immunoprecipitation of ESCRT proteins. 
HEK293 cells were co-transfected with Plk1-YFP or Plk1.K82R-YFP and (A) CHMP3-
myc, CHMP4B-myc or (B) CHMP6-HA. Lysates were prepared and anti-GFP antibody 
was added to each cell lysate. Complexes were dissociated from Protein A sepharose 
beads (IP: one-fifteenth was loaded). Input refers to the cell lysate that was 
interrogated: 5 µg was loaded. No CHMP6+Plk1 lysate remained after 
immunoprecipitation to analyse via SDS-PAGE. Various exposures are shown of 
immunoblots derived from a single SDS gel. Immunoblot splices used to rearrange 
lanes are from a single exposure. *IgG heavy chain. Experiments were repeated with 
qualitatively similar results and data from a typical experiment are shown. Molecular 
weight standards and antibodies used for immunoblotting are indicated. 
B 
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CHMP3-myc, CHMP4B-myc and CHMP6-HA were over-expressed with Plk1-YFP and 
Plk1.K82R-YFP in HEK293 cells. Plk1-YFP and Plk1.K82R-YFP were 
immunoprecipitated using anti-GFP antibody. CHMP3, CHMP4B (Figure 4.9A) and 
CHMP6 (Figure 4.9B) were detected in lysates, but not in the 
immunoprecipitation of Plk1-YFP or Plk1.K82R-YFP. 
These results suggest that Plk1-YFP did not interact with ESCRT proteins, 
possibly because Plk1-YFP and ESCRT proteins were expressed in different cells.  
4.2.2.7 Immunoprecipitation of ESCRT proteins did not result in detection of 
Plk1.K82R-YFP 
Plk1-YFP did not co-immunoprecipitate with ESCRT proteins (Figure 4.8). To 
investigate if Plk1.K82R-YFP could be detected on immunoprecipitation of ESCRT 
proteins, co-transfected lysates from Section 4.2.2.6 were interrogated with 
anti-HA or anti-myc antibody to immunoprecipitate ESCRT proteins. CHMP6-HA, 
CHMP4B-myc and CHMP3-myc were immunoprecipitated from HEK293 cells co-
expressing Plk1-YFP or kinase-dead Plk1.K82R-YFP. Both over-expressed Plk1 
species were detected in lysates but neither was co-immunoprecipitated with 
ESCRT proteins (data not shown).  
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4.2.3 Investigating interactions between Plk1 and over-expressed 
ESCRT proteins in HeLa cells 
Following observation of interactions between Plk1 and ESCRT proteins in 
HEK293 cells, HeLa cells were revisited to transfect with purified DNA for ESCRT 
protein over-expression. Although Plk1-ESCRT interactions were observed in 
HEK293 cells by immunoprecipitating Plk1, immunoprecipitating ESCRT proteins 
did not reveal interactions. However, Plk1 had been more readily detected on 
immunoblotting HeLa cell lysates than HEK293 cell lysates (Section 4.2.1), 
therefore, it was hypothesised that immunoprecipitation of ESCRT proteins could 
reveal interactions with co-immunoprecipitated Plk1 in HeLa cells. 
4.2.3.1 Over-expression of ESCRT proteins in HeLa cells was not robust and 
did not yield observable interactions 
Purified DNA for CHMP6-GFP was transfected into HeLa cells and lysates were 
prepared (Section 4.2.2.1). One mg of cell lysate was interrogated with anti-Plk1 
antibody, or Protein A sepharose beads alone. However, immunoblot analysis of 
lysates revealed poor expression of CHMP6-GFP, and co-immunoprecipitation 
was not detected (data not shown). 
Transfection method, purified DNA, lysate preparation, immunoprecipitation, 
SDS-PAGE and immunoblotting were all performed identically for HEK293 and 
HeLa cells. However, ESCRT proteins were not detected in high abundance in 
HeLa cell lysates. Fresh HeLa cell stocks were used, but over-expression was 
never as effective as in HEK293 cells (Section 4.2.2). 
4.2.3.2 Immunoprecipitation of over-expressed ESCRT proteins did not yield 
detection of Plk1 
To assay if interactions could be detected when the immunoprecipitation was 
performed in reverse, ESCRT proteins were immunoprecipitated and screened to 
detect Plk1. Purified DNA for CHMP6-GFP and CHMP2A-GFP was individually 
transfected into HeLa cells and lysates were prepared (Section 4.2.2.1). One mg 
of each cell lysate was interrogated with anti-GFP antibody. Immunoblot analysis 
of lysates and subsequent immunoprecipitated products revealed 
immunoprecipitation of CHMP6 and CHMP2A, but not co-immunoprecipitation of 
Plk1 (data not shown).  
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4.2.4 Investigating an ESCRT protein phospho-mobility shift in 
the presence of Plk1 kinase inhibition 
Following the observations of interactions between Plk1 and ESCRT proteins, the 
potential functional consequence of these interactions was examined. As Plk1 is 
a protein kinase, it controls interacting proteins through phosphorylation. 
Changes in phosphorylation status of proteins can be detected by SDS-PAGE, as 
this sometimes results in changes in protein mobility under these conditions, 
likely due to changes in protein conformation (Wegener & Jones 1984). 
Introducing a Plk1 kinase inhibitor to HeLa cells allowed the putative control of 
Plk1 over the phosphorylation status of ESCRT proteins to be tested. ESCRT 
protein mobility was then examined by SDS-PAGE before and after treatment to 
search for changes. 
HeLa cells were arrested in metaphase and telophase by thymidine-nocodazole 
block. Plk1 inhibitor BI 2536 was added to cells (Lénárt et al. 2007). Lysates 
were prepared and subjected to SDS-PAGE, and the position of CHMP6 (ESCRT-III) 
was assayed by immunoblotting (Figure 4.10). 
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Figure 4.10: A phospho-mobility shift in the position of CHMP6 was not detected 
on inhibition of Plk1. 
HeLa cells were arrested in metaphase and telophase by thymidine-nocodazole block. 
BI 2536 was introduced to inhibit Plk1 kinase. Lysates were prepared and 25 µg of 
each cell lysate was subjected to SDS-PAGE. Experiments were repeated with 
qualitatively similar results and data from a typical experiment are shown. Molecular 
weight standards and antibodies used for immunoblotting are indicated. 
Immunoblotting Plk1 kinase-inhibited lysates did not reveal a shift in the position 
of CHMP6 relative to untreated lysates, suggesting that, under these conditions, 
Plk1 was not influencing the phosphorylation status of CHMP6. However, kinase 
inhibition was not confirmed in lysates treated with BI 2536. Furthermore, a 
loading control was not included: this would likely have identified the uneven 
detection of CHMP6 as an artefact of SDS-PAGE.  
A phospho-mobility shift was observed on immunoblotting CHMP3 from Plk1 
kinase-inhibited HeLa cell lysates (data not shown). Graduate student Craig 
Shepherd, whom I supervised, performed this assay; however, as this experiment 
needs to be repeated to reproduce this result, these data have not been 
presented.  
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4.2.5 Investigating interactions between CDC14A and ESCRT 
proteins on over-expressing both in HEK293 cells 
Following the detection of genetic and physical interactions between Plo1p and 
ESCRT proteins in fission yeast (Sections 3.2.3 and 3.2.5) interactions were 
observed between Plk1 and ESCRT proteins in human cells (Section 4.2.2). Since 
genetic and physical interactions were also detected between Clp1p (CDC14) and 
ESCRT proteins in fission yeast (Section 3.2.3 and 3.2.5), this prompted an 
investigation into interactions between CDC14 and ESCRT proteins in human 
cells. HEK293 cells were co-transfected with DNA for both, and assayed by 
immunoprecipitation and co-immunoprecipitation methods. 
4.2.5.1 CDC14A phosphatase interacts with CHMP4B (Vps32p, ESCRT-III) 
HEK293 cells were transfected with purified DNA for CHMP4B-YFP alone, and co-
transfected with DNA for CDC14A-myc. Lysates were prepared (Section 4.2.2.1) 
and 1 mg of each cell lysate was interrogated with anti-myc antibody. 
Immunoblot analysis of lysates and subsequent immunoprecipitated products 
revealed immunoprecipitation of CDC14A and co-immunoprecipitation of 
CHMP4B (Figure 4.11). 
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Figure 4.11: CHMP4B co-immunoprecipitates with CDC14A from HEK293 cell 
lysates. 
HEK293 cells were transfected with DNA for CHMP4B-YFP or co-transfected with 
CDC14A-myc. Lysates were also prepared with Lipofectamine 2000 in the absence of 
transforming DNA. Lysates were interrogated with anti-myc antibody. Complexes were 
dissociated from beads (IP: one-eighth was loaded). Input refers to the cell lysate that 
was interrogated: 10 µg was loaded. Various exposures are shown of immunoblots 
derived from a single SDS gel. Immunoblot splices used to rearrange lanes are from a 
single exposure. *IgG heavy chain. Molecular weight standards and antibodies used 
for immunoblotting are indicated. 
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CDC14A-myc was detected in lysate co-expressing CHMP4B and subsequent anti-
myc immunoprecipitation of this lysate by immunoblotting with anti-myc 
antibody (Figure 4.11, top panel). Multiple non-specific reactive proteins are 
detected in all lysates and immunoprecipitations on immunoblotting using anti-
myc antibody. 
Immunoprecipitation using anti-myc antibody from HEK293 cell lysate over-
expressing CHMP4B revealed the presence of CHMP4B in the absence of any myc-
tagged partner (Figure 4.11, bottom panel). However, over-expressing CDC14A-
myc with CHMP4B resulted in immunoprecipitation of CDC14A and the stronger 
detection of CHMP4B. This indicates that CHMP4B interacts with CDC14A in 
human cells. Further ESCRT proteins were then assayed for interactions with 
CDC14A. 
4.2.5.2 CDC14A interacts with CHMP4B (Vps32p, ESCRT-III) and CHMP2A 
(Vps2p, ESCRT-III) 
HEK293 cells were co-transfected with purified DNA for CDC14A-myc and VPS28-
V5, CHMP6-GFP, CHMP4B-YFP, or CHMP2A-GFP. Lysates were prepared (Section 
4.2.2.1) and 1 mg of each cell lysate was interrogated with anti-myc antibody or 
Protein A sepharose beads alone. Immunoblot analysis of lysates and subsequent 
immunoprecipitated products revealed immunoprecipitation of CDC14A and co-
immunoprecipitation of CHMP4B and CHMP2A (Figure 4.12). 
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Figure 4.12: CHMP4B and CHMP2A co-immunoprecipitate with CDC14A from 
HEK293 cell lysates. 
HEK293 cells were co-transfected with purified DNA for CDC14A-myc and (A) 
CHMP6-GFP, CHMP4B-YFP, CHMP2A-GFP or (B) VPS28-V5. Lysates were 
interrogated with anti-myc antibody or with Protein A sepharose beads alone. 
Complexes were dissociated from beads (IP: one-fifteenth was loaded). Input refers to 
the cell lysate that was interrogated: 5 µg was loaded. Various exposures are shown 
of immunoblots derived from a single SDS gel. *IgG heavy chain. Experiments were 
repeated with qualitatively similar results and data from a typical experiment are 
shown. Molecular weight standards and antibodies used for immunoblotting are 
indicated. 
CDC14A-myc was detected in co-expressing lysates and subsequent 
immunoprecipitations by immunoblotting with anti-myc antibody (Figure 4.12A 
and B, top panels). CDC14A-myc was not detected in lysate prepared in the 
absence of transfecting DNA, nor by immunoprecipitating from over-expressing 
lysates with Protein A sepharose in the absence of anti-myc antibody. CHMP6-
GFP, CHMP4B-YFP, CHMP2A-GFP (Figure 4.12A, bottom panel) and VPS28-V5 
(Figure 4.12B, bottom panel) were all detected in co-expressing lysates.  
A B 
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Immunoprecipitation of CDC14A resulted in the co-immunoprecipitation of 
CHMP4B and CHMP2A (Figure 4.12A, bottom panel). CHMP6 (Figure 4.12A, 
bottom panel) and VPS28 (Figure 4.12B, bottom panel) were not detected on 
immunoprecipitation of CDC14A. 
4.2.5.3 Phosphatase-dead CDC14A.C278S interacts with CHMP4B and 
CHMP2A 
To investigate whether a phosphatase-dead form of CDC14A affected its 
interactions with ESCRT proteins, HEK293 cells were co-transfected with purified 
DNA for CDC14A.C278S-myc (Lanzetti et al. 2007) and VPS28-V5, CHMP6-GFP, 
CHMP4B-YFP, or CHMP2A-GFP. Lysates were prepared (Section 4.2.2.1) and 1 mg 
of each cell lysate was interrogated with anti-myc antibody or Protein A 
sepharose beads alone. Immunoblot analysis of lysates and subsequent 
immunoprecipitated products revealed immunoprecipitation of CDC14A.C278S 
and co-immunoprecipitation of CHMP4B and CHMP2A (Figure 4.13).  
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Figure 4.13: CHMP4B and CHMP2A co-immunoprecipitate with phosphatase-
dead CDC14A.C278S from HEK293 cell lysates. 
HEK293 cells were co-transfected with purified DNA for CDC14A.C278S-myc and (A) 
CHMP6-GFP, CHMP4B-YFP, CHMP2A-GFP or (B) VPS28-V5. Lysates were 
interrogated with anti-myc antibody or with Protein A sepharose beads alone. 
Complexes were dissociated from beads (IP: one-fifteenth was loaded). Input refers to 
the cell lysate that was interrogated: 5 µg was loaded. Various exposures are shown 
of immunoblots derived from a single SDS gel. Immunoblot splices used to rearrange 
lanes are from a single exposure. *IgG heavy chain. Experiments were repeated with 
qualitatively similar results and data from a typical experiment are shown. Molecular 
weight standards and antibodies used for immunoblotting are indicated. 
CDC14A.C278S-myc was detected in co-expressing lysates and subsequent 
immunoprecipitations by immunoblotting with anti-myc antibody (Figure 4.13A 
and B, top panels). CDC14A.C278S-myc was not detected in lysate prepared in 
the absence of transfecting DNA, nor by immunoprecipitating from over-
expressing lysates with Protein A sepharose in the absence of anti-myc antibody. 
CHMP6-GFP, CHMP4B-YFP, CHMP2A-GFP (Figure 4.13A, bottom panel) and VPS28-
V5 (Figure 4.13B, bottom panel) were all detected in co-expressing lysates.  
A B 
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Immunoprecipitation of CDC14A.C278S resulted in the co-immunoprecipitation of 
CHMP4B and CHMP2A (Figure 4.13A, bottom panel). CHMP6 (Figure 4.13A, 
bottom panel) and VPS28 (Figure 4.13B, bottom panel) were not detected on 
immunoprecipitation of CDC14A.C278S. 
4.2.5.4 Immunoprecipitation of ESCRT proteins yields detection of CDC14A  
Immunoprecipitation of CDC14A resulted in co-immunoprecipitated ESCRT 
proteins (Figure 4.12). To investigate if CDC14A could be detected on 
immunoprecipitation of ESCRT proteins, HEK293 cell lysates from Section 4.2.5.2 
were interrogated with either anti-GFP or anti-VPS28 antibody. Immunoblot 
analysis of lysates and subsequent immunoprecipitated products revealed 
immunoprecipitation of ESCRT proteins and co-immunoprecipitation of CDC14A 
with CHMP4B and CHMP2A (Figure 4.14). 
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Figure 4.14: CDC14A co-immunoprecipitates with CHMP4B and CHMP2A. 
HEK293 cells were co-transfected with purified DNA for CDC14A-myc and (A) 
CHMP6-GFP, CHMP4B-YFP, CHMP2A-GFP or (B) VPS28-V5. Lysates were 
interrogated with either anti-GFP or anti-VPS28 antibody. Non-transfected HEK293 
cell lysates were also interrogated with anti-VPS28 antibody. Complexes were 
dissociated from beads (IP: one-fifteenth was loaded). Input refers to the cell lysate 
that was interrogated: 5 µg was loaded. Various exposures are shown of immunoblots 
derived from a single SDS gel. Immunoblot splices used to rearrange lanes are from a 
single exposure. *IgG heavy chain. Molecular weight standards and antibodies used 
for immunoblotting are indicated. 
CHMP6-GFP, CHMP4B-YFP, CHMP2A-GFP (Figure 4.14A, top panel) and VPS28-V5 
(Figure 4.14B, top panel) were all detected in co-expressing lysates with 
CDC14A-myc and subsequent immunoprecipitation with either anti-GFP or anti-
VPS28 antibody. CDC14A-myc was detected in co-expressing lysates with ESCRT 
proteins (Figure 4.14A and B, bottom panels). 
A B 
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Immunoprecipitation of CHMP4B and CHMP2A resulted in the detection of 
CDC14A, demonstrating that CDC14A co-immunoprecipitated with CHMP4B and 
CHMP2A (Figure 4.14A, bottom panel). However, this has not presented well 
here and should be repeated with larger amounts of material to enhance 
detection.  
CDC14A was not detected on immunoprecipitation of either CHMP6 (Figure 
4.14A, bottom panel) or VPS28 (Figure 4.14B, bottom panel). 
4.2.5.5 Immunoprecipitation of ESCRT proteins did not yield detection of 
phosphatase-dead CDC14A.C278S 
Immunoprecipitation of CDC14A.C278S resulted in co-immunoprecipitated ESCRT 
proteins (Figure 4.13). To investigate whether interactions could be detected in 
reverse, HEK293 cells from Section 4.2.5.3 were interrogated with either anti-
GFP or anti-VPS28 antibody. Immunoblot analysis of lysates and subsequent 
immunoprecipitated products did not reveal co-immunoprecipitation of 
CDC14A.C278S with the ESCRT proteins (Figure 4.15). 
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Figure 4.15: CDC14A.C278S was not detected on immunoprecipitation of VPS28, 
CHMP4B or CHMP2A. 
HEK293 cells were co-transfected with purified DNA for CDC14A.C278S-myc and (A) 
CHMP4B-YFP, CHMP2A-GFP or (B) VPS28-V5. Lysates were interrogated with either 
anti-GFP or anti-VPS28 antibody. Non-transfected HEK293 cell lysates were also 
interrogated with anti-VPS28 antibody. Complexes were dissociated from beads (IP: 
one-fifteenth was loaded). Input refers to the cell lysate that was interrogated: 5 µg 
was loaded. Various exposures are shown of immunoblots derived from a single SDS 
gel. Immunoblot splices used to rearrange lanes are from a single exposure. *IgG 
heavy chain. Molecular weight standards and antibodies used for immunoblotting are 
indicated. 
CHMP4B-YFP, CHMP2A-GFP (Figure 4.15A, top panel) and VPS28-V5 (Figure 
4.15B, top panel) were all detected in co-expressing lysates with CDC14A.C278S-
myc and subsequent immunoprecipitation with either anti-GFP or anti-VPS28 
A B 
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antibody. CDC14A.C278S-myc was detected in co-expressing lysates with ESCRT 
proteins (Figure 4.15A and B, bottom panels). Phosphatase-dead CDC14A.C278S 
was not detected on immunoprecipitation of CHMP4B, CHMP2A (Figure 4.15A, 
bottom panel) or VPS28 (Figure 4.15B, bottom panel). However, this assay would 
benefit from being repeated with larger amounts of material.  
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4.2.6 Concluding remarks 
4.2.6.1 Principal findings 
Due to genetic and physical interactions observed between fission yeast 
counterparts, interactions were investigated in human cells between ESCRT 
proteins and Plk1 and CDC14A. Immunoprecipitation methods were employed to 
purify proteins from human cell lysates and to allow detection of co-
immunoprecipitated interacting partners. 
A published binding partner of Plk1, FOXM1 (Fu et al. 2008), was co-
immunoprecipitated from HeLa cells arrested in metaphase (Figure 4.2). 
However, ESCRT proteins could not be shown to interact with Plk1 in HeLa cells 
arrested in metaphase or telophase (Figure 4.2). ESCRT-I component, VPS28, was 
immunoprecipitated from asynchronous HeLa cells and cells arrested in 
metaphase and telophase, but Plk1 was not shown to interact (Figure 4.3). 
ESCRT proteins were next over-expressed in HEK293 cells, due to published 
observed interactions on immunoprecipitation of Plk1 (Fu et al. 2008). Under 
these conditions, interactions were detected between Plk1 and ESCRT-III 
components CHMP6, CHMP4B, CHMP3 and CHMP2A (Figure 4.5). Plk1 was 
depleted from lysates by sequential immunoprecipitation and ESCRT co-
immunoprecipitation significantly diminished, despite almost unchanged 
expression levels in lysates (Figure 4.6). 
However, other experimental conditions did not confirm these interactions. Plk1 
was not detected on immunoprecipitation of ESCRT proteins from HEK293 cell 
lysates (Figure 4.8). Plk1-YFP was co-expressed with ESCRT proteins in HEK293 
cells. Immunoprecipitation of Plk1-YFP using anti-GFP antibody did not result in 
detection of ESCRT proteins (Figure 4.9). This outcome was also shown for 
kinase-dead Plk1.K82R and ESCRT proteins (Figure 4.9). Furthermore, no reverse 
interaction was found on immunoprecipitation of ESCRT proteins and screening 
for Plk1-YFP or Plk1.K82R-YFP (data not shown). ESCRT proteins were over-
expressed in HeLa cells less effectively than in HEK293 cells. Interactions were 
not found between Plk1 and ESCRT proteins in HeLa cells (data not shown).  
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A functional assay was performed. HeLa cells were arrested in metaphase and 
telophase and subjected to Plk1 kinase inhibition. A phospho-mobility shift of 
ESCRT-III protein CHMP6 was not detected (Figure 4.10). 
CDC14A and ESCRT proteins were subsequently over-expressed in HEK293 cells. 
CDC14A was revealed to interact with CHMP4B and CHMP2A (Figure 4.12). 
Interactions were also shown when the experiment was performed in reverse 
(Figure 4.14). Phosphatase-dead CDC14A.C278S was also shown to interact with 
CHMP4B and CHMP2A (Figure 4.13); however, reverse assays did not reveal 
interactions (Figure 4.15). 
4.2.6.2 Summary 
Immunoprecipitation of proteins from human cell lysates was an effective 
technique in assaying interactions between human proteins. Use of this 
technique revealed interactions between Plk1 and ESCRT-III proteins CHMP6, 
CHMP4B, CHMP3 and CHMP2A. Furthermore, CDC14A was also shown to interact 
with CHMP4B and CHMP2A. 
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Chapter 5 Discussion 
5.1 Plo1p kinase and Clp1 (Cdc14) phosphatase interact 
with ESCRT proteins in fission yeast 
5.1.1 Analysis of the key findings 
ESCRT genes were shown in this study to be required for cell division in fission 
yeast. Analysis of septation in fission yeast revealed an increase in septal defects 
in fission yeast strains with individual chromosomal deletions of ESCRT genes. 
Staining newly deposited cell wall with Calcofluor facilitated characterisation of 
a number of septation phenotypes in fission yeast (Figure 3.1A). These 
separation defects could be broadly separated into two mechanistic failures: 
that of septum assembly and separation following septation. In relation to wild-
type cells, strains with chromosomal deletions in ESCRT genes sst4, vps20, vps24 
and vps4 were shown to have a significant (p < 0.05) increase in the F 
phenotype, characterised as delayed separation following septation (Figure 
3.1B). The F phenotype may be related to a failure to hydrolyse the septum 
edging material, as mutants in genes required for hydrolysis have been described 
as having delayed separation, albeit described with the E phenotype as 
characterised in this study (Liu et al 1999; Jin et al. 2008).  
Mitchison and Nurse (1985) calculated a delay of 0.12 of a cell cycle between 
septation and cell separation, so-called hanging. The delayed separation F 
phenotype was identified as defective cell separation on the basis of its higher 
frequency among fission yeast with deleted ESCRT genes. However, were this 
phenotype to be characterised further, it would be worthwhile to subject 
stained yeast suspensions to brief sonication before visualisation. This has been 
employed to disrupt hanging following septation (Mitchison & Nurse 1985). By 
this method, it may be possible to distinguish between typical hanging and 
delayed separation following septation. 
Fission yeast double mutants were generated by crossing strains containing 
individual deletions of ESCRT genes with a temperature-sensitive mutant strain 
of plo1, plo1-ts35, and various mutants of clp1. Genetic interactions may be 
inferred by synthetic lethality among offspring (Papadopoulou et al. 2010), 
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however, all double mutants in this study were found to be viable. Subtle 
synthetic interactions were inferred by assaying growth rates among parent and 
offspring strains on rich and minimal solid media at various temperatures. In 
several instances, such as in the double mutant plo1-ts35 vps20Δ, growth rate 
defects were noted at 30°C, indicating that the restrictive temperature of plo1-
ts35, 36°C, had been lowered. This principle has been shown previously between 
plo1+ and clp1+, whereby clp1.D257A reduced the restrictive temperature of 
plo1-ts35, indicative of exacerbated cell stress as a result of genetic interactions 
(Papadopoulou et al. 2010). Defective growth rates were observed among double 
mutants with mutant plo1 and clp1 from every class of ESCRT gene (0, I, II and 
III), as well as vps4 (Table 3.2). Thus, it has been shown that plo1+ and clp1+ 
interact genetically with ESCRT genes. Furthermore, an increased prevalence of 
septal defects was observed in double mutants of fission yeast strains with 
individual ESCRT gene deletions and plo1-ts35, clp1Δ, a deletion mutant of 
mid1, as well as two temperature-sensitive mutants of Aurora B kinase, ark1-T8 
and ark1-T11 (Appendix 6.2). 
Genetic interactions between plo1+, clp1+ and ESCRT genes were further 
analysed by investigating vacuolar sorting in fission yeast; the cellular 
distributions of GFP-labelled receptor Ub-GFP-SpCPS and vacuolar stain FM 4-64 
were analysed. Using this method, the ESCRT machinery was confirmed to be 
required for downregulation of ubiquitin-labelled receptors via the 
multivesicular body pathway, and the requirement of individual ESCRT genes for 
correct sorting was demonstrated (Figure 3.4; Iwaki et al. 2007).  
The cellular distributions of Ub-GFP-SpCPS and FM 4-64 were then characterised 
in fission yeast with mutations in plo1 and clp1 to test the hypothesis that Plo1p 
and Clp1p are required for vacuolar sorting. Fission yeast strains with mutations 
in plo1 and clp1 exhibited defective sorting, but with distinct phenotypes to 
those observed in ESCRT deletion strains (Figure 3.5). Cells containing the 
temperature-sensitive plo1 mutant, plo1-ts35, exhibited a uniform array of 
vacuoles at permissive temperature, with Ub-GFP-SpCPS precisely co-localised to 
the vacuolar periphery. In contrast, cells with a chromosomal deletion of the 
clp1 gene, clp1Δ, exhibited a luminal pattern of Ub-GFP-SpCPS localisation. Cells 
with loss-of-function mutation clp1.D257A were similar to wild-type cells in their 
Ub-GFP-SpCPS and vacuolar distributions. Finally, cells with gain-of-function clp1 
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mutation clp1.3A were phenotypically intermediate between the distribution 
reported for wild-type cells (Iwaki et al. 2007) and the plo1-ts35 distribution 
patterns reported here. Examining Ub-GFP-SpCPS and FM 4-64 localisation 
patterns in double mutants of ESCRT deletions with clp1.D257A and clp1.3A may 
provide further definition of the functions of these clp1 mutants in fission yeast 
vacuolar sorting. 
Similar defective sorting phenotypes to budding yeast strains with ESCRT 
deletions were identified in a deletion mutant of the endosomal ion exchanger 
nhx1 (Kallay et al. 2011). However, these findings showed that Nhx1 functioned 
independently to the ESCRT proteins, despite the observation of synthetic 
phenotypes in double mutants of nhx1Δ and a number of ESCRT deletions. 
The observations reported here indicate novel functions for plo1+ and clp1+ in 
vacuolar sorting in fission yeast. However, the phenotypes observed in strains 
with mutations in plo1 and clp1 were distinct to the punctate phenotype 
observed in strains with single deletions in ESCRT genes. There are two potential 
ways to explain this difference: firstly, that Plo1p and Clp1p regulate vacuolar 
sorting independently of the ESCRT machinery; or secondly, that Plo1p and 
Clp1p regulate vacuolar sorting through more than one ESCRT protein. 
To investigate the dependency of ESCRT proteins on Plo1p and Clp1p in 
controlling vacuolar sorting, double mutants of plo1-ts35 and clp1Δ with ESCRT 
deletions were examined. Ub-GFP-SpCPS and FM 4-64 distributions were 
characterised in fission yeast strains with double mutants of plo1-ts35 and 
individual ESCRT deletions. Double mutant phenotypes were more similar to 
plo1-ts35, although the converse was noted for plo1-ts35 vps4Δ (Figure 3.6). 
Analysis of double mutants of clp1Δ and individual ESCRT deletions revealed 
phenotypes more similar to each respective ESCRT single deletion mutant 
(Figure 3.7). These epistasis experiments suggest that plo1+ functions upstream 
of ESCRT genes in controlling vacuolar sorting and that clp1+ functions 
downstream of ESCRT genes. These data are consistent with a model of 
regulation whereby Plo1p and Clp1p interact with ESCRT proteins, respectively, 
before and after ESCRT functions in vacuolar sorting. In particular, the similarity 
between the plo1-ts35 and clp1.3A mutant strains may indicate that increased 
Clp1p activity conferred by this gain-of-function mutation reverses Plo1p 
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phosphorylation to maintain ESCRT proteins in a hypophosphorylated form, thus 
trapping Ub-GFP-SpCPS upon the peripheral membrane. The genetic dependency 
of ESCRT genes upon plo1+ and clp1+ may be further characterised by producing 
yeast strains with multiple deletions in ESCRT genes. Epistasis experiments of 
this type may allow identification of the specific genetic pathway involving these 
genes in vacuolar sorting.  
Previous studies have demonstrated the translation of genetic interactions into 
protein interactions (Papadopoulou et al. 2010). In this study, the yeast two-
hybrid assay was used to further analyse the genetic interactions observed 
between plo1+, clp1+, and ESCRT genes. Plo1p was shown to physically interact 
with Sst4p (ESCRT-0), Vps28p (ESCRT-I), Vps25p (ESCRT-II), Vps20p and Vps32p 
(both ESCRT-III) (Table 3.6).  
Wild-type Plo1p did not exhibit interactions with Sst4p or Vps25p. Instead, 
interactions were observed between kinase-dead Plo1.K69R and Sst4p and 
Vps25p. These observations allude to the possible nature of the interactions 
between Plo1p and these ESCRT proteins. The yeast two-hybrid assay allows 
detection of in vivo protein-protein interactions, but is sometimes insensitive to 
transient interactions (Brückner et al. 2009). Therefore, interactions observed 
after mutating one of the binding partners indicates stability conferred by the 
mutation. Interactions have been shown in yeast two-hybrid using ‘substrate-
trap’ phosphatase-dead mutants (Fukada et al. 2005). In the present study, as 
kinase function has been inactivated in Plo1.K69R, these interactions suggest 
that Plo1p binds to and phosphorylates Sst4p and Vps25p; these interactions may 
be characterised as being transient and to occur in a manner that requires 
phosphorylation prior to dissociation. 
Clp1p was shown to interact with just Vps28p (ESCRT-I) (Figure 3.12). Yeast two-
hybrid assays investigating interactions with Clp1p proved difficult due to the in 
vivo transcriptional activity of Clp1p (Papadopoulou et al. 2010), although this 
ultimately proved advantageous in the identification of a solitary interaction. 
The interaction between Clp1p and Vps28p was identified on the basis of 
inhibited auto-activation of the gal4 promoter by truncation mutant Clp1aa.1-
371 in the presence of Vps28p. However, this observation does not necessitate a 
negative interaction assay for the remaining ESCRT proteins with Clp1p.  
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Nevertheless, in light of this result with Vps28p, negative interactions were 
scored for the remaining ESCRT proteins. It may be possible to clarify ESCRT 
protein interactions with Clp1p by utilising different transcriptional readouts in 
the yeast two-hybrid assay, such as auxotrophic markers (Brückner et al. 2009). 
Alternatively, assaying β-galactosidase activity in liquid cultures would allow 
calculation of a baseline value for transcription. It may then be possible to 
quantitatively identify increased transcription when assaying Clp1p yeast two-
hybrid with ESCRT proteins. Quantifying β-galactosidase activity was attempted 
in this study (data not shown), and although published values for interactions 
between Plo1p, Clp1p and Mbx1p were replicated (Papadopoulou et al. 2008), 
subsequent assay of ESCRT proteins with Plo1p resulted in irreproducible values. 
The β-galactosidase assay was eventually discarded to focus on assaying 
interactions in human cells. 
5.1.2 A model for ESCRT regulation by Plo1p and Clp1p 
Plo1p physically interacts with proteins in ESCRT classes 0, I, II and III. Clp1p 
physically interacts with Vps28p, a member of ESCRT-I. Current views of 
cytokinesis in human cells describe roles for ESCRT-I and -III in abscission (Elia et 
al. 2012). However, ESCRT classes 0–III have also been implicated in MVB 
formation (Wollert & Hurley 2010). Therefore, if ESCRT subunit function is 
conserved between fission yeast and humans, these findings suggest that Plo1p 
regulates the ESCRT proteins in vacuolar sorting and cytokinesis (Figure 5.1). 
Similarly, the observation of interactions between Clp1p and an ESCRT-I subunit, 
combined with the epistasis data on vacuolar sorting, suggest that Clp1p is 
regulating ESCRT proteins in cytokinesis, and possibly in vacuolar sorting (Figure 
5.1).  
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Figure 5.1: Plo1p and Clp1p interact with members of the ESCRT machinery in 
fission yeast. 
This model illustrates proteins of each fission yeast ESCRT subunit and the linkers 
between each subunit. Plo1p and Clp1p are shown interacting with members of the 
ESCRT machinery. 
The implication of this model is that Plo1p and Clp1p regulate ESCRT proteins via 
their phosphorylation state. In particular, the vps4Δ vacuolar sorting phenotype 
was quite dissimilar to the primary ESCRT genes. Furthermore, although 
synthetic growth phenotypes were noted, epistasis experiments provided little 
information about vps4+ interactions with plo1+ and clp1+, and yeast two-hybrid 
indicated that these proteins do not interact. Taken together, these data 
suggest a model for ESCRT function in vacuolar sorting whereby Plo1p 
phosphorylates ESCRT proteins to elicit some conformational change, perhaps to 
allow association with other ESCRT components, cargo, lipids, or other proteins; 
Vps4p then redistributes ESCRT-III, then Clp1p dephosphorylates ESCRT proteins 
to reverse Plo1p-mediated conformational changes.  
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5.2 Plk1 kinase and CDC14A phosphatase interact with 
ESCRT proteins in humans 
5.2.1 Analysis of the key findings 
Following the observation of genetic and physical interactions between Plo1p, 
Clp1p and ESCRT proteins, human homologues Plk1 and CDC14A were 
investigated using immunoprecipitation and co-immunoprecipitation methods. 
HeLa cells were initially used due to their ease of manipulation and 
synchronisation. Furthermore, a known binding partner of Plk1, FOXM1, has been 
shown to co-immunoprecipitate with Plk1 from asynchronous and mitotic HeLa 
cell lysates (Fu et al. 2008) and could therefore by used as a positive control. In 
this study, FOXM1 was successfully co-immunoprecipitated with Plk1 from 
metaphase-arrested HeLa cells (Figure 4.2B); however, ESCRT proteins were not 
shown to co-immunoprecipitate. To overcome the possibility that this negative 
result was due to low abundance of ESCRT proteins preventing detection, ESCRT 
proteins were over-expressed to seek interactions with Plk1. As HeLa cells did 
not efficiently accept transfecting DNA to over-express proteins, HEK293 cells 
were used instead, as they have been used previously to observe interactions 
between endogenous Plk1 and over-expressed binding partners (Fu et al. 2008). 
Over-expressed ESCRT-III protein CHMP6 was co-immunoprecipitated with Plk1 
from HEK293 cells (Figure 4.4). FIP3-GFP was used to show that CHMP6-GFP was 
co-immunoprecipitated due to interactions between Plk1 and CHMP6, rather 
than via GFP. However, it should be noted that, formally, GFP may bind to anti-
Plk1 antibody in a manner blocked by fusion to FIP3. Therefore, a more 
appropriate control would be to over-express cells with un-fused GFP, or to 
incubate lysates with recombinant GFP. If these lysates then 
immunoprecipitated Plk1 with anti-Plk1 antibody, but not GFP, this would 
indicate that CHMP6-GFP does not co-immunoprecipitate due to interactions 
between GFP and anti-Plk1 antibody. A further control to include in this 
immunoprecipitation assay would be to incubate anti-Plk1 antibody with the 
purified epitope of the Plk1 motif that binds to the antibody to block the 
antibody sites. If CHMP6 does not co-immunoprecipitate in these conditions, this 
would indicate that CHMP6 co-immunoprecipitates due to interactions with Plk1, 
rather than anti-Plk1 antibody. The combination of these controls would more 
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robustly demonstrate that ESCRT proteins co-immunoprecipitate from human 
cell lysates due to interactions with Plk1. However, on the basis of the 
subsequent results obtained, it would seem unlikely that non-specific 
interactions with anti-Plk1 antibody underlie the interactions observed. 
ESCRT proteins CHMP6, CHMP4B, CHMP3 and CHMP2A were shown to co-
immunoprecipitate with Plk1 (Figure 4.5). Immunoblotting Plk1 from HEK293 cell 
lysates was often not robust. However, the sequential immunoprecipitation of 
Plk1 from these lysates demonstrated, firstly, that Plk1 immunoprecipitated 
from lysates and, secondly, that the ESCRT proteins co-immunoprecipitated due 
to direct interactions with Plk1 (Figure 4.6). This experiment was analogous to 
an RNAi knockdown assay of Plk1, but rather than using RNAi, which can be 
costly, complex to achieve, and may affect other cell processes, the levels of 
Plk1 within lysates were gradually reduced. Repeated immunoprecipitation of 
human cell lysates with anti-Plk1 antibody resulted in the loss of co-
immunoprecipitated ESCRT proteins. However, the supernatants resulting from 
the final immunoprecipitation were qualitatively shown to still express ESCRT 
proteins to a degree almost indistinguishable to the first lysate before 
immunoprecipitation. These data are strong indicators that the ESCRT proteins 
interact with Plk1, rather than with anti-Plk1 antibody – neither directly, nor by 
their respective tags. However, as a further consideration, it is possible that 
ESCRT proteins are co-immunoprecipitated due to interactions with an unknown 
protein, which binds to either Plk1 or anti-Plk1 antibody. Nevertheless, the data 
gathered in yeast imply the veracity of the interactions observed in human cells. 
The consensus motif for Plk1 substrate phosphorylation was determined as 
[(D/E)-Xaa-(S/T)-Φ-Xaa-(D/E), Φ=hydrophobic] (Nakajima et al. 2003), while the 
substrate binding motif for the polo box domain has been described as [S-
(pT/pS)-(P/Xaa)] (Elia et al. 2003). The kinase motif is present within many 
ESCRT proteins, several of which have co-immunoprecipitated with Plk1 in this 
study: TSG101 and VPS28 (ESCRT-I), EAP45 and EAP20 (ESCRT-II), CHMP6 and 
CHMP4B (ESCRT-III), as well as in VPS4B. Variations of the Plk1 substrate-binding 
motif are present within almost all ESCRT proteins. Interestingly, although both 
motifs are found within CEP55, a phospho-substrate of Plk1, CEP55 is 
phosphorylated on Ser436 within NESLVE (Bastos & Barr 2010), which lacks full 
fidelity with the target motif (Nakajima et al. 2003). This indicates that Plk1 
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exerts flexibility in substrate phosphorylation with respect to a non-canonical 
substrate motif and may phosphorylate certain substrates in a distributive mode 
(Park et al. 2010). 
All of the ESCRT proteins assayed co-immunoprecipitated with Plk1. One 
explanation for this observation is that ESCRT proteins are pulled down in a 
complex; therefore, interaction with one ESCRT protein allows detection of the 
rest. Attempts were made to address this by increasing the detergent 
concentration within the buffer conditions to disrupt the complex. Triton X-100 
was increased in concentration tenfold, yet ESCRT proteins continued to co-
immunoprecipitate with Plk1 (Figure 4.7). However, when compared to previous 
assays (Figure 4.5), the co-immunoprecipitation of CHMP3 in the presence of 
higher Triton X-100 appeared to be reduced. Subsequent attempts to dissociate 
the ESCRT proteins from their complex should be analysed by SDS-PAGE 
alongside basal immunoprecipitation conditions to detect subtle changes; a 
loading control may be required for this experiment. It should be noted that 
ESCRT complex dissociation was not shown. Future experiments to dissociate 
ESCRT proteins may be designed around changes in salt and pH conditions (Eisele 
et al. 2011). An important consideration in attempting to dissociate the ESCRT 
complex is that the interactions between the ESCRT proteins and Plk1 must 
remain extant. Whatever the means employed, a balance would need to be 
reached for this to be achieved. Given the yeast two-hybrid data suggesting 
transient interactions between Plo1p and Sst4p and Vps25p, there may be a high 
likelihood of disrupting kinase-substrate interactions. 
However, it may not be necessary to dissociate ESCRT proteins from their 
complex. Although all assayed ESCRT proteins were co-immunoprecipitated with 
Plk1, not all co-immunoprecipitated with CDC14A. VPS28 and CHMP6 did not 
appear to interact with CDC14A (Figure 4.12); were the ESCRT proteins still in 
complex, it would be reasonable to expect that these proteins would be 
detected on immunoprecipitation of CDC14A. Assaying immunoprecipitated Plk1 
for co-immunoprecipitated over-expressed VPS28 may reveal a similar result to 
that observed for CDC14A. Finally, although this was not attempted, 
immunoblotting ESCRT immunoprecipitations for different ESCRT proteins may 
confirm whether ESCRT proteins immunoprecipitate individually or in complex. 
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Yeast two-hybrid data revealed that certain interactions between Plo1p and 
ESCRT proteins were only observed in assays with kinase-dead Plo1.K69R. In this 
study, there were no ESCRT proteins that over-expressed well in HEK293 cells 
that were not subsequently co-immunoprecipitated with Plk1. Therefore, ESCRT 
proteins were expected to co-immunoprecipitate with kinase-dead Plk1.K82R. 
However, it was observed that anti-GFP immunoprecipitation of Plk1-YFP and 
Plk1.K82R-YFP from lysates over-expressed with ESCRT proteins produced 
effective immunoprecipitation of tagged species of Plk1, yet no co-
immunoprecipitation of ESCRT proteins (Figure 4.9). One interpretation of these 
results is that Plk1-YFP and ESCRT proteins were co-expressed within a 
population, but not within individual cells, which may not result in interactions. 
Future assays should include confirmation of co-expression, or otherwise, within 
individual cells; this could be achieved by fluorescence microscopy of fixed cells 
following co-transfection performed in parallel with co-transfection for lysate 
preparation. Time prevented further exploration of this hypothesis. 
Following observation of interactions between Plk1 and ESCRT proteins in 
HEK293 cells, CDC14A and ESCRT proteins were over-expressed in HEK293 cells 
to detect interactions using immunoprecipitation and co-immunoprecipitation 
methods. Over-expressed ESCRT-III proteins CHMP4B-YFP and CHMP2A-GFP were 
shown to co-immunoprecipitate with CDC14A-myc from HEK293 cell lysates 
(Figure 4.12); these interactions remained when assayed with phosphatase-dead 
CDC14A.C278S (Figure 4.13). Interactions were also shown by co-
immunoprecipitating CDC14A with CHMP4B and CHMP2A (Figure 4.14). To more 
robustly demonstrate these interactions, anti-myc immunoprecipitations should 
be performed in cell lysates over-expressing ESCRT proteins in the absence of 
CDC14A-myc. Furthermore, a larger volume of material analysed by SDS-PAGE 
may clarify the CDC14A co-immunoprecipitation. The CHMP6 reverse 
immunoprecipitation was not performed as Protein A sepharose beads were 
mistakenly omitted from the incubated cell lysate-antibody mixture. To 
complete these assays, this CHMP6 reverse immunoprecipitation should be 
performed. 
CHMP6 and, perhaps surprisingly, VPS28, did not co-immunoprecipitate with 
CDC14A (Figure 4.12 and 4.13). In the yeast two-hybrid screen of fission yeast 
protein-protein interactions, fission yeast Vps28p was the only protein regarded 
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to interact with Clp1p (CDC14) (Figure 3.12). This observation may necessitate a 
reinterpretation of the yeast two-hybrid data in light of the immunoprecipitation 
data, or it may simply reflect variances in the conservation of interactions 
between these two species. 
5.2.2 Refining the model 
Plk1 interacts with ESCRT-III proteins CHMP6, CHMP4B, CHMP3 and CHMP2A. 
Furthermore, CDC14A interacts with ESCRT-III proteins CHMP4B and CHMP2A. 
These observations are consistent with ESCRT functions in cytokinesis (Guizetti 
et al. 2011). This model suggests, therefore, that Plk1 and CDC14A interact with 
ESCRT-III proteins in cytokinesis to control their phosphorylation state (Figure 
5.2). 
 
 
 
 
 
 
Figure 5.2: Plk1 and CDC14A interact with members of the ESCRT machinery in 
human cells. 
This model illustrates proteins of ESCRT-III. Plk1 and CDC14A are shown interacting 
with members of ESCRT-III in human cells. 
The genetic and physical interactions revealed in this study are summarised in 
Table 5.1. 
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Table 5.1: Genetic and physical interactions were observed between ESCRT 
proteins, polo kinase and Cdc14 phosphatase in fission yeast and humans. 
The table summarises the genetic and physical interactions observed in this study. 
Y2H, yeast two-hybrid; CoIP, co-immunoprecipitation; ND, not determined. 
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5.3 Future work 
The observations of genetic interactions between ESCRT genes and the Aurora 
kinase ark1+ and the anillin mid1+ require further study. In both cases, yeast 
two-hybrid could be used to examine if the encoded proteins interact and 
immunoprecipitation experiments used to detect physical interactions in human 
cells. Furthermore, vacuolar sorting using Ub-GFP-SpCPS could be investigated in 
ark1 and mid1 mutants. Experiments are ongoing with ark1+ using yeast-two 
hybrid. Preliminary data suggests an interaction between VPS4B and anillin in 
human cells (GW Gould pers. comm.), and vps4 and mid1 deletion mutants show 
synthetic lethality in fission yeast (CJ McInerny pers. comm.). Temperature-
sensitive mutant, ark1-T8, also appears to affect vacuolar sorting in fission yeast 
(CJ McInerny pers. comm.).  
Mid1p has a prominent role in fission yeast controlling the deposition of the 
contractile ring that determines the site of septation and is known to interact 
with both Plo1p and Clp1p (Almonacid et al. 2011; Clifford et al. 2008), so it 
possible that it also plays a role in controlling ESCRT function during cytokinesis 
in fission yeast. Similarly, Ark1p controls late cell cycle events (Petersen & 
Hagan 2003), and thus the genetic experiments presented here suggest that it 
too may play a role in controlling ESCRT function. 
The yeast two-hybrid system was used to assay interactions between fission 
yeast proteins. This assay could also be used to study interactions between 
human homologues. Wild-type and catalytically inactive forms of PLK1 and 
CDC14A genes were amplified from plasmid vectors and cloned into the 
intermediate StrataClone vector used in the cloning throughout this study. It was 
hoped that these would be cloned into appropriate bait and prey vectors for 
inclusion in a yeast two-hybrid screen against human ESCRT proteins. Although 
this was not completed within the timeframe of this project, this assay should 
complement the observations made in this study.  
A yeast two-hybrid screen for interactions between human proteins would be 
advantageous for several reasons. Firstly, the assay would deliver rapid results in 
comparison to immunoprecipitation assays. Secondly, as proved elusive with 
Plk1, a yeast two-hybrid screen would be particularly useful for identifying 
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differences in interactions between ESCRT proteins and the catalytically inactive 
forms of Plk1 and CDC14A. Indeed, stable interactions have been demonstrated 
in yeast two-hybrid screens of CDC14A.C278S, in which screens of wild-type 
CDC14A were negative (Lanzetti et al. 2007); and this was similarly observed 
using kinase-dead fission yeast Plo1.K69R (Section 3.2.5). Finally, a yeast two-
hybrid screen of human ESCRT proteins would resolve the question of ESCRT 
proteins remaining in complex; this is because amplifying ESCRT genes using 
specific primers would eliminate the possibility of other proteins remaining in 
complex with the amplified ESCRT.  
This study focused on interactions between Plk1, CDC14A and ESCRT proteins, 
with a brief attempt to investigate functional relevance. Plk1 kinase inhibitor BI 
2536 was added to mitotic HeLa cells. Lysates were then immunoblotted for 
CHMP6 to seek a mobility shift on SDS-PAGE (Figure 4.10). This experiment could 
be repeated with several modifications. Firstly, future use of BI 2536 should 
include detection of a marker for inhibition. For instance, immunoblotting BubR1 
should reveal a mobility shift on treating HeLa cells with BI 2536 (Lénárt et al. 
2007). Secondly, untreated and Plk1-inhibited lysates should be run in parallel. 
Thirdly, a loading control, such as GAPDH, should be used as a control for 
conditions that may result in aberrant protein positions during SDS-PAGE.  
As a further consideration, the mobility shift may be exacerbated by addition of 
reagent Phos-Tag™ to the SDS gel. Phos-Tag™ selectively binds phosphorylated 
proteins (Kinoshita et al. 2004) and can be used to retard them during SDS-PAGE 
(Kinoshita et al. 2006). Use of Phos-Tag™ while subjecting untreated and Plk1 
kinase-inhibited cell lysates to SDS-PAGE and immunoblotting for ESCRT proteins 
may elucidate whether Plk1 activity results in phosphorylation of ESCRT 
proteins. Combined with the results of immunoprecipitation and co-
immunoprecipitations, Phos-Tag™ SDS-PAGE could provide compelling evidence 
that Plk1 phosphorylates ESCRT proteins. Equivalent experiments could also be 
performed using the competitive inhibitor of CDC14A, sodium tungstate (Lanzetti 
et al. 2007). However, performing in vitro kinase assays could provide definitive 
evidence of ESCRT phosphorylation by Plk1. 
In vitro kinase assays have been performed by incubating [γ-32P]ATP with 
substrate protein Tau and various kinases (Kinoshita-Kikuta et al. 2007). Silver-
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staining subsequent Phos-Tag™ SDS gels produced multiple phospho-species and 
autoradiography showed that kinase reactions proceeded correctly. Similar 
assays with recombinant Plk1 could show that Plk1 phosphorylates ESCRT 
proteins. Furthermore, subsequent incubation of kinase reactions with CDC14A 
could show, generally, that CDC14A dephosphorylates ESCRT proteins, and 
specifically, that CDC14A dephosphorylates ESCRT proteins following 
phosphorylation by Plk1. 
In vitro kinase assays performed with Plk1 have confirmed that Plk1 binding to 
FOXM1 is required for substrate phosphorylation (Fu et al. 2008). Furthermore, 
in vitro kinase assays could be performed with ESCRT proteins. ESCRT-III protein 
CHMP4C was shown to be phosphorylated by Aurora B kinase (Carlton et al. 
2012); phosphorylation was revealed to have an inhibitory role, and further 
insights into ESCRT function were therefore revealed (Carlton et al. 2012). These 
approaches would have the advantage of allowing estimation of the 
stoichiometry of phosphorylation, thus revealing the effectiveness of a particular 
ESCRT subunit as a substrate for Plk1. 
This research by the Martin-Serrano group raises potential future dimensions to 
this study (Carlton et al. 2012). Further to ESCRT binding and mapping studies, 
the functional impact of Plk1 and CDC14A activity upon ESCRT proteins requires 
elucidation. Is binding of Plk1 and CDC14A to ESCRT proteins required for 
mediating phosphorylation status? Which ESCRT residues are phosphorylated? 
Examining ESCRT sequences for Plk1 binding motifs provides clues (Section 
5.2.1); mutating these residues may abolish binding and phosphorylation by Plk1. 
Do the ESCRT proteins require modification or phosphorylation prior to Plk1 
binding? Do alterations in phosphorylation state elicit ESCRT conformational 
changes that regulate interactions with other ESCRT subunits, proteins or even 
lipids? Finally and most crucially, determining the functional significance of 
controlling ESCRT phosphorylation status may provide insights into future 
methods of manipulating abscission in instances of uncontrolled cell division.   
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5.4 Conclusion 
ESCRT proteins are required for cell division in humans (Morita et al. 2007). This 
study has shown that ESCRT proteins are required for septation and cell 
separation in fission yeast. Genetic interactions were observed between ESCRT 
genes and plo1+, clp1+, mid1+ and ark1+. Furthermore, novel roles were 
demonstrated for Plo1p and Clp1p in vacuolar sorting in fission yeast, and 
genetic analysis facilitated characterisation of a genetic pathway in vacuolar 
sorting for plo1+, ESCRT genes and clp1+. Yeast two-hybrid analysis of fission 
yeast proteins revealed physical interactions between Plo1p and ESCRT proteins 
from classes 0, I, II and III. Physical interactions were also observed between 
Clp1p and ESCRT-I. Immunoprecipitation and co-immunoprecipitation analyses in 
human cell lysates revealed physical interactions between Plk1, CDC14A and 
ESCRT-III proteins.  
These findings provide evidence for ESCRT regulation by polo kinase and Cdc14 
phosphatase during cytokinesis in fission yeast and humans. It is proposed that 
mediating ESCRT phosphorylation status may elicit conformational changes, such 
as ESCRT-III nucleation, that drive abscission (Elia et al. 2011). Consistent with 
this model, Plk1 has recently been shown to reappear at the midbody following 
initial downregulation (Hu et al. 2012). Therefore, future characterisation of 
these interactions and their functional significances may provide useful insights 
towards manipulating ESCRT proteins in controlling cell division in disease 
processes. 
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Chapter 6 Appendices 
6.1 Strains list 
6.1.1 Schizosaccharomyces pombe strains 
Lab no. Genotype Source 
GG 1146 h+ clp1 ::ura4+ ura4-D18 leu1-32 ade6-210 (Trautmann et al. 
2001) 
GG 1167 h+ plo1-ts35 ura4-D18 leu1-32 (Anderson et al. 
2002) 
GG 1171 h- plo1-ts35 leu1-32 (Anderson et al. 
2002) 
GG 1191 h- clp1.D257A-13myc:kanR ura4-D18 leu1-32 ade6-210 (Wolfe et al. 2006) 
GG 1193 h- clp1.3A-13myc:kanR ura4-D18 leu1-32 ade6-216 (Wolfe et al. 2006) 
GG 1202 h+ clp1.D257A-13myc:kanR cdc25-22 leu1-32 ura4-D18 ade6-210 (Wolfe et al. 2006) 
GG 1204 h+ clp1.3A-13myc:kanR cdc25-22 leu1-32 ura4-D18 ade6-216 (Wolfe et al. 2006) 
GG 1279 975 h+ Laboratory stock 
GG 1306 h- clp1::kanR leu1-32 ura4-D18 (Trautmann et al. 
2001) 
GG 1307 h+ clp1 ::kanR leu1-32 ura4-D18 (Trautmann et al. 
2001) 
GG 1455 h- leu1-32 Laboratory stock 
GG 1554 h+ dmf1::kanMX4 ura4-D18 leu1-32 ade6-216 (Celton-Morizur et 
al. 2004) 
GG 1615 h90 sst6::ura4+ leu1-32 ura4-D18 ade6-M210 (Iwaki et al. 2007) 
GG 1616 h90 vps28::ura4+ leu1-32 ura4-D18 ade6-M210 (Iwaki et al. 2007) 
GG 1617 h- vps36::ura4+ leu1-32 ura4-D18 (Iwaki et al. 2007) 
GG 1618 h- vps25::ura4+ leu1-32 ura4-D18 (Iwaki et al. 2007) 
GG 1619 h90 vps20::ura4+ leu1-32 ura4-D18 ade6-M210 (Iwaki et al. 2007) 
GG 1620 h- vps24::ura4+ leu1-32 ura4-D18 ade6-M210 (Iwaki et al. 2007) 
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GG 1622 h- vps4::ura4+ leu1-32 ura4-D18 (Iwaki et al. 2007) 
GG 1623 h- sst4::ura4+ leu1-32 ura4-D18 (Iwaki et al. 2007) 
GG 1637 h90 vps28::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 1646 h+ vps2::LEU2 clp1 ::kanR leu1-32 ura4-C190T / ura4-D18 This study  
GG 1649 h90 vps20::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study  
GG 1654 h+ vps36::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 1657 h- vps25::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 1660 h+ sst4::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 1663 h+ vps4::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 1666 h+ sst4::ura4+ plo1-ts35 leu1-32 ura4-D18 This study  
GG 1676 h- vps36::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
GG 1679 h+ vps25::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
GG 1682 h90 vps28::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
GG 1688 h90 sst6::ura4+ plo1-ts35 leu1-32 ura4-D18 ade6-M210 This study 
GG 1691 h90 vps20::ura4+ plo1-ts35 leu1-32 ura4-D18 ade6-M210 This study 
GG 1694 h+ vps2::LEU2 plo1-ts35 leu1-32 ura4-C190T This study 
GG 1705 h- vps4::ura4+ clp1.D257A-13myc:kanR cdc25-22 leu1-32 ura4-D18 
ade6-210 
This study  
GG 1706 h- sst4::ura4+ clp1.D257A-13myc:kanR leu1-32 ura4-D18 ade6-210 This study 
GG 1714 h+ sst6::ura4+ cdc25-22 leu1-32 ura4-D18 ade6-M210 This study 
GG 1717 h90 vps28::ura4+ clp1.D257A-13myc:kanR leu1-32 ura4-D18 ade6-M210 This study 
GG 1725 h- vps4::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
GG 1760 h+ vps36::ura4+ clp1.D257A-13myc:kanR leu1-32 ura4-D18 ade6-210 This study 
GG 1765 h- vps25::ura4+ clp1.D257A-13myc:kanR leu1-32 ura4-D18 ade6-210 This study 
GG 1785 h90 vps20::ura4+ clp1.D257A-13myc:kanR leu1-32 ura4-D18 ade6-M210 This study 
GG 1791 h- vps2::LEU2 clp1.D257A-13myc:kanR leu1-32 ura4-D18/ura4-C190T This study 
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GG 1805 h? vps28::ura4+ clp1.3A-13myc:kanR leu1-32 ura4-D18 ade6-M21X This study  
GG 1809 h? vps36::ura4+ clp1.3A-13myc:kanR leu1-32 ura4-D18 This study 
GG 1826 h? vps25::ura4+ clp1.3A-13myc:kanR leu1-32 ura4-D18 This study 
GG 1832 h? vps4::ura4+ clp1.D257A-13myc:kanR leu1-32 ura4-D18 ade6-210 This study 
GG 1836 h? vps4::ura4+ clp1.3A-13myc:kanR leu1-32 ura4-D18 ade6-216 This study 
GG 1842 h? sst4::ura4+ clp1.3A-13myc:kanR leu1-32 ura4-D18 ade6-216 This study 
GG 1844 h? vps20::ura4+ clp1.3A-13myc:kanR leu1-32 ura4-D18 ade6-M21X This study 
GG 1850 h? vps2::LEU2 clp1.3A-13myc:kanR leu1-32 ura4-D18/ura4-C190T 
ade6-216 
This study 
GG 2127 pREP41:Ub-GFP-SpCPS h- leu1-32 This study  
GG 2132 pREP41:Ub-GFP-SpCPS h+ clp1 ::ura4+ ura4-D18 leu1-32 ade6-210 This study  
GG 2139 pREP41:Ub-GFP-SpCPS h+ sst6::ura4+ ura4-D18 leu1-32 ade6-210 This study 
GG 2142 pREP41:Ub-GFP-SpCPS h+ vps20::ura4+ ura4-D18 leu1-32 ade6-210 This study 
GG 2145 pREP41:Ub-GFP-SpCPS plo1-ts35 leu1-32 This study 
GG 2184 pREP41:Ub-GFP-SpCPS h- sst4::ura4+ leu1-32 ura4-D18 This study 
GG 2187 pREP41:Ub-GFP-SpCPS h90 vps28::ura4+ leu1-32 ura4-D18 ade6-M210 This study 
GG 2190 pREP41:Ub-GFP-SpCPS h- vps36::ura4+ leu1-32 ura4-D18 This study 
GG 2193 pREP41:Ub-GFP-SpCPS h- vps4::ura4+ leu1-32 ura4-D18 This study 
GG 2196 pREP41:Ub-GFP-SpCPS h+ clp1 ::ura4+ ura4-D18 leu1-32 ade6-210 This study 
GG 2206 pREP41:Ub-GFP-SpCPS h- plo1-ts35 leu1-32 This study 
GG 2216 pREP41:Ub-GFP-SpCPS h+ sst4::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 2219 pREP41:Ub-GFP-SpCPS h90 vps28::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 2222 pREP41:Ub-GFP-SpCPS h+ vps36::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 2225 pREP41:Ub-GFP-SpCPS h90 vps20::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 2228 pREP41:Ub-GFP-SpCPS h+ vps4::ura4+ clp1 ::kanR leu1-32 ura4-D18 This study 
GG 2239 pREP41:Ub-GFP-SpCPS h+ sst4::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
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GG 2242 pREP41:Ub-GFP-SpCPS h90 vps28::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
GG 2245 pREP41:Ub-GFP-SpCPS h90 vps20::ura4+ plo1-ts35 leu1-32 ura4-D18 
ade6-M210 
This study 
GG 2248 pREP41:Ub-GFP-SpCPS h- vps4::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
GG 2251 pREP41:Ub-GFP-SpCPS h- vps36::ura4+ plo1-ts35 leu1-32 ura4-D18 This study 
GG 2275 pREP41:Ub-GFP-SpCPS h- clp1.3A-13myc:kanR ura4-D18 leu1-32 ade6-
216 
This study  
GG 2296 pREP41:Ub-GFP-SpCPS h- clp1.3A-13myc:kanR ura4-D18 leu1-32 ade6-
216 
This study 
GG 2299 pREP41:Ub-GFP-SpCPS h+ clp1 ::ura4+ ura4-D18 leu1-32 ade6-210 This study 
GG 2302 pREP41:Ub-GFP-SpCPS h- clp1.D257A-13myc:kanR ura4-D18 leu1-32 
ade6-210 
This study  
GG 2412 h+ ark1-T11<<kanR leu1-32 (Koch et al. 2011) 
GG 2423 h- ark1-T11<<kanR vps2::LEU2 leu1-32 Graduate student, 
Brinta Roy 
GG 2426 h+ ark1-T8-GFP-flag-His<<kanR ura4-D18 leu1-32 ade6-210 Laboratory stock 
GG 2451 h+ ark1-T11<<kanR ura4-C190T leu1-32 Graduate student, 
Brinta Roy 
GG 2452 h- ark1-T11<<kanR ura4-C190T leu1-32 Graduate student, 
Brinta Roy 
GG 2453 h+ sst6::ura4+ ark1-T8-GFP-flag-His<<kanR ura4-D18 leu1-32 ade6-210 Graduate student, 
Brinta Roy 
GG 2458 h+ sst6::ura4+ ark1-T11<<kanR ura4-D18/C190T leu1-32 Graduate student, 
Brinta Roy 
GG 2462 h+ ark1-T11<<kanR ura4-C190T Graduate student, 
Brinta Roy 
GG 2466 h- vps4::ura4+ ark1-T8-GFP-flag-His<<kanR ura4-D18 leu1-32 ade6-210 Graduate student, 
Brinta Roy 
GG 2471 h- vps4::ura4+ ark1-T11-GFP-flag-His<<kanR ura4-D18 leu1-32 Graduate student, 
Brinta Roy 
GG 2476 h- sst4::ura4+ ark1-T8-GFP-flag-His<<kanR ura4-D18 leu1-32 ade6-210 Graduate student, 
Brinta Roy 
GG 2481 h+ sst4::ura4+ ark1-T11-GFP-flag-His<<kanR ura4-D18 leu1-32 Graduate student, 
Brinta Roy 
165 
 
GG 2486 h90 vps28::ura4+ ark1-T8-GFP-flag-His<<kanR ura4-D18 leu1-32 ade6-
M210 
Graduate student, 
Brinta Roy 
GG 2491 h+ ark1-T11<<kanR vps28::ura4+ ura4-D18/C190T leu1-32 Graduate student, 
Brinta Roy 
GG 2496 h- ark1-T8-GFP-flag-His<<kanR vps36::ura4+ ura4-D18 leu1-32 ade6-
210 
Graduate student, 
Brinta Roy 
GG 2501 h+ ark1-T11<<kanR vps36::ura4+ ura4-D18/C190T leu1-32 Graduate student, 
Brinta Roy 
GG 2506 h+ ark1-T8-GFP-flag-His<<kanR vps25::ura4+ ura4-D18 leu1-32 Graduate student, 
Brinta Roy 
GG 2511 h- ark1-T11<<kanR vps25::ura4+ ura4-D18 /ura4-C190T leu1-32 Graduate student, 
Brinta Roy 
GG 2516 h90 ark1-T8-GFP-flag-His<<kanR vps20::ura4+ ura4-D18 leu1-32 ade6-
M210/ade6-210 
Graduate student, 
Brinta Roy 
GG 2521 h90 ark1-T11<<kanR ura4-C190T vps20::ura4+ ura4-D18 leu1-32 ade6-
M210 
Graduate student, 
Brinta Roy 
GG 2526 h+ ark1-T8-GFP-flag-His<<kanR vps2::LEU2 leu1-32 Graduate student, 
Brinta Roy 
GG 2531 h90 vps32:ura4+ leu1-32 ura4-D18 ade6-M210 (Iwaki et al. 2007) 
GG 2559 h? vps32:ura4+ plo1-ts35 ura4-D18 leu1-32 ade6-M210 Graduate student, 
Brinta Roy 
GG 2562 h? vps32:ura4+ clp1 ::kanR leu1-32 ura4-D18 ade6-M210 Graduate student, 
Brinta Roy 
GG 2566 h? vps32:ura4+ ark1-T11<<kanR leu1-32 ura4-D18/C190T ade6-M210 Graduate student, 
Brinta Roy 
GG 2571 h? vps32:ura4+ dmf1::kanMX4 ura4-D18 leu1-32 ade6-216 /210 Graduate student, 
Brinta Roy 
GG 2575 h? vps32:ura4+ ark1-T8-GFP-flag-His<<kanR ura4-D18 leu1-32 ade6-210 Graduate student, 
Brinta Roy 
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6.1.2 Saccharomyces cerevisiae strains 
Lab no. Genotype Source 
GGBY 138 MATa URA3::lexA-lacZ met- his3 ade2 trp1 leu2 gal4-D gal80-D (Reynolds & Ohkura 
2003) 
GGBY 171 MATa trp1-190 leu2-3, 112, ura 3-52 his 3-200 gal4 delete gal80 
delete LYS2 replaced by GAL1-HIS3 GAL2-ADE2 met2 replaced by GAL-
lacZ 
(James et al. 1996) 
GGBY 173 pGBT9:clp1+ PJ69-4A (James et al. 1996) 
GGBY 174 pGBT9:clp1aa 1-371 PJ69-4A (James et al. 1996) 
GGBY 208 pBTM116:plo1+ and pACT2:vps20+ This study 
GGBY 211 pBTM116:plo1+ and pACT2:sst6aa.97-1503 This study 
GGBY 214 pGBT9:clp1+ and pACT2:sst6aa.97-1503 This study 
GGBY 217 pBTM116 empty bait vector and pACT2:sst6aa.97-1503 This study 
GGBY 220 pBTM116 empty bait vector and pACT2:vps20+ This study 
GGBY 221 pGBT9 empty bait vector and pACT2 empty prey vector This study 
GGBY 224 pGBT9 empty bait vector and pACT2:vps20+ This study 
GGBY 226 pGBT9 empty bait vector and pACT2:sst6aa.97-1503 This study 
GGBY 229 pBTM116 empty bait vector and pACT2:vps20+ This study 
GGBY 231 pBTM116 empty bait vector and pACT2:mbx1+ This study 
GGBY 234 pGBT9:clp1+ and pACT2:mbx1+ This study 
GGBY 237 pGBT9:clp1+ and pACT2:vps20+ This study 
GGBY 239 pBTM116:plo1.K69R and pACT2:vps20+ This study 
GGBY 242 pBTM116:plo1.K69R and pACT2:sst6aa.97-1503 This study 
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GGBY 245 pBTM116-plo1.472-684 and pACT2:vps20+ This study 
GGBY 248 pBTM116-plo1.472-684 and pACT2:sst6aa.97-1503 This study 
GGBY 251 pBTM116-plo1.DHK625AAA and pACT2:vps20+ This study 
GGBY 254 pBTM116-plo1.DHK625AAA and pACT2:sst6aa.97-1503 This study 
GGBY 257 pGBT9:clp1aa 1-371 and pACT2:sst6 This study 
GGBY 260 pGBT9:clp1aa 1-371 and pACT2:vps20+ This study 
GGBY 261 pBTM116 empty bait vector and pACT2:sst4+ This study 
GGBY 263 pBTM116:plo1+ and pACT2:sst4+ This study 
GGBY 265 pBTM116:plo1.K69R and pACT2:sst4+ This study 
GGBY 267 pBTM116-plo1.472-684 and pACT2:sst4+ This study 
GGBY 269 pBTM116-plo1.DHK625AAA and pACT2:sst4+ This study 
GGBY 271 pBTM116 empty bait vector and pACT2:vps28+ This study 
GGBY 273 pBTM116:plo1+ and pACT2:vps28+ This study 
GGBY 275 pBTM116:plo1.K69R and pACT2:vps28+ This study 
GGBY 277 pBTM116-plo1.472-684 and pACT2:vps28+ This study 
GGBY 279 pBTM116-plo1.DHK625AAA and pACT2:vps28+ This study 
GGBY 281 pBTM116 empty bait vector and pACT2:vps36+ This study 
GGBY 283 pBTM116:plo1+ and pACT2:vps36+ This study 
GGBY 285 pBTM116:plo1.K69R and pACT2:vps36+ This study 
GGBY 287 pBTM116-plo1.472-684 and pACT2:vps36+ This study 
GGBY 289 pBTM116-plo1.DHK625AAA and pACT2:vps36+ This study 
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GGBY 291 pGBT9 empty bait vector and pACT2:sst4+ This study 
GGBY 293 pGBT9:clp1+ and pACT2:sst4+ This study 
GGBY 295 pGBT9:clp1aa 1-371 and pACT2:sst4+ This study 
GGBY 297 pGBT9 empty bait vector and pACT2:vps28+ This study 
GGBY 299 pGBT9:clp1+ and pACT2:vps28+ This study 
GGBY 301 pGBT9:clp1aa 1-371 and pACT2:vps28+ This study 
GGBY 303 pGBT9 empty bait vector and pACT2:vps36+ This study 
GGBY 305 pGBT9:clp1+ and pACT2:vps36+ This study 
GGBY 307 pGBT9:clp1aa 1-371 and pACT2:vps36+ This study 
GGBY 353 pBTM116-plo1.DHK625AAA and pACT2-vps25+ This study 
GGBY 359 pBTM116-plo1.DHK625AAA and pACT2-+ This study 
GGBY 361 pBTM116-empty and pACT2-vps2+ This study 
GGBY 363 pBTM116-plo1+ and pACT2-vps2+ This study 
GGBY 365 pGBT9-clp1+ and pACT2-vps25+ This study 
GGBY 367 pGBT9-clp1aa.1-371 and pACT2-vps25+ This study 
GGBY 369 pGBT9-empty and pACT2-vps2+ This study 
GGBY 371 pGBT9-clp1+ and pACT2-vps2+ This study 
GGBY 373 pGBT9-clp1aa.1-371 and pACT2-vps2+ This study 
GGBY 375 pGBT9-empty and pACT2-vps25+ This study 
GGBY 377 pBTM116-empty and pACT2-vps25+ This study 
GGBY 379 pBTM116-plo1+ and pACT2-vps25+ This study 
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GGBY 381 pBTM116-plo1.K69R and pACT2-vps25+ This study 
GGBY 383 pBTM116-plo1.472-684 and pACT2-vps25+ This study 
GGBY 385 pBTM116-plo1.K69R and pACT2-vps2+ This study 
GGBY 387 pBTM116-plo1.472-684 and pACT2-vps2+ This study 
GGBY 389 pBTM116-empty and pACT2-vps32+ This study 
GGBY 391 pBTM116-plo1+ and pACT2-vps32+ This study 
GGBY 393 pBTM116-plo1.K69R and pACT2-vps32+ This study 
GGBY 395 pBTM116-plo1.472-684 and pACT2-vps32+ This study 
GGBY 397 pBTM116-plo1.DHK625AAA and pACT2-vps32+ This study 
GGBY 399 pGBT9-empty and pACT2-vps32+ This study 
GGBY 401 pGBT9-clp1+ and pACT2-vps32+ This study 
GGBY 403 pGBT9-clp1aa.1-371 and pACT2-vps32+ This study 
GGBY 405 pBTM116-empty and pACT2-vps4+ This study 
GGBY 407 pBTM116-plo1+ and pACT2-vps4+ This study 
GGBY 409 pBTM116-plo1.K69R and pACT2-vps4+ This study 
GGBY 411 pBTM116-plo1.472-684 and pACT2-vps4+ This study 
GGBY 413 pBTM116-plo1.DHK625AAA and pACT2-vps4+ This study 
GGBY 415 pGBT9-empty and pACT2-vps4+ This study 
GGBY 417 pGBT9-clp1+ and pACT2-vps4+ This study 
GGBY 419 pGBT9-clp1aa.1-371 and pACT2-vps4+ This study 
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6.2 Septation defects in mutants of plo1, clp1, mid1 and 
ark1 
6.2.1 Single mutants plo1-ts35, clp1Δ, mid1Δ, ark1-T8 and ark1-
T11 exhibit septation defects 
 
 
A 
B 
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Figure 6.1: Fission yeast with mutants in plo1, ark1, clp1 and mid1 exhibit septal 
defects. 
Wild-type fission yeast were grown in rich liquid medium to mid-exponential phase at 
either (A) 25°C along with strains with temperature-sensitive mutations plo1-ts35, 
ark1-T8 or ark1-T11, or (B) 30°C along with strains with chromosomal deletions clp1Δ 
or mid1Δ. Cells were harvested and stained with Calcofluor white and visualised by 
fluorescence microscopy. The graph represents the frequency of phenotypes A-F 
among various single and double mutant strains (400 cells, n=3): (A) a normal 
septum, (B) a misaligned septum, (C) a non-perpendicular septum, (D) multiple septa, 
(E) no septal formation, and (F) failed separation of daughter cells following septation, 
and (G) branched cells with multiple septa. Data was collected by graduate student 
Brinta Roy. 
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6.2.2 Septation defects in plo1-ts35 double mutants 
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Figure 6.2: Double mutants of ESCRT deletions and plo1-ts35 exhibit septation 
defects in fission yeast. 
Fission yeast with temperature-sensitive plo1 mutation plo1-ts35 combined with 
individual ESCRT deletions were grown in rich liquid medium to mid-exponential 
phase and harvested. Cells were stained with Calcofluor white and visualised by 
fluorescence microscopy. The graph represents the frequency of phenotypes A-F 
among various single and double mutant strains (400 cells, n=3): (A) a normal 
septum, (B) a misaligned septum, (C) a non-perpendicular septum, (D) multiple septa, 
(E) no septal formation, and (F) failed separation of daughter cells following septation. 
Each of the ESCRT genes labels is accompanied by its respective ESCRT subunit (E-
0-III). Data was collected by graduate student Brinta Roy. 
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6.2.3 Septation defects in clp1Δ double mutants 
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Figure 6.3: Double mutants of ESCRT deletions and clp1Δ exhibit septation 
defects in fission yeast. 
Fission yeast with clp1 chromosomal deletion mutation clp1Δ combined with individual 
ESCRT deletions were grown in rich liquid medium to mid-exponential phase and 
harvested. Cells were stained with Calcofluor white and visualised by fluorescence 
microscopy. The graph represents the frequency of phenotypes A-F among various 
single and double mutant strains (400 cells, n=3): (A) a normal septum, (B) a 
misaligned septum, (C) a non-perpendicular septum, (D) multiple septa, (E) no septal 
formation, and (F) failed separation of daughter cells following septation. Each of the 
ESCRT genes labels is accompanied by its respective ESCRT subunit (E-0-III). Data 
was collected by graduate student Brinta Roy. 
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6.2.4 Septation defects in mid1Δ double mutants 
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Figure 6.4: Double mutants of ESCRT deletions and mid1Δ exhibit septation 
defects in fission yeast. 
Fission yeast with mid1 chromosomal deletion mutation mid1Δ combined with 
individual ESCRT deletions were grown in rich liquid medium to mid-exponential 
phase and harvested. Cells were stained with Calcofluor white and visualised by 
fluorescence microscopy. The graph represents the frequency of phenotypes A-F 
among various single and double mutant strains (400 cells, n=3): (A) a normal 
septum, (B) a misaligned septum, (C) a non-perpendicular septum, (D) multiple septa, 
(E) no septal formation, (F) failed separation of daughter cells following septation, and 
(G) branched cells with multiple septa. Each of the ESCRT genes labels is 
accompanied by its respective ESCRT subunit (E-0-III). Data was collected by 
graduate student Brinta Roy. 
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6.2.5 Septation defects in ark1ts double mutants 
6.2.5.1 Septation defects in ark1-T8 double mutants 
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Figure 6.5: Double mutants of ESCRT deletions and ark1-T8 exhibit septation 
defects in fission yeast. 
Fission yeast with temperature-sensitive ark1 mutation ark1-T8 combined with 
individual ESCRT deletions were grown in rich liquid medium to mid-exponential 
phase and harvested. Cells were stained with Calcofluor white and visualised by 
fluorescence microscopy. The graph represents the frequency of phenotypes A-F 
among various single and double mutant strains (400 cells, n=3): (A) a normal 
septum, (B) a misaligned septum, (C) a non-perpendicular septum, (D) multiple septa, 
(E) no septal formation, and (F) failed separation of daughter cells following septation. 
Each of the ESCRT genes labels is accompanied by its respective ESCRT subunit (E-
0-III). Data was collected by graduate student Brinta Roy. 
  
180 
 
6.2.5.2 Septation defects in ark1-T11 double mutants 
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Figure 6.6: Double mutants of ESCRT deletions and ark1-T11 exhibit septation 
defects in fission yeast. 
Fission yeast with temperature-sensitive ark1 mutation ark1-T8 combined with 
individual ESCRT deletions were grown in rich liquid medium to mid-exponential 
phase and harvested. Cells were stained with Calcofluor white and visualised by 
fluorescence microscopy. The graph represents the frequency of phenotypes A-F 
among various single and double mutant strains (400 cells, n=3): (A) a normal 
septum, (B) a misaligned septum, (C) a non-perpendicular septum, (D) multiple septa, 
(E) no septal formation, and (F) failed separation of daughter cells following septation. 
Each of the ESCRT genes labels is accompanied by its respective ESCRT subunit (E-
0-III). Data was collected by graduate student Brinta Roy. 
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